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Summary 
The immune system combines potent humoral and cellular mechanisms fighting 
invading pathogens and infections. To prevent excessive inflammation and 
autoimmunity, immune responses are subject to extensive regulation on different levels 
of gene expression. Signaling via costimulatory receptors for example sets a threshold 
for T cell activation. Roquin-1 is an RNA-binding protein targeting the inducible 
costimulator (Icos) mRNA in T cells for post-transcriptional repression. The importance 
of Roquin-1 function for immune regulation became obvious in sanroque mice 
developing severe lupus-like autoimmune disease due to a single amino acid exchange 
in Roquin-1. A lack of Roquin-1 in T cells is compensated by its paralog Roquin-2, 
suggesting that Roquin-2 similarly represses mRNAs.  
In this thesis work, assays were established to identify additional mRNAs that are 
bound and regulated by Roquin proteins in T helper cells. Acute deletion of Roquin-
encoding genes in primary CD4+ T cells led to an upregulation of more than 50 
mRNAs. One newly identified target was the mRNA of the costimulator Ox40, being 
specifically bound and post-transcriptionally regulated by Roquin proteins via its 
3’UTR. To address the molecular requirements of Roquin-RNA interactions, I 
performed affinity-based selection experiments (SELEX) from a random RNA library 
and found a novel RNA sequence motif embedded in an RNA hexaloop to be 
preferentially bound by the Roquin-1 N-terminus. In collaboration with structural 
biologists we investigated the crystal structure of a protein-RNA complex that contains 
the RNA-binding ROQ domain and an RNA stem-loop structure from the Tnf 3’UTR, 
called constitutive decay element (CDE). The structure of this complex identified amino 
acids forming close RNA contacts and showed mainly non-sequence-specific protein-
RNA interactions via the phosphate backbone of the RNA stem. In cell-based reporter 
assays using Roquin-1 mutants, I proved that the ability to bind RNA is required for 
Roquin-mediated post-transcriptional regulation of Icos and Ox40. Furthermore, I 
analyzed the Ox40 3’UTR and identified a CDE-like triloop and a SELEX-like 
hexaloop as the two functional cis-elements through which Roquin-1 regulates Ox40 
expression. 
Taken together, my studies identified potential mRNA targets of Roquin in T helper 
cells and shed light on the molecular picture of Roquin-RNA interactions. Thereby, I 
could show that Roquin accepts a number of different cis-regulatory RNA elements, 
which are rather defined by structural than sequence requirements. My work contributes 
to the understanding of Roquin-mediated post-transcriptional gene regulation, 
underlying the prevention of excessive inflammation and autoimmunity. 
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Zusammenfassung 
Das Immunsystem vereint wirksame humorale und zelluläre Mechanismen zur 
Bekämpfung von Pathogenen und Infektionen. Um übermäßige Inflammation und 
Autoimmunität zu verhindern, unterliegen Immunantworten umfassender Regulation 
auf verschiedenen Ebenen der Genexpression. Signaltransduktion kostimulatorischer 
Rezeptoren erzeugt beispielsweise einen Schwellenwert für die T-Zell-Aktivierung. 
Roquin-1 ist ein RNA-bindendes Protein, das die mRNA des induzierbaren 
Kostimulators Icos auf post-transkriptioneller Ebene reprimiert. Die Bedeutung der 
Roquin-1 Funktion für Immunregulation zeigte sich deutlich in sanroque Mäusen, die 
aufgrund eines Aminosäureaustausches in Roquin-1 eine schwere Lupus-ähnliche 
Autoimmunerkrankung entwickeln. Das Fehlen von Roquin-1 in T-Zellen wird durch 
sein Paralog Roquin-2 kompensiert, was nahelegt, dass Roquin-2 ebenfalls mRNAs 
reprimiert.  
In dieser Dissertation wurden Experimente etabliert, um weitere mRNAs zu 
identifizieren, die von Roquin-Proteinen in T-Helfer-Zellen gebunden und reguliert 
werden. Akute Deletion der Roquin-kodierenden Gene in primären CD4+ T-Zellen 
führte zu einer Hochregulation von mehr als 50 mRNAs. Eines der neu identifizierten 
Zielmoleküle war die mRNA des Kostimulators Ox40, die über den 3’UTR von Roquin 
Proteinen spezifisch gebunden und post-transkriptionell reguliert wird. Um die 
molekularen Voraussetzungen der Roquin-RNA Interaktion zu adressieren, führte ich 
affinitätsbasierte Selektionsexperimente (SELEX) mit einer RNA Bibliothek mit 
zufälliger Nukleotidsequenz durch. Dabei identifizierte ich ein neuartiges, in eine 
Sechserschleife eingebettetes Sequenzmotiv, das vom Roquin-1 N-Terminus bevorzugt 
gebunden wird. In Zusammenarbeit mit Strukturbiologen untersuchten wir die 
Kristallstruktur eines Protein-RNA Komplexes bestehend aus der RNA-bindenden ROQ 
Domäne und einer RNA Haarnadelstruktur aus dem Tnf 3’UTR, die als „constitutive 
decay element“ (CDE) bezeichnet wird und eine Dreierschleife ausbildet. Die Struktur 
dieses Komplexes zeigte Aminosäuren auf, die in engem Kontakt zur RNA stehen und 
es stellte sich heraus, dass hauptsächlich sequenzunabhängige Protein/RNA 
Interaktionen über das Phosphat-Rückgrat der doppelsträngigen RNA-Abschnitte 
stattfinden. In zellbasierten Reporter-Experimenten wies ich unter der Verwendung von 
Roquin-1 Mutanten nach, dass die Fähigkeit RNA zu binden notwendig ist für die 
Roquin-vermittelte post-transkriptionelle Regulation von Icos und Ox40. Darüberhinaus 
analysierte ich den Ox40 3’UTR und identifizierte eine CDE-ähnliche und eine SELEX-
ähnliche Haarnadelstruktur als die zwei funktionellen cis-Elemente, über die Roquin-1 
Ox40 reguliert.  
6   Zusammenfassung  
Zusammengefasst identifizierten meine Untersuchungen potentielle Ziel-mRNAs in T-
Helfer-Zellen und gaben Aufschluss über die molekulare Gestalt von Roquin-RNA 
Interaktionen. Dabei konnte ich zeigen, dass Roquin eine Anzahl verschiedener cis-
regulatorischer RNA Elemente akzeptiert, die sich eher über strukturelle als 
sequenzabhängige Bedingungen definieren. Meine Arbeit leistet einen Beitrag zum 
Verständnis der Roquin-vermittelten post-transkriptionellen Genregulation, welche der 
Verhinderung übermäßiger Inflammation und Autoimmunität zugrunde liegt. 
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  T	  helper	  cell	  
TGF	   Transforming	  growth	  factor	  
Th1	  cell	   Type	  1	  T	  helper	  cell	  
TIA-­‐1	   T-­‐cell-­‐restricted	  intracellular	  antigen	  1	  
TIAR	   TIA-­‐1-­‐related	  protein	  
TLR	   Toll-­‐like	  receptor	  
Tnf	   Tumor	  necrosis	  factor	  
TRAF	   Tnf	  receptor	  associated	  factor	  
Treg	   Regulatory	  T	  cell	  
tRNA	   Transfer	  RNA	  
TTP	   Tristetraprolin	  
UTR	   Untranslated	  region	  
UV	   Ultraviolet	  
WH	   Winged-­‐helix	  
WT	   Wild-­‐type	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1 Introduction 
1.1 The immune system 
Throughout its lifetime every organism is in close contact with foreign structures and 
molecules, which may be harmless as parts of nutrition or threatening as infectious 
agents. The natural barriers of an organism are specialized for selective exchange with 
the outside world. In addition, plants and animals evolved an innate immune system 
mounting rapid responses (within hours) against invading pathogens based on the 
recognition of pathogen-associated molecular patterns (PAMPs) (Ausubel 2005). In 
animals this is accomplished by innate immune cells or by the complement system 
(Murphy et al. 2008). The complement system is constituted of preformed proteins 
circulating in the blood to be activated in a cascade of proteolytic cleavage resulting in 
pathogen opsonization, chemotaxis and cell lysis. In contrast, tissue-resident innate 
immune cells such as macrophages and dendritic cells carry a number of different 
receptors, termed pattern recognition receptors (PRRs), to identify invading pathogens 
by surface structures and molecules distinguishable from the organism’s own repertoire 
(Janeway & Medzhitov 2002). Toll-like receptors (TLRs) are a group of PRRs and they 
recognize for example bacterial cell wall components like LPS (lipopolysaccharide) or 
double-stranded viral RNA (ribonucleic acid). Upon binding TLRs trigger signaling 
pathways that lead to the activation of innate immune cells and secretion of immune 
stimulatory molecules. This promotes phagocytosis of the recognized microbe by 
macrophages and recruitment of neutrophil granulocytes, which are also potent 
phagocytes. 
However, pathogens have developed mechanisms to evade this first line of host defense. 
Therefore, a second line of defense, the adaptive immune system, evolved in jawed fish 
and higher vertebrates (Murphy et al. 2008). The characteristics distinguishing the 
adaptive from the innate immune system are the generation of specific receptors to 
detect the invading pathogen and the establishment of memory cells to be protected 
against re-infection with the same pathogen. In contrast to PRRs that are inherited via 
the germ-line, receptors of the adaptive immune system (namely B and T cell receptors) 
are encoded by various gene segments that undergo somatic rearrangement during cell 
maturation. This process is known as V(D)J recombination. Different variable (V), 
diversity (D) and joining (J) gene segments are joined together by the lymphocyte-
specific RAG (recombination-activating gene) proteins (Grawunder et al. 1998). This 
somatic recombination occurs independently in individual lymphocytes and brings 
about a polyclonal receptor repertoire of 1013-1018 mainly through combinatorial and 
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junctional diversity. The abundance of one receptor specific for a certain pathogen is 
increased by clonal expansion of the respective cell clone within 4 to 5 days (Murphy et 
al. 2008). Instead of PAMPs, receptors of the adaptive immune system recognize 
antigens, consisting of protein and polysaccharide and rarely also of lipid structures. 
Yet, the specifically bound epitope is only a small part of the antigen. On the one hand, 
this allows the discrimination between closely related antigens, resulting in very 
specific immune responses. On the other hand, because of the merely molecular 
restrictions, epitopes can be derived from harmless foreign or self-molecules, involving 
the danger of inappropriate immune activation. 
The cell types representing the adaptive immunity are T and B lymphocytes developing 
from common lymphoid progenitor cells within the bone marrow. Whereas B cells 
undergo further maturation in the bone marrow, T cell precursors migrate to the thymus 
where final maturation takes place. Like the innate immune system, the adaptive 
immunity is composed of a cellular and a humoral arm, the latter being provided by B 
cells that produce antibodies, also known as immunoglobulins, after differentiation into 
plasma cells. Antibodies, as the secreted form of the B cell receptor, exhibit a broad 
range of antigen specificities allowing them to potently bind pathogens or toxins within 
the extracellular space. On the molecular level they possess a variable region for 
specific epitope binding and a constant region by which they are recognized themselves. 
Thus, they tackle foreign structures and at the same time recruit other innate immune 
cells or activate the complement system. Hence, immunoglobulins are one example for 
the interaction between adaptive and innate immunity. After class switch and affinity 
maturation, antibody binding to epitopes can achieve a remarkably high affinity (lower 
nanomolar to picomolar range) (Estep et al. 2013), which in part explains their potency 
in fighting infections and re-infections. In mammals, the importance of antibodies is 
further underlined by the fact that maternal immunoglobulins are transferred to the 
developing fetus via the placenta. These antibodies remain in the organism for several 
weeks after birth and thereby provide protection against infections. The cellular arm of 
adaptive immunity is conferred by different T cell subsets, which either induce 
apoptosis in infected cells or stimulate other immune cells through secretion of 
cytokines. Despite its importance for the integrity of higher organisms, the adaptive 
immunity does not act independently but depends on antigen presentation and 
stimulatory signals provided by cells of the innate immunity. 
 
1.1.1 T cell immunity 
T lymphocytes obtained their name from the dependency on the thymus during 
development (Murphy et al. 2008). The thymus is colonized by T cell precursors from 
the bone marrow, which undergo differentiation, proliferation and maturation steps. 
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Different stages of this development are defined by the presence of the rearranged T cell 
receptor (TCR) chains in the context of the cluster of differentiation (CD) 3 TCR 
complex and expression of the co-receptor molecules CD4 and CD8. Following the 
double-negative (CD4- CD8-) state, thymocytes with a successful rearrangement of TCR 
α and β chains reach the double-positive (CD4+ CD8+) state. During the subsequent 
maturation steps, expression of one co-receptor is lost, finally resulting in single-
positive (CD4+ or CD8+) αβ T cells. Only a small portion of thymocytes rearranges the 
TCR γ and δ chains and develops into γδ T cells (Murphy et al. 2008). 
Apart from T cell maturation and differentiation, the thymus also provides space for 
important selection procedures. Since peripheral antigen presentation to T cells is 
performed within the context of MHC (Major histocompatibility complex) molecules on 
the surface of antigen presenting cells (APCs), these molecules have to be recognized 
by T cells. Therefore, TCR rearrangement is followed by positive selection of TCRs 
that are able to recognize self-MHC molecules. Interestingly, T cells recognizing 
predominantly MHC I (class 1) molecules will maintain the expression of CD8, whereas 
specificity for MHC II (class 2) is accompanied by CD4 expression. The second 
selection step is termed negative selection and is based on the expression of ubiquitous 
proteins of the organism by specialized thymic stromal cells and bone marrow-derived 
antigen presenting cells. These cells process the proteins and present them as antigen on 
MHC molecules to identify self-reactive T cells. Strong TCR signaling in this process 
causes the elimination of the respective T cell clone, whereas weak TCR signaling in 
response to stimulation with self-antigen leads to the development of thymic regulatory 
T cells (Tregs) (Josefowicz et al. 2012). Tregs are a subset of T cells that suppresses 
immune responses of other cells. In total, only 3% of the double-positive thymocytes 
pass both the positive and the negative selection procedure and are released into the 
periphery (Shortman et al. 1990; Murphy et al. 2008). Thus, the thymus is the important 
organ to shape the peripheral TCR repertoire and to establish self-tolerance. However, 
some autoreactive T cells recognizing tissue-specific antigens escape the process of 
negative selection. To prevent autoimmunity, these T cells must be kept in check by 
mechanisms of peripheral tolerance. Deletion, anergy or exhaustion of self-reactive T 
cells, the dependency on different co-occurring signals for T cell activation or 
suppression by Tregs are examples of how self-tolerance can be achieved in the 
periphery (Srinivasan & Frauwirth 2009). 
According to the expression of the co-receptors CD4 and CD8, T cells exhibit different 
effector functions. CD8+ T cells are termed cytotoxic T lymphocytes (CTLs), because 
they induce apoptosis in virus-infected or dysfunctional somatic cells. In contrast, CD4+ 
T cells, also known as T helper cells, produce cytokines and thereby shape immune 
reactions and support other immune cells in their function. After leaving the thymus, T 
cells are predominantly located in secondary lymphoid organs (spleen and lymph 
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nodes), where they are in a naïve state. This naïve state is defined by high CD62L (L-
selectin) expression and low expression of CD44. CD62L is a lymphoid tissue homing 
receptor, which is downregulated upon T cell activation (Camerini et al. 1989). On the 
other hand, CD44 is a marker for activated T cells with an effector-memory phenotype 
and plays a role in lymphocyte extravasation (DeGrendele, Kosfiszer, et al. 1997; 
DeGrendele, Estess, et al. 1997). High expression of both surface markers characterizes 
central-memory T cells. Naïve T cells become productively activated in secondary 
lymphoid organs by APCs with antigen-loaded MHC molecules stimulating the cognate 
TCRs. Effective T cell activation requires simultaneous costimulatory signaling and 
results in clonal expansion and differentiation into effector T cells. 
 
1.1.1.1 T helper cell differentiation 
The cytokine environment during T cell activation triggers the differentiation of T 
helper cells into different subsets that are defined by the expression of specific 
transcription factors and effector functions (Figure 1). The major T helper cell subtypes 
are Th1, Th2 and Th17 cells as well as induced Tregs (iTregs) (Nakayamada et al. 2012; 
Yamane & Paul 2013). Th1 cell differentiation is triggered by interleukin (IL)-12 and 
marked by expression of the transcription factor T-bet. Secreting interferon (IFN)-γ, 
Th1 cells are important in immune responses against intracellular bacteria and protozoa 
and they can be the driving force in autoimmune diseases. In contrast, Th2 cells 
stimulate humoral immunity against extracellular pathogens such as parasites and can 
cause allergy and asthma. Th2 cell differentiation is dependent on IL-4 stimulation and 
results in the expression of the transcription factor Gata3 and the production of IL-4,  
IL-5 and IL-13. Another T helper cell subset has been named Th17 due to its production 
of IL-17A and IL-17F and is involved in fighting extracellular bacterial and fungal 
infections. However, Th17 cells are also involved in the development of autoimmunity. 
Expression of Rorγt and the presence of transforming growth factor (TGF)-β, IL-6,    
IL-21 and IL-23 drive Th17 differentiation. Thymic as well as induced Tregs are 
defined by expression of the forkhead transcription factor FoxP3, and the differentiation 
of iTregs in the periphery requires TGF-β in combination with IL-2. Tregs suppress 
immune responses and maintain peripheral tolerance by production of inhibitory 
cytokines such as IL-10 and TGF-β. 
In addition, follicular T helper (Tfh) cells were suggested as separate T helper cell 
subset due to their specific localization at the periphery of B cell follicles in secondary 
lymphoid organs (Crotty 2011). There, Tfh cells provide stimulatory signals to germinal 
center (GC) B cells by cytokine secretion and via CD40 and thereby support high-
affinity antibody production. Differentiation of Tfh cells is driven by the expression of 
the transcription factor Bcl-6 and characterized by IL-21 secretion (Nurieva et al. 2009; 
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Johnston et al. 2009; Yu et al. 2009; Spolski & Leonard 2010). Interestingly, Tfh cells 
exhibit a substantial functional overlap with other T helper cell subsets in terms of 
cytokine production and transcription factor expression, and Tfh cells keep a 
considerable plasticity in response to different cytokine milieus (Lu Kanno 2011, 
Cannons 2013). 
 
 
Figure 1: Schematic representation of T helper cell differentiation and plasticity. TCR stimulation 
via antigen-loaded MHC II together with costimulatory signaling activates naïve CD4+ T cells and pro-
motes differentiation into T helper cell subsets depending on cytokine milieu. Differentiated T helper 
cells express specific transcription factors (shown in the nuclei) and produce cytokines. Dashed arrows 
indicate possible ways of T helper cell reprogramming and plasticity. The scheme was drawn on the basis 
of Yamane & Paul 2013 and Nakayamada et al. 2012. 
 
Plasticity between T helper cell subsets was also described for Th1, Th2, Th17 cells and 
iTregs. Fully differentiated Th2 cells were reprogrammed to exhibit a Th1 phenotype 
(expression of T-bet and IFN-γ) by an in vivo virus infection model that drives Th1-type 
immune responses (Hegazy et al. 2010). Similarly, in the absence of TGF-β, committed 
Th17 cells suppressed IL-17 production and expressed the Th1 cytokine IFN-γ and      
T-bet (Lee et al. 2009). Moreover, the principle of one subset-defining transcription 
factor was challenged by the finding that Tregs express T-bet or Gata3 in addition to 
FoxP3 (Koch et al. 2009; Wohlfert et al. 2011). The current concept assumes that 
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additional transcription factors guide Treg functions required in specific inflammatory 
settings. 
Another factor influencing the outcome of T helper cell activation is the strength and 
duration of the TCR stimulus. Already in 1995 it was published that high antigen doses 
induced Th1 differentiation in primary cultures of TCR-transgenic CD4+ T cells, while 
the same cells underwent Th2 differentiation in response to low doses of antigen 
(Constant et al. 1995; Hosken et al. 1995). Experiments measuring the interaction-time 
of T cells and dendritic cells now revealed that Th1 differentiation requires long-term 
interaction, which was achieved by higher antigen concentrations (van Panhuys et al. 
2014). In contrast, lower antigen concentrations resulted in shorter interaction duration 
and Th2 differentiation. Furthermore, differentiation of iTregs seems to be 
preferentially induced by low doses of high-affinity antigenic peptides or by weak 
costimulatory signaling (Gottschalk et al. 2010; Josefowicz et al. 2012).  
Hence, the impact of the cytokine environment, TCR signaling strength or costimulation 
on T helper cell differentiation and effector phenotypes has been studied intensively and 
revealed interesting concepts. However, due to the diversity of influencing parameters, 
the challenge remains to investigate and integrate single contributions in order to better 
understand this central process in T-cell-mediated immunity. 
 
1.1.1.2 Costimulatory receptors on T helper cells 
The importance of costimulatory signaling during T helper cell activation was 
acknowledged by the ‘two-signal model’, which was proposed for the first time in 1975 
and further specified afterwards (Lafferty & Cunningham 1975). The two-signal model 
describes that T cell activation is dependent on antigen presentation within the context 
of MHC molecules as first signal and costimulation via CD28 as second signal. By now, 
a number of co-receptors providing stimulatory and inhibitory signals and regulating all 
phases of T cell activation has been identified (Figure 2) (Chen & Flies 2013). 
The most prominent costimulatory receptor of T cell activation is CD28, being 
constitutively expressed on naïve T cells. While the TCR-CD3 complex is stimulated by 
MHC II bound antigen, B7-1 and B7-2 (CD80 and CD86) on the respective APC bind 
to CD28. This is crucial for the initiation of most T cell responses, since CD28 signaling 
induces transcription of IL-2 and expression of CD25, the IL-2 receptor alpha chain, 
thereby rendering the cells responsive to IL-2-mediated proliferative signals. CD28 is 
expressed from a gene cluster on the mouse chromosome 1 together with the cytotoxic 
T lymphocyte antigen (Ctla) 4 and the Inducible costimulator (Icos), suggesting that 
these genes were derived from gene duplication (Carreno & Collins 2002; Ling et al. 
2001). The sequence identity on the amino acid level between CD28, Ctla4 and Icos is 
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around 30%. In contrast to CD28, which is present on naïve T cells, Icos expression is 
only induced upon T cell activation. Interestingly, Icos-induced cytokine expression is 
of disparate importance for different T helper cell subsets. Whereas Th2 and Th17 
cytokine expression (Il-4 and IL-17 respectively) is reduced in Icos-/- CD4+ T cells, 
IFN-γ levels are increased, suggesting a bias towards Th1 differentiation (Park et al. 
2005; Tafuri et al. 2001; Dong et al. 2001; McAdam et al. 2001). Moreover, Tfh cell 
differentiation is absent in Icos-deficient mice, indicating a dependency on Icos 
costimulatory signals (Akiba et al. 2005). Unlike CD28 and Icos, Ctla4 provides an 
inhibitory signal to T cells. Ctla4 is expressed on the cell surface during the late phase 
of T cell activation and in Tregs. By trans-endocytosis it removes B7 ligands from the 
surface of APCs and thereby antagonizes stimulation via CD28 (Qureshi et al. 2011). In 
addition, the competition of Ctla4 and CD28 for B7 ligands reduces CD28 signaling. 
Other closely related co-receptors providing inhibitory signals to activated T cells are 
programmed cell death (PD)-1 and B and T lymphocyte attenuator (Btla). Like Icos, 
PD-1 and Btla are highly expressed on Tfh cells (Crotty 2011), and PD-1 together with 
CXCR5 serves as surface marker to identify Tfh cells among CD4+ T cells. 
The tumor necrosis factor receptor super family (Tnfrsf) is another group of receptors 
on T cells that provide costimulatory signals (Figure 2 upper half). The most 
prominent member of this family in terms of T helper cell costimulation is Tnfrsf4, also 
known as Ox40. Like Icos, Ox40 is not expressed on naïve T cells, but it is induced 
within 24 hours upon T cell activation with a peak after 48 hours and subsequent 
decline between 72 and 96 hours (Gramaglia et al. 1998). Mice with transgenic 
overexpression of Ox40 ligand (Ox40L) on dendritic cells exhibit accumulation of 
CD4+ T cells in B cell follicles (Brocker et al. 1999). In line with this, high Ox40 levels 
were observed on Tfh cells, indicating an impact of Ox40 signaling on Tfh 
differentiation and function even though it is not required for germinal center formation 
(Crotty 2011; Kopf et al. 1999). Ox40 stimulation results in increased cytokine 
production as well as survival due to an upregulation of anti-apoptotic factors. 
Moreover, Ox40 stimulates proliferation of T cells, particularly during memory 
formation. This is underlined by the finding that antigen-specific memory T cells are 
strongly reduced in Ox40-/- mice (Gramaglia et al. 2000). Studies, in which interrupting 
the Ox40-Ox40L interaction ameliorated autoimmunity or inflammatory responses, 
emphasize the pathogenic potential of Ox40 costimulation (Watts 2005). 
Other members of the Tnfrsf promoting T helper cell survival and cytokine production 
are CD30 (Tnfrsf8), 4-1BB (Tnfrsf9), CD27 (Tnfrsf7), GITR (Tnfrsf18), DR3 
(Tnfrsf25) and Hvem (Tnfrsf14) (Watts 2005; Chen & Flies 2013). CD30, 4-1BB and 
DR3 exhibit similar expression kinetics like Ox40, whereas CD27 and GITR are 
expressed on naïve cells and further induced upon T cell activation. However, CD27 is 
downregulated on effector T cells and Hvem levels are reduced in response to T cell 
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activation. Furthermore, activated T cells upregulate CD40L (Tnfsf5), the ligand of 
CD40 (Tnfrsf5), which is mainly expressed on B cells, dendritic cells and macrophages. 
Thereby, T cells provide costimulatory signals to APCs and further increase the level of 
immune activation. 
 
 
Figure 2: Overview of costimulatory receptors on T helper cells and their corresponding ligands on 
antigen presenting cells. The upper half shows receptors of the Tnf receptor super family, whereas the 
lower half shows receptors of the CD28 type. Pink color indicates inhibitory and black color stimulatory 
signals. The Figure was developed based on Chen & Flies 2013 and Watts 2005. 
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Signaling of Tnfrsf members involves trimerization of ligand and receptor and 
interaction with different Tnf receptor associated factor (TRAF) adaptor proteins 
(Figure 3) (Chen & Flies 2013; Watts 2005). Ox40 and CD27 recruit TRAF2, 3 and 5, 
4-1BB was found to be associated with TRAF1, 2 and 3 and CD30 signaling uses 
TRAF1, 2, 3 and 5, yet the precise connection between these adapter proteins and 
downstream effectors is largely unknown. A common feature of most Tnfrsf members is 
the activation of both the canonical and the non-canonical NF-κB pathway, resulting in 
enhanced T cell survival and reduced apoptosis due to increased anti-apoptotic factors 
(Bcl-2, Bcl-XL and Bcl2a1). In addition, the mitogen-activated protein (MAP) kinases 
JNK (c-Jun N-terminal kinases), p38 and ERK (extracellular signal-regulated kinases) 
are targeted by Tnfrsf signaling. Via the phosphatidylinositol 3-kinase (PI3K) AKT 
pathway, activation of further downstream effectors, namely activator protein 1 (AP1), 
mammalian target of rapamycin (mTOR) and nuclear factor of activated T cells 
(NFAT), is achieved. These factors are also activated by TCR signaling, which suggests 
a synergistic effect resulting in increased cytokine production and cell cycle progression 
of activated T cells. Moreover, Tnfrsf interactions with the respective ligands also 
induce APCs to proliferate and express cytokines, which amplifies the immune 
response. Thus, costimulation via members of the Tnfrsf on the one hand controls the 
size of the effector T helper cell population through proliferation and survival signals 
and on the other hand controls the effector functions of these T helper cells by 
supporting cytokine production. 
Interestingly, CD28 and Icos partially trigger the same pathways as the Tnfrsf (Figure 
3). Stimulation of PI3K will activate AKT and its numerous downstream effectors such 
as NFAT, mTOR, AP1/2 and NF-κB. Thereby, CD28 and Icos likewise promote 
proliferation and survival of T helper cells. The inhibitory members of the CD28 family 
of co-receptors, Ctla4 and PD-1, are supposed to target the same key players, however 
the extent of their signaling potential remains elusive. The complex interplay of these 
numerous costimulatory receptors within separate and convergent signaling pathways 
supposedly allows precise T helper cell activation and differentiation and prevents 
inappropriate or prolonged T helper cell immune responses. 
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Figure 3: T helper cell signaling pathways involved in costimulation. CD28 type receptors and Tnf 
receptor super family members use different and convergent pathways to provide costimulatory signals, 
resulting in activation of the same set of downstream factors in the nucleus (shown in yellow). Dashed red 
lines indicate inhibitory signals. The scheme was developed based on Chen & Flies, 2013. 
 
1.1.2 Peripheral tolerance and autoimmunity 
At the beginning of the twentieth century, the immunologist Paul Ehrlich coined the 
term ‘horror autotoxicus’ (Chang 2014). This described a concept according to which 
autoreactive immune responses are not possible due to the fatal consequences they 
would have on an individual. Later on, Paul Ehrlich modified his point of view by 
admitting that self-reactive immunity is possible but suppressed immediately by 
protective mechanisms of the immune system. Today, some of the mechanisms 
preventing immune reactions against self-antigens and their failure, leading to diverse 
manifestations of autoimmunity, are examined in detail.  
In the periphery, autoreactive T cell clones encountering their cognate antigen presented 
by MHC molecules are often not properly activated due to a lack of costimulation in a 
non-inflammatory environment. Furthermore, self-antigens usually cannot be removed 
by cells of the innate immune system, which leads to chronic TCR stimulation. Both 
situations bring about T cell anergy, the temporary unresponsiveness of a T cell to 
signals promoting proliferation, differentiation and cytokine production. The 
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importance of the TCR signaling strength in preventing autoimmunity was 
demonstrated in a study with autoreactive TCR-transgenic mice (Olasz et al. 2012). 
Only a particular TCR signal strength induced T-cell-dependent, antibody-mediated 
autoimmune arthritis, whereas stronger TCR signaling resulted in increased apoptosis of 
self-reactive T cells. The suppressive capacity of Treg cells is another mechanism 
counteracting self-reactive immune responses. This is impressively displayed in mice 
and humans lacking Tregs due to mutations of the transcription factor FoxP3 (Bennett et 
al. 2001; Brunkow et al. 2001). The scurfy mouse and the IPEX (immune dysregulation, 
polyendocrinopathy, enteropathy, X-linked) syndrome in humans are characterized by 
severe immune dysregulation and systemic autoimmunity attacking all endocrine 
organs. Interestingly, genomic deletion of the costimulatory molecules Ox40 and CD30 
in combination with FoxP3 deficiency completely abrogated this systemic autoimmune 
disease in mice (Gaspal et al. 2011). Therefore, it is assumed that excessive 
costimulation of T cells, resulting in increased proliferation, cytokine expression, 
inflammation, B cell help and thus antibody production, can promote autoimmunity. 
In line with this, blocking Ox40 signaling ameliorated different autoimmune diseases in 
mice such as collagen-induced arthritis (Yoshioka et al. 2000), chronic colitis (Higgins 
et al. 1999; Totsuka et al. 2003) and autoimmune diabetes (Martin-Orozco et al. 2003). 
Moreover, experimentally induced autoimmune encephalomyelitis (EAE), resembling 
the human autoimmune disease multiple sclerosis, was dependent on Ox40 signaling 
and preventing the Ox40-Ox40L interaction reduced disease parameters (Weinberg et 
al. 1999; Ndhlovu et al. 2001; Nohara et al. 2001). Conversely, mice expressing an 
Ox40L transgene causing constitutive Ox40 signaling developed autoimmunity marked 
by inflammatory bowel disease and anti-DNA antibodies (Murata et al. 2002). Other 
members of the Tnfrsf with costimulatory properties were equally investigated in 
models for autoimmune diseases. For example, DR3-/- mice or injection of a neutralizing 
antibody targeting its receptor TL1A showed strongly reduced disease symptoms of 
EAE, colitis and arthritis (Bull et al. 2008; Meylan et al. 2008; Takedatsu et al. 2008). 
Systemic autoimmunity accompanied by excessive T cell activation and anti-nuclear 
autoantibodies was also observed in the so-called sanroque mice (Vinuesa et al. 2005). 
These mice express a mutated form of the Roquin-1 protein, which will be introduced in 
detail in 1.3, resulting in an upregulation of the costimulatory receptor Icos (Yu et al. 
2007). Accordingly, Icos levels were reduced introducing a heterozygous Icos+/-
background, but this only ameliorated the phenotype of the sanroque mice. 
Nevertheless, this finding suggested substantial contribution of excessive Icos signaling 
to the development of autoimmunity. 
Despite potent tools to regulate adaptive immune responses, T cell activation and 
peripheral tolerance to self-antigens, these mechanisms can fail leading to inappropriate 
immune reactions against tissues of the own body. The etiology of autoimmune diseases 
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is not clear, however environmental factors and a genetic predisposition, mainly based 
on certain MHC molecules, are among the known risk factors. Treatment is generally 
performed by immunosuppressive medication and only few drugs directly target 
mediators of inflammation. One example are neutralizing monoclonal anti-TNF 
antibodies used in the therapy of rheumatoid arthritis and colitis (Lippert et al. 2014; 
Patel & Moreland 2010; Lapadula et al. 2014). Clearly, a deeper understanding of 
immune regulation in health and disease is required and desired to establish targeted 
therapeutic approaches. 
 
1.2 Post-transcriptional gene regulation 
For the last decades, gene regulation on the level of transcription through activators, 
repressors and epigenetic modifications has been studied intensively to examine 
regulatory networks. The increasing awareness of the abundance and variety of RNA 
molecules raised the interest in regulatory processes on the messenger RNA (mRNA) 
level. Upon gene transcription, pre-mRNAs are processed by addition of a                    
7-methylguanosine structure as 5’ cap and by 3’ polyadenylation both increasing the 
stability of the mRNA molecule. Furthermore, splicing events remove intronic 
sequences and thereby define the final mRNA sequence. A mature mRNA usually 
contains a 5’ untranslated region (UTR), the coding sequence (CDS) determining the 
amino acid sequence of the encoded protein, a 3’UTR and the poly(A)-tail. After the 
processing steps, mRNAs are exported from the nucleus to the cytoplasm, where they 
are exposed to a comprehensive network of regulatory mechanisms targeting mRNA 
translation and stability. 
 
1.2.1 Processes targeted during post-transcriptional regulation 
Without changing the number of mRNA molecules, factors that target translation have a 
strong impact on the abundance of the encoded protein. Thereby, different steps of 
translation are found under the control of post-transcriptional regulators, namely the 
initiation, the elongation of the polypeptide chain and the termination. 
To start translation, eukaryotic initiation factors (eIFs) bind to the 5’cap and 5’UTR of 
mRNAs and recruit the ribosomal subunits. Concurrently, the cap-binding eIF4F 
complex protects the mRNA from decapping and interacts with the poly(A)-binding 
protein (PABP) resulting in a circularization of the mRNA (Figure 4). During 
translation, eukaryotic elongation factors (eEFs) mediate transfer RNA (tRNA) 
positioning and catalyze the translocation of the tRNA and mRNA within the ribosome, 
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thereby promoting the synthesis of the polypeptide chain. Ribosomal pausing describes 
a queuing or stacking of ribosomes that interrupts translation progression and therefore 
has an influence on the overall translation rate of a certain protein. Finally, the 
termination of translation involves the eukaryotic release factor 1 (eRF1), which 
recognizes stop codons and promotes the release of the nascent protein. 
Different methods can be applied to globally investigate translation in cells. Polysome 
profiling uses sucrose gradient centrifugation to separate the monosomal fractions of a 
cell lysate from the polysomal fractions. Accordingly, mRNAs contained in these 
fractions were strongly (polysomes) or weakly (monosomes) translated within the cell. 
The advances of high-throughput sequencing gave rise to a new approach termed 
ribosome profiling. Here, the ribosome occupancy of mRNAs is determined by 
sequencing RNA fragments, which were protected against nuclease degradation through 
the binding of ribosomes (Ingolia et al. 2009). Reduced numbers of ribosome-protected 
fragments or the accumulation of ribosomes at certain positions of the mRNA thereby 
indicate ongoing translational control.  
Apart from translational control, a major impact on the expression of proteins is given 
by mRNA turnover. Stability of mRNAs is influenced by binding of stabilizing or 
destabilizing proteins to the 3’UTR that recruit or reject factors of the mRNA decay 
pathways. In general, removal of the poly(A)-tail initiates the degradation of mRNAs 
and is followed by two distinct pathways (Figure 4), one targeting the 5’cap followed 
by 5’ to 3’ degradation and the other marked by 3’ to 5’ nuclease activity (Garneau et 
al. 2007). Inhibition of either one of these degradation processes did not result in 
prominent changes of the transcriptome, indicating a certain redundancy between both 
pathways (He et al. 2003; Houalla et al. 2006). Initial shortening of the mRNA poly(A)-
tail is performed by the PABP-dependent PAN2-PAN3 nuclease, resulting in PABP 
removal and thus in the disruption of the stabilizing eIF4F-PABP interaction. Complete 
deadenylation is subsequently promoted by the Ccr4-Not protein complex, with Ccr4 
and Caf1 exhibiting exonuclease activity (Temme et al. 2004). 3’ to 5’ decay of 
deadenylated mRNAs is performed by the exosome, another protein complex with core 
subunits functioning as RNases. The final step of 3’ to 5’ degradation is the removal of 
the 5’cap by the scavenger decapping enzyme DcpS. On the other hand, the 
deadenylated 3’ end of an mRNA can be bound by the heptameric complex of Sm-like 
proteins (Lsm) 1 to 7 (Tharun et al. 2000). The Lsm1-7 complex together with other 
factors, such as enhancers of decapping (Edc proteins) and the RNA helicase Rck, is 
required to efficiently promote decapping of the mRNA. Thereby, the dimeric 
decapping enzyme Dcp1 Dcp2 is recruited to the 5’ end of the mRNA and removes the 
7-methylguanosine structure. Subsequently, 5’ to 3’ degradation is performed by the 
exoribonuclease Xrn1. While the majority of mRNAs is degraded via the described 
pathways, there are also examples of decapping initiated through deadenylation-
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independent mechanisms (Garneau et al. 2007). Furthermore, mRNAs can be targeted 
by endonucleolytic cleavage, which is followed by rapid 5’ to 3’ and 3’ to 5’ 
degradation starting from the cleavage site. 
 
 
Figure 4: Scheme of mRNA degradation pathways. During translation, the mRNA 5’cap is bound by 
initiation factors (e.g. eIF4F) contacting the poly(A)-binding protein (PABP) at the 3’ end for 
circularization. Deadenylation of the mRNA removes the PABP and is performed by the Ccr4-Not 
complex with Ccr4 and Caf1 as enzymatically active subunits. Deadenylation can be followed by 
exosomal 3’ to 5’ degradation and subsequent DcpS decapping (left side). Deadenylated mRNA can also 
be bound by Lsm1-7, the RNA helicase Rck and enhancers of decapping (Edc) to promote Dcp1/2 
decapping and subsequent Xrn1-mediated 5’ to 3’ degradation. 
 
Within the cytoplasm, mRNA storage and turnover takes place in distinct granular 
structures, called processing (P) bodies, which were identified due to the accumulation 
of proteins and enzymes involved in 3’UTR binding, mRNA decay and miRNA-
induced mRNA silencing (Eulalio et al. 2007). P bodies are no pre-defined structures, 
but their formation depends on the amount of RNA to be degraded and on the presence 
of early decay factors. Upon cellular stress, a similar kind of foci, called stress granules, 
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can be induced. In contrast to P bodies, stress granules are mainly involved in mRNA 
storage during cellular stress, presumably to protect mRNA from toxic or highly 
reactive agents in the cytoplasm. Aggregation of the 3’UTR-binding protein TIA-1      
(T cell-restricted intracellular antigen 1) is used as marker for stress granule formation 
(Kedersha et al. 1999; Kedersha et al. 2000). Proteins that colocalize at sites of stress 
granules or P bodies are assumed to be likewise involved in 3’UTR binding or mRNA 
decay. RNAs within P bodies and stress granules can be released and redirected to the 
translational machinery underlining the dynamic storage function of these structures 
(Brengues et al. 2005; Kedersha et al. 2000). 
 
1.2.2 Mediators of post-transcriptional gene regulation 
The concept of trans-acting factors and cis-regulatory elements introduced for 
transcriptional regulation has also been implemented in post-transcriptional gene 
regulation. Thereby, a cis-regulatory element is a certain sequence or structure of an 
mRNA that mediates regulatory processes targeting the same mRNA molecule (cis-
acting). Accordingly, a trans-acting factor is a molecule promoting regulation of a 
target molecule. In terms of post-transcriptional regulation trans-acting factors can be 
RNA-binding proteins (RBPs), or microRNAs (miRNAs) and other non-coding RNAs 
that influence mRNA translation or stability in trans. 
 
1.2.2.1 Cis-regulatory RNA elements 
Target elements of post-transcriptional gene regulation are predominantly located in the 
UTRs of mRNAs. Whereas translation factors often bind to the 5’UTR, the great 
majority of miRNA binding sites and cis-elements for RBPs can be found in the 3’UTR 
(Matoulkova et al. 2012). miRNA binding sites are a class of cis-elements that has been 
intensively investigated in the context of computational miRNA target site prediction. 
This study focuses on RBPs and cis-regulatory elements involving sequence and 
structure requirements. Therefore, miRNA binding sites, which are clearly dependent on 
the sequence of the trans-acting miRNA, will not be discussed in detail. 
The most prominent target sequences of post-transcriptional regulation in mammalian 
cells are AU-rich elements (AREs). This heterogeneous group of sequences is 
characterized by a high uridylate content interspersed with adenine residues and the 
presence of the AUUUA pentamer sequence, occurring in variable numbers of repeats 
(Matoulkova et al. 2012). The function of AREs was first described for the short-lived 
mRNAs of cytokines (such as Tnf and Il6) and proto-oncogenes (such as Myc and Fos) 
and involves the direct binding of proteins that mostly recruit mRNA decay factors 
32   Introduction  
(Chen & Shyu 1995). Thereby, protein expression is kept at low levels but can be 
upregulated quickly by interrupting ARE-mediated mRNA decay. In line with this, 
removal of an ARE from the Tnf 3’UTR abrogated mRNA decay and increased mRNA 
and protein levels (Kontoyiannis et al. 1999). By computational approaches, the ARE 
database (ARED) identified ARE sites within human and murine transcripts, suggesting 
about 10% of human and at least 5% of murine genes to harbor AREs within their 
3’UTR (Halees et al. 2008). A variant of AREs are GU-rich elements, sharing the 
presence of a pentamer core sequence (GUUUG) and the functional involvement in 
mRNA destabilization (Matoulkova et al. 2012). 
Other RNA elements are rather defined by a certain secondary structure than a 
nucleotide sequence. One example is a hairpin structure at the 3’ end of histone mRNAs 
that serves as stabilizing element instead of a poly(A)-tail and plays a role for 
translation efficiency (Williams & Marzluff 1995). Distinct sequence and structural 
properties of some cis-regulatory elements were investigated in detail. In Drosophila 
embryogenesis anterior-posterior patterning involves tight spatial control of Nanos 
protein expression, which is achieved by translational regulation of the nanos mRNA 
(Dahanukar & Wharton 1996). The nanos 3’UTR translation control element (TCE) 
was reported to contain two distinct stem-loop structures, and its function depended on 
sequence as well as structural properties (Crucs et al. 2000). A number of different 
RNA stem-loops was suggested to be recognized by the regulatory RNase Regnase-1 
(also known as MCPIP1 or Zc3h12a), a post-transcriptional regulator of cytokine 
mRNAs (Li et al. 2012; Paschoud et al. 2006; Uehata et al. 2013). These stem-loops 
have diverse loop sizes and stem lengths, and specific binding of Regnase-1 to these 
putative cis-regulatory elements has not been addressed experimentally.  
Several groups used global approaches to identify RNA motifs specifically bound by a 
certain RBP. In affinity-based selection experiments from random RNA libraries 
potential cis-elements for a number of proteins, among them MEX-3, Pum2 and QKI-5, 
were identified (White et al. 2001; Pagano et al. 2009; Galarneau & Richard 2005). 
Even though the given examples focus on linear sequence motifs, recent studies on 
high-throughput sequencing data analysis expose an increasing awareness of RNA 
secondary structures (Hoinka et al. 2012). 
Taken together, cis-regulatory RNA elements cover a broad spectrum from distinct 
RNA sequence motifs and AREs to RNA stretches with certain secondary structures, 
being recognized by their shape rather than by the nucleotide sequence. For most of 
these RNA elements, little is known about how trans-acting factors recognize a 
particular cis-element. Even though bioinformatics tools and high-throughput methods 
provide some predictive power, the precise modes and requirements of these 
interactions still have to be addressed in small experimental steps. 
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1.2.2.2 Trans-acting factors and mechanisms of post-transcriptional 
regulation 
The cis-regulatory RNA elements described in the previous paragraph can be targeted 
by different kinds of molecules, including miRNAs and other non-coding RNAs. 
However, this paragraph will only discuss RBPs, their modes of RNA recognition and 
downstream effects. A global approach identifying RBPs in HeLa cells by cross-linking 
of protein-RNA interactions with ultraviolet (UV) light and subsequent pull-down 
revealed that there are as many as 860 proteins qualifying as RBPs in the given setting 
(Castello et al. 2012). This underlines the potential lying within post-transcriptional 
processes and the demand for further investigations of this level of gene regulation. 
The most intensively studied group of RBPs are ARE-binding proteins, among them 
tristetraprolin (TTP), AU-binding factor 1 (AUF1), K homology splicing regulatory 
protein (KSRP), TIA-1, TIA-1-related protein (TIAR) and ELAV proteins. With a 
tandem CCCH-type zinc finger TTP binds to AREs within the 3’UTR of Tnf, Il10 and 
other target mRNAs and promotes degradation by recruiting deadenylation factors to 
the bound mRNA (Lai et al. 1999; Lai et al. 2000; Stoecklin et al. 2008). Upon 
activation of the p38 MAP kinase, TTP function is repressed by phosphorylation 
leading to an upregulation of its target mRNAs (Marchese et al. 2010; Clement et al. 
2011). Another factor mediating ARE-dependent mRNA decay is KSRP, which 
promotes deadenylation and 3’ to 5’ degradation by the exosome. KSRP contacts the 
RNA via four nucleic-acid-binding KH domains, whose flexible organization allows 
recognition of diverse targets. Like TTP, KSRP is inactivated by phosphorylation. In 
contrast, AUF1 activity as RNA destabilizing protein is controlled by its preferred 
nuclear localization. Upon shuttling to the cytoplasm, it can bind to AREs and recruit 
the exosome for mRNA degradation (Loflin et al. 1999). However, there are also 
reports showing stabilization and increased translation of mRNAs upon AUF1 binding 
(Liao et al. 2007). In the cited study, Myc is post-transcriptionally regulated by 
competitive binding of AUF1 and TIA-1 to an ARE within its 3’UTR. Thereby, AUF1 
antagonizes TIA-1-mediated translational silencing. Both, TIA-1 and TIAR, interfere 
with translation through the formation of a pre-initiation complex with eIF1 and eIF3, 
which blocks translation initiation (Piecyk et al. 2000; Matoulkova et al. 2012). RNA 
binding by TIA-1 and TIAR is performed via three RNA recognition motif (RRM) 
domains, which bind to U-rich RNA stretches with high affinity (Dember et al. 1996). 
HuR, as representative of ELAV proteins, is an mRNA stabilizing factor and binds to 
RNA via three RRM domains. HuR interferes with destabilizing factors mainly by 
competing for AREs but also by relocating RNAs from P bodies to polysomes 
(Matoulkova et al. 2012; Bhattacharyya et al. 2006). Interestingly, all described ARE-
binding proteins share a modular composition with several RNA-binding domains, 
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which was proposed to increase the affinity and the specificity of RNA recognition 
(Lunde et al. 2007). 
To investigate the quantity and quality of mRNAs targeted by a specific RBP within 
cells, a method based on UV cross-linking and immunoprecipitation (CLIP) was 
established by Jernej Ule and colleagues (Ule et al. 2005). Cells are treated with UV 
light of 254 nm wavelength inducing covalent bonding between proteins and RNAs. 
Afterwards, a cell lysate is prepared and treated with an RNase to achieve RNA 
fragmentation, which is followed by immunoprecipitation (IP) of the RBP of interest. 
Thus, RNA fragments bound by the RBP can be purified and identified by reverse 
transcription and sequencing. In the following years, high-throughput sequencing was 
used and allowed a global view on specifically bound RNAs (Licatalosi et al. 2008). 
Also, the cross-linking procedure was further developed by incorporation of                 
4-thiouridine (4SU) within cellular RNAs and the use of 365 nm UV light, termed 
photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) (Hafner et al. 2010). This 
procedure resulted in specific T to C exchanges at positions of close protein-RNA 
interaction and thereby enabled the identification of preferentially bound RNA motifs.  
The protein Smaug was identified as trans-acting factor on the nanos TCE, where it 
recognizes one of the two proposed stem-loop structures (Smibert et al. 1996; Smibert 
et al. 1999; Dahanukar et al. 1999). The mechanism by which Smaug regulates nanos 
mRNA involves translational inhibition but also recruitment of the Ccr4-Not complex 
for deadenylation and subsequent mRNA degradation (Zaessinger et al. 2006). A 
protein named Oskar counteracts Smaug-mediated mRNA decay to allow Nanos protein 
expression at the posterior pole of the Drosophila embryo. Binding of Smaug to the 
nanos mRNA is achieved by a sterile-α-motif (SAM) domain, whose RNA-binding 
interface and consensus RNA cis-element were determined by mutational analyses 
(Aviv et al. 2003). 
The 3’ stem-loop of histone mRNAs is bound by the stem-loop binding protein (SLBP) 
and the 3’ to 5’ exonuclease Eri1, which degrades the stem-loop structure and thereby 
destabilizes histone mRNAs (Battle & Doudna 2001; Dominski et al. 2003; Hoefig et al. 
2013). Analyzing the crystal structure of the ternary complex (SLBP, Eri1 and stem- 
loop RNA) revealed only few base-specific contacts, since both proteins recognize the 
shape of the RNA stem-loop rather than its nucleotide sequence (Tan et al. 2013). This 
study demonstrates the requirement for structural analyses of protein-RNA complexes 
to understand the molecular and steric characteristics of protein-RNA interactions.  
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1.2.3 Post-transcriptional gene regulation in the immune system 
Cellular processes that require fast and precise regulation of gene expression are under 
the control of extensive regulatory networks targeting the post-transcriptional level. In 
addition to embryonic development and differentiation, the immune system was shown 
to be largely dependent on regulation of mRNA decay and translation. In fact, 50% of 
the differentially expressed mRNAs during T cell activation were attributed to changes 
in mRNA stability instead of transcription (Cheadle et al. 2005). Also, mechanisms 
promoting T cell anergy involve post-transcriptional regulation and translational 
silencing, since cytokine mRNA expression is not reduced to the same degree as 
cytokine production in T cells upon stimulation with self-antigen (Villarino et al. 2011). 
As AREs were identified in many cytokine mRNAs, ARE-binding proteins play a major 
role in post-transcriptional regulation of immune responses and cytokine production. 
TTP destabilizes Tnf, Il1b and Il2 mRNAs in a negative feedback loop during 
inflammation but also in the absence of pathogens. This was shown with TTP-deficient 
mice, which spontaneously develop severe autoimmunity due to excessive Tnf 
expression by macrophages (Taylor et al. 1996). Similarly, AUF1-deficient mice exhibit 
symptoms of endotoxic shock due to excessive Tnf and IL-1β production (Lu et al. 
2006). Even though KSRP destabilizes Tnf and Il8 mRNAs, mice lacking this ARE 
binding protein do not exhibit a prominent phenotype (Lin et al. 2011). It is evident that 
RBPs in this context do not only target several mRNAs, but one mRNA is also targeted 
by different RBPs that compete or collaborate with each other (Ivanov & Anderson 
2013). This is also true for the Tnf mRNA being targeted by TTP, AUF1, KSRP as well 
as HuR, which stabilizes the mRNA but at the same time inhibits translation by 
cooperation with TIA-1 (Katsanou et al. 2005). Furthermore, an ARE-independent 
constitutive decay element (CDE) mediating mRNA degradation was identified within 
the Tnf 3’UTR (Stoecklin et al. 2003). Thus, a combination of different stabilizing and 
destabilizing effects on one mRNA is decisive for the resulting protein expression level. 
The Il6 mRNA has a short half-life due to AREs within its 3’UTR. However, in a study 
investigating the contribution of different 3’UTR segments to mRNA decay, a 
conserved cis-element forming a stem-loop structure was identified (Paschoud et al. 
2006). Whereas ARE-mediated mRNA decay could be inhibited by overexpression of 
AUF1 proteins, the mechanism of stem-loop-mediated mRNA decay was not 
deciphered. In an independent approach the same conserved region within the Il6 
3’UTR was identified as cis-element for the regulatory RNase Regnase-1 (Matsushita et 
al. 2009). Other proposed target elements of Regnase-1 are located within the Il2, cRel 
and Zc3h12a (Regnase1) 3’UTRs and are likewise predicted to fold into stem-loop 
structures (Iwasaki et al. 2011; Li et al. 2012; Uehata et al. 2013). Degradation of target 
mRNAs was proposed to be induced by the endonuclease activity of Regnase-1, but 
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proof of the direct interaction of Regnase-1 and RNA stem-loop structures is still 
missing. Nevertheless, Regnase-1-deficient mice exhibit prominent immune 
dysregulation marked by infiltration of lymphocytes into the lung and other organs, 
disruption of the splenic architecture, anti-DNA autoantibody production and increased 
serum levels of inflammatory cytokines (Miao et al. 2013; Matsushita et al. 2009; 
Uehata et al. 2013). This illustrates the power of post-transcriptional gene regulation in 
the immune system and emphasizes the need for molecular studies to understand 
protein-RNA interactions and their regulatory potential. 
 
1.3 The protein Roquin 
In an ENU (N-ethyl-N-nitrosourea) mutagenesis screen for anti-nuclear antibodies 
(ANAs), a point mutation of a single gene resulting in an amino acid exchange was 
found to cause severe autoimmunity in mice resembling the human disease systemic 
lupus erythematosus (SLE) (Vinuesa et al. 2005). The gene affected by this mutation 
was Rc3h1, and the corresponding protein was called Roquin-1. The M199R mutation 
of Roquin-1 is one rare case of a monogenic cause for autoimmunity in mice. In 
addition to ANAs, the so-called sanroque mice also exhibited massive T cell activation, 
high levels of Icos on T cells, spontaneous germinal center formation and plasmacytoid 
infiltrations in lung, kidney and liver. Subsequently, homozygosity for Roquin-1san was 
also found to promote or enhance other autoimmune diseases. Mice prone to developing 
autoimmune diabetes showed more severe disease parameters and progression when 
they carried Rc3h1san/san alleles (Silva et al. 2011). Also, antibody-induced arthritis was 
aggravated in sanroque mice (Pratama et al. 2013). The underlying cause was proposed 
to be increased T cell activation and Tfh cell expansion resulting from high levels of the 
costimulator Icos on T cells (Yu et al. 2007; Lintermanet al. 2009a; Linterman et al. 
2009b). In an adoptive transfer experiment of Rc3h1san/san T cells into wild-type 
recipient mice, this was shown to be a T cell-intrinsic process. Since Tfh cells 
efficiently support and stimulate B cells during the germinal center reaction, their 
increased abundance presumably drives the generation of high-affinity ANAs in 
sanroque mice. Heterozygosity of Roquin-1san led to a slight increase in Icos expression 
on T cells and late-onset autoimmunity (Ellyard et al. 2012). Yet, about 50% of these 
mice developed angioimmunoblastic T cell lymphomas possibly caused by Tfh 
accumulation. Little is known about the regulation of Roquin protein levels in T cells. 
However, one group investigated transcription factors targeting the Rc3h1 locus and 
their involvement in Roquin-1 transcription regulation (Schaefer et al. 2014). Roquin-1 
mRNA levels were increased by IL-10 stimulation of a murine T cell line (EL4) through 
the induction of signal transducer and activator of transcription (STAT) 1, STAT3, 
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GATA2 and c-Rel. These transcription factors were shown to bind to the Rc3h1 
promoter region, indicating that they enhance Roquin-1 transcription. The same group 
identified 26 miRNAs, which might act as negative regulators of Roquin-1 expression, 
suggesting intensive post-transcriptional regulation of the Roquin-1 mRNA (Schaefer et 
al. 2011). 
 
1.3.1 Roquin in mouse models 
Due to the prominent phenotype caused by a single amino acid exchange within the 
Roquin-1 protein, mice deficient for Roquin-1 were expected to similarly show the 
described autoimmune symptoms. Deletion of the Rc3h1 exons 4-6 resulted in a 
complete loss of Roquin-1 protein and caused perinatal lethality probably due to 
impaired lung function (Bertossi et al. 2011). Therefore, a conditional knockout in T 
cells was established, crossing mice with floxed Rc3h1 alleles to CD4 Cre mice. 
Surprisingly, these mice did not develop autoimmunity, even though Icos levels were 
elevated on Rc3h1-/- T cells and the frequencies and numbers of activated CD8+ T cells 
were significantly increased. Assuming that the sanroque phenotype was not caused 
entirely by T cell intrinsic mechanisms, Bertossi et al. investigated the effect of  
Roquin-1 deletion in all hematopoietic cells by crossing Rc3h1fl/fl mice to Vav Cre mice. 
These mice exhibited accumulation of CD8+ and CD4+ effector T cells with high Icos 
levels, spontaneous germinal center formation and increased levels of IgG2. However, 
ANAs or signs of autoimmunity were not detected. 
The described study suggested that deregulation of Icos levels on T cells may not be the 
exclusive disease-causing mechanism of sanroque mice but rather one sign of vast 
alterations in T cell homeostasis. This was further supported by Roquinsan/san; Icos-/- 
mice exhibiting unaltered spleen cellularity and percentage of effector memory CD4+ T 
cells compared to sanroque mice (Lee et al. 2012). Moreover, the lack of Icos in 
sanroque mice did not abrogate the production of ANAs. The analysis of Rc3h1-/- mice 
also indicated that the presence of the mammalian paralog of Roquin-1, Roquin-2, also 
known as membrane-associated nucleic acid binding protein (Mnab) (Siess et al. 2000), 
might prevent disease progression in Roquin-1 knockout mice. Roquin-2 is encoded by 
the Rc3h2 gene, and Roquin-1 and Roquin-2 are highly conserved in the N-terminus, 
whereas lower amino acid similarity was found in the C-terminus (Figure 5). Roquin-1 
and Roquin-2 expression was detected by immunoblotting in different tissues, including 
spleen, lymph nodes, brain and lung, indicating that Roquin proteins also play a role 
outside of the immune system (Vogel et al. 2013). 
Deletion of the Rc3h2 exon 4 resulted in a postnatally lethal loss of Roquin-2 protein, 
and therefore a T-cell-specific knockout (Rc3h2fl/fl; CD4 Cre) of Roquin-2 was 
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investigated in detail (Vogel et al. 2013). However, T cells lacking Roquin-2 exhibited 
normal development and homeostasis without increased activation or Tfh 
differentiation. In line with this, Icos levels were not elevated on Rc3h2-/- T cells. 
Therefore, mice with a combined deletion of Roquin-1 and Roquin-2 in T cells were 
analyzed showing excessive CD4+ and CD8+ T cell activation with an accumulation of 
CD62loCD44hi cells (Vogel et al. 2013). Moreover, Icos levels on Roquin-1/2-deficient 
T cells were even higher than on sanroque T cells, suggesting residual function of 
Roquin-1san or compensatory effects of Roquin-2 in sanroque mice. Surprisingly, 
Rc3h1-2fl/fl; CD4 Cre mice did not produce ANAs despite strongly increased numbers 
of Tfh and GC B cells. This was attributed to a vastly destroyed spleen architecture 
lacking intact follicle structures. A different targeting strategy deleting exon 2 of 
Roquin-1 and Roquin-2 resulted in alternative transcripts encoding RING-less Roquin-1 
and Roquin-2 proteins (Pratama et al. 2013). Mice with a T-cell-specific expression of 
RING-less Roquin-1/2 only exhibited a mild phenotype with slightly elevated Icos 
levels on activated T cells and increased frequencies of Tfh and GC B cells upon 
immunization.  
Furthermore, transgenic mice overexpressing Roquin-1 in a T cell-restricted manner 
were generated (Kim et al. 2012). Upon anti-CD3 and anti-CD28 activation, CD4+ T 
cells from these mice showed increased expression of CD28, IL-2 and Tnf, and 
expectedly lower Icos levels than wild-type mice. However, the underlying molecular 
mechanism remains entirely elusive. 
 
1.3.2 Domain organization and function of Roquin proteins 
The domain organization of the newly identified Roquin-1 protein was described based 
on conservation and homology studies of the Rc3h1 gene and the amino acid sequence 
(Vinuesa et al. 2005). The N-terminus of Roquin-1 contains a RING (really interesting 
new gene)-type E3 ubiquitin ligase domain, a novel ROQ domain and a CCCH-type 
zinc finger. In contrast, the C-terminus appears to be rather unstructured with a proline-
rich sequence and a coiled-coil domain at the C-terminal end. The Roquin-2 protein 
shows the same domain organization and high sequence homology in its N-terminus, 
whereas the C-terminus is largely different from the Roquin-1 protein with only about 
50% amino acids sequence identity (Figure 5) (Pratama et al. 2013). 
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Figure 5: Roquin-1 and Roquin-2 domain organization and amino acid (aa) sequence similarity. 
The scheme shows the RING-type E3 ubiquitin ligase domain (RING, yellow), the ROQ domain (blue), 
the CCCH zinc finger (ZnF, red) in the N terminus of Roquin-1/2. The C-teminus contains proline-rich 
sequences (PRS, grey) and a coiled coil region (in Roquin-1, magenta) or a hydrophobic region (in 
Roquin-2, orange). The scheme is based on Pratama et al. 2013 and Vinuesa et al. 2005. 
 
It is not known whether the RING domain of Roquin-1 is a functional E3 ubiquitin 
ligase. However, for Roquin-2 it has been shown that it acts as ubiquitin ligase of Ask1 
and thereby prevents apoptosis in response to reactive oxygen species-induced cell 
death (Maruyama et al. 2014). Mice expressing RING-less Roquin-1 and Roquin-2 
variants exhibit mild immune dysregulation, suggesting the presence of the RING 
domain to be favorable for Roquin function (Pratama et al. 2013). Yet, it is unclear 
whether this is due to a function as E3 ubiquitin ligase or because the RING domain is 
required for protein integrity and stability. 
The ROQ domain was first defined by sequence homology and conservation between 
different species, and it was described to be involved in mouse and human ICOS mRNA 
binding and post-transcriptional regulation as well as stress granule localization 
(Athanasopoulos et al. 2010; Glasmacher et al. 2010). This was shown in functional 
studies with truncated Roquin-1 variants or Roquin-1 lacking the ROQ domain (here: 
amino acids (aa) 138-337) and will be discussed in more detail in 1.3.3. 
Zinc finger structural motifs are involved in nucleic acid binding in various proteins 
including the post-transcriptional regulator TTP, which uses a tandem CCCH zinc 
finger to bind to AREs on target mRNAs (Hall 2005). In electrophoretic mobility shift 
assays (EMSAs) the Roquin CCCH zinc finger alone (aa 407-484) exhibited RNA-
binding activity, however with lower affinity than the ROQ domain (Athanasopoulos et 
al. 2010). Furthermore, it was shown that mutating the third coordinating cysteine 
residue of the zinc finger in a construct containing RING domain, ROQ domain and 
CCCH zinc finger (aa 1-484) reduced binding to an RNA fragment from the Icos 
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3’UTR. This suggests a minor role of the Roquin zinc finger in RNA binding compared 
to the ROQ domain. 
 
1.3.3 Roquin as RNA-binding protein and post-transcriptional regulator 
It was found that Roquin-1 regulates the expression level of Icos protein by directly 
binding to its mRNA (Athanasopoulos et al. 2010; Glasmacher et al. 2010). High-
affinity binding required the Roquin-1 N-terminus (RING-ROQ-ZnF, aa 2-440) and the 
Icos 3’UTR. In different experimental approaches two RNA fragments of this about two 
kilobases (kb) long 3’UTR were identified as binding partners. Shortening the human 
ICOS 3’UTR yielded a fragment at the 5’ end of the 3’UTR (Glasmacher et al. 2010), 
whereas Athanasopoulos et al. successfully used a fragment from the 3’ end for in vitro 
binding assays (Athanasopoulos et al. 2010). Yet, a general RNA motif recognized by 
Roquin proteins was not identified in these experiments. 
The direct interaction of Roquin with the ICOS 3’UTR results in reduced ICOS protein 
levels as shown in cell-based functional assays. Thereby, ICOS surface expression from 
a construct harboring the 3’UTR was reduced by increased Roquin-1 levels, whereas 
ICOS expression from a CDS construct did not respond. In contrast to assays measuring 
ICOS mRNA half-life, which neglect effects of translational control, reporter assays 
integrate all possible effects of post-transcriptional regulation by measuring protein 
amounts. Using a truncated form of Roquin-1, these assays also revealed a requirement 
of the Roquin-1 C-terminus for mRNA repression, even though the N-terminus was 
sufficient for binding (see Figure 5). 
In addition, Roquin-1 localization to stress granules and P bodies indicated an 
involvement in mechanisms of post-transcriptional regulation (Athanasopoulos et al. 
2010; Glasmacher et al. 2010). In co-immunoprecipitations from T helper cell extracts 
Roquin-1 was associated with factors of the mRNA decapping pathway, namely Edc4 
and Rck, which promote 5’ to 3’ mRNA degradation (Glasmacher et al. 2010). This 
suggests that Roquin-1 is an RBP recruiting mRNA decay factors to promote Icos 
mRNA degradation and thereby regulating Icos expression on the post-transcriptional 
level. 
In the course of this thesis work, Leppek et al. described an RNA cis-element for 
Roquin-mediated mRNA regulation (Leppek et al. 2013). Using the mRNA decay-
mediating CDE from the Tnf 3’UTR they found that Roquin-1 specifically binds to this 
RNA fragment. It was shown that the CDE folds into a hairpin structure with a triloop 
and a stem of six Watson and Crick base pairs. The same kind of stem-loop was found 
in other mRNAs potentially targeted by Roquin. Furthermore, Roquin-1 and Roquin-2 
were found to be associated with Caf1 and Not1, subunits of the Ccr4-Not1 
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deadenylation complex, suggesting that Roquin-mediated post-transcriptional regulation 
also involves deadenylation of target mRNAs (Figure 6). 
 
 
Figure 6: Scheme of Roquin function as RNA-binding protein. Roquin proteins directly bind to their 
target mRNA via a cis-regulatory element within the 3’UTR. This interaction takes place in P bodies and 
promotes mRNA degradation by recruiting factors of the different mRNA decay pathways. 
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2 Aim of the project 
The analyses of mice with a point mutation in Roquin-1 and mice lacking Roquin-1 and 
Roquin-2 in T cells revealed a major impact of Roquin function on T cell activation and 
differentiation that had T cell-intrinsic causes. Appropriate function of these proteins 
was required to prevent excessive immune responses and autoimmunity. The first 
investigated target of Roquin was the inducible costimulator Icos. As an RNA-binding 
protein, Roquin promotes mRNA degradation and thereby reduces Icos protein levels. 
However, mice with a T-cell-specific Roquin-1 knockout did not develop autoimmune 
disease despite increased Icos levels on T cells. Furthermore, Icos-deficient sanroque 
mice still exhibited immune dysregulation and autoimmunity. From this, we concluded 
that Icos most likely is not the only mRNA targeted by Roquin-mediated post-
transcriptional regulation, but that additional mRNAs are deregulated in sanroque mice 
to bring about the severe autoimmune phenotype.  
Therefore, the first aim of this study was to establish assays to identify Roquin target 
mRNAs. These experiments were confined to T helper cells due to their pivotal role in 
shaping immune responses. Deletion of Roquin-encoding genes in primary T helper 
cells leads to a deregulation of putative Roquin target mRNAs compared to wild-type T 
helper cells. Those differentially expressed mRNAs can be identified with high 
sensitivity using mRNA expression arrays. CLIP and PAR-CLIP assays directly target 
the protein-RNA interaction by combining UV cross-linking and immunoprecipitation 
with high-throughput sequencing. Here, the identity of mRNAs bound by Roquin 
proteins as well as the contact site of the protein on the mRNAs can be identified. Since 
both methods cover different levels of Roquin-mediated regulation, they are supposed 
to complement each other in this study. Yet, there is a certain rate of false positive 
target candidates. Therefore, a validation strategy to prove post-transcriptional 
regulation by direct binding of Roquin proteins had to be established. 
On the molecular level, this study aimed at investigating the Roquin-mRNA interaction 
in detail to identify and define cis-regulatory RNA elements targeted by Roquin 
proteins. An affinity-based selection procedure with recombinant Roquin-1 protein from 
a random RNA library was chosen to find preferentially bound RNA motifs. 
Furthermore, in close collaboration with structural biologists we aimed to characterize 
the ROQ domain and its RNA-binding interface. Crystallization of the ROQ domain 
and of a ROQ-RNA complex as well as nuclear magnetic resonance (NMR) approaches 
provided the basis to identify critical amino acid residues in mutational analyses. This 
led to functional studies dissecting the molecular requirements of Roquin-mediated 
post-transcriptional gene regulation. 
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3 Material and Methods 
3.1 Material 
3.1.1 Mice 
CAG-CARstop-fl transgenic mice (Vogel et al. 2013) express a truncated version of the 
human coxsackievirus and adenovirus receptor (CAR) lacking the intracellular signaling 
domain (CARΔ1) under the control of the synthetic CMV early enhancer/chicken beta-
actin (CAG) promoter (Figure 7). CAR expression is only achieved when the preceding 
loxP-flanked STOP cassette (bovine growth hormone polyadenylation site) is excised 
by the Cre recombinase. 
Rc3h1-2fl/fl mice are transgenic for Rc3h1 with loxP-flanked exons 4 to 6 (Bertossi et al. 
2011) and Rc3h2 with loxP-flanked exon 4 (Vogel et al. 2013) respectively (Figure 7). 
 
 
Figure 7: Schematic representation of genetically modified alleles used in this study. 
 
CD4 Cre mice (Lee et al. 2001) were used for T-cell-specific loxP site recombination of 
the Rc3h1-2fl/fl alleles or as control group in combination with Rc3h1-2+/+ alleles. Icos-/- 
mice (McAdam et al. 2001) were obtained from Prof. Dr. Richard Kroczek (Robert-
Koch-Institut, Berlin). Ox40-/- mice (B6.129S4-Tnfrsf4tm1Nik/J) were purchased from the 
Jackson Laboratories. The Gt(ROSA)26Sortm2(cre/ERT2)Brn mouse line was provided by 
Prof. Dr. Anton Berns (Hameyer et al. 2007) and expresses a Cre recombinase estrogen 
receptor fusion protein. All animals were bred on a C57BL/6 genetic background and 
housed in a special pathogen-free barrier facility in accordance with the Helmholtz 
Zentrum München institutional, state and federal guidelines. 
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Primary T helper cells used for CLIP and PAR-CLIP assays at the Biozentrum in Basel 
were isolated from C57BL/6J mice. These mice were offspring from mice obtained 
from JANVIER LABS and were kept in a special pathogen-free barrier facility and 
according to the Swiss law. 
 
3.1.2 Cell lines and cell culture 
Human embryonic kidney cells (HEK293T) were purchased at ATCC.  
Mouse embryonic fibroblasts (MEFs) were generated from embryos with the respective 
genotypes (Rc3h1-2-/- and Rc3h1-2fl/fl; Cre ERT2; CAG-CARstop-fl) according to a 
standard protocol (Ansel et al. 2008).  
To generate a Roquin-1 inducible cell line, Rc3h1-2-/- MEFs were lentivirally 
transduced with a CMVtight-Roquin-1-p2A-mCherry expression vector and a vector 
encoding the rtTA3 transactivator. This led to stable integration and allowed induced 
expression of Roquin-1 and the fluorescent protein mCherry in response to doxycycline 
treatment of the cells. 
MEFs were cultured at 37°C, 10% CO2 in DMEM complemented with 10% FCS, 100 
U/ml penicillin/streptomycin and 10 mM HEPES. Primary T helper cell cultures were 
performed at 37°C, 5% CO2 in RPMI complemented with 10% FCS, 1% HEPES, 
penicillin/streptomycin, non-essential amino acids (NEAA), sodium pyruvate, vitamin 
solution and β-mercaptoethanol-L-glutamine respectively (Table 1). 
 
Table 1: Cell culture components 
Name	   Company	  
Dulbecco's Modified Eagle Medium (DMEM) Gibco, life technologies 
Fetal calf serum (FCS) PAN BIOTECH GmbH 
GIBCO™ L-Glutamine 200 mM (100x), solution Gibco, life technologies 
GIBCO™ MEM Vitamin Solution (100x), solution Gibco, life technologies 
HEPES, pH 7.4 (1M) Gibco, life technologies 
Non-essential amino acids (NEAA) (100x) BioWhittaker, Lonza 
Penicillin/Streptomycin (10,000 U/ml) Gibco, life technologies 
RPMI 1640, without L-glutamine BioWhittaker, Lonza 
Sodium pyruvate (100mM) BioWhittaker, Lonza 
β-mercaptoethanol Sigma-Aldrich 
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3.1.3 Plasmids and bacteria culture 
Table 2: Entry vectors 
Entry	  vector	   Insert	  
pCR8-GW Ox40 CDS 
pCR8-GW Ox40 full-length 
pCR8-GW Ox40 3’UTR 1 to 40 
pCR8-GW Ox40 3’UTR 1 to 80 
pCR8-GW Ox40 3’UTR 1 to 120 (Ox40 ΔCDE-like) 
pCR8-GW Ox40 SELEX-like mut 
pCR8-GW Ox40 CDE-like mut 
pCR8-GW Ox40 SELEX/CDE-like mut 
pCR8-GW ICOS full-length 
pCR8-GW ICOS CDS 
pCR8-GW ICOS CDE260 
pCR8-GW ICOS 1-2438 (ICOS ΔCDE) 
pCR8-GW Roquin-1 
pCR8-GW Roquin-1 K220A 
pCR8-GW Roquin-1 K239A 
pCR8-GW Roquin-1 R260A 
pCR8-GW Roquin-1 K239A R260A 
 
After being cloned into pCR8-GW entry vectors using the TOPO®TA cloning kit (life 
technologies), inserts were transferred by lambda recombination (LR) into destination 
vectors for different applications (Table 3). The pDEST17 vector contains a T7 
transcription start site making it suitable as template for in vitro transcription reactions. 
The retroviral expression vectors pKMV-IRES-GFP and pMSCV-IRES-Thy1.1 were 
used for subsequent virus production in combination with ecotropic or amphotropic 
packaging vectors (Eco-pac or gag-pol and ampho-env). Plasmids were amplified and 
cloned in chemically competent Dh5α Escherichia coli (E. coli). 
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Table 3: Destination vectors and their applications 
Destination	  vector	   Insert	   Application	  
pDest17 Ox40 CDS In vitro transcription 
pKMV-IRES-GFP Ox40 CDS Retroviral expression 
pDest17 Ox40 full-length In vitro transcription 
pKMV-IRES-GFP Ox40 full-length Retroviral expression 
pKMV-IRES-GFP Ox40 3’UTR 1-40 Retroviral expression 
pKMV-IRES-GFP Ox40 3’UTR 1-80 Retroviral expression 
pKMV-IRES-GFP Ox40 3’UTR 1-120 (Ox40 ΔCDE-like) Retroviral expression 
pKMV-IRES-GFP Ox40 SELEX-like mut Retroviral expression 
pKMV-IRES-GFP Ox40 CDE-like mut Retroviral expression 
pKMV-IRES-GFP Ox40 SELEX/CDE-like mut Retroviral expression 
pKMV-IRES-GFP ICOS full-length Retroviral expression 
pKMV-IRES-GFP ICOS CDS Retroviral expression 
pKMV-IRES-GFP ICOS CDE260 Retroviral expression 
pKMV-IRES-GFP ICOS 1-2438 (ICOS ΔCDE) Retroviral expression 
pMSCV-IRES-Thy1.1 Cre recombinase Retroviral expression 
pMSCV-IRES-Thy1.1 Roquin-1 WT Retroviral expression 
pMSCV-IRES-Thy1.1 Roquin-1 K220A Retroviral expression 
pMSCV-IRES-Thy1.1 Roquin-1 K239A Retroviral expression 
pMSCV-IRES-Thy1.1 Roquin-1 R260A Retroviral expression 
pMSCV-IRES-Thy1.1 Roquin-1 K239A R260A Retroviral expression 
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Table 4: Plasmids for recombinant protein expression 
Plasmid	   Insert	  
petM11 Roquin-1 
petM11 Roquin-1 (2-440) 
petM11 Roquin-1 M199R (2-440) 
petM11 Roquin-2 (2-438) 
pETTrx1a Roquin-1 (171-326) 
pETTrx1a Roquin-1 (146-326) 
pETTrx1a Roquin-1 (146-326) R188A 
pETTrx1a Roquin-1 (146-326) R219A 
pETTrx1a Roquin-1 (146-326) K220A 
pETTrx1a Roquin-1 (146-326) R229A 
pETTrx1a Roquin-1 (146-326) R233A 
pETTrx1a Roquin-1 (146-326) S238A 
pETTrx1a Roquin-1 (146-326) K239A 
pETTrx1a Roquin-1 (146-326) Y250A 
pETTrx1a Roquin-1 (146-326) R251A 
pETTrx1a Roquin-1 (146-326) S253A 
pETTrx1a Roquin-1 (146-326) K259A 
pETTrx1a Roquin-1 (146-326) S264A 
pETTrx1a Roquin-1 (146-326) S265Y 
pETTrx1a Roquin-1 (146-326) E293A 
pETTrx1a Roquin-1 (146-326) K314A 
pETTrx1a Roquin-1 (146-326) K239A R260A 
 
Expression of recombinant proteins was performed in the Rosetta (DE3) pLysS 
(petM11 constructs) or the BL21 (DE3) E. coli strain (pETTrx1a constructs). 
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3.1.4 Oligonucleotides 
3.1.4.1 RNA Oligonucleotides 
RNA oligonucleotides used for EMSA experiments were synthesized and PAGE-
purified by IBA GmbH (Göttingen, Germany). 
 
Table 5: RNA oligonucleotides 
Name	   Sequence	  (5’	  to	  3’)	  
Tnf CDE ACA UGU UUU CUG UGA AAA CGG AG 
Tnf CDE Ext GG UGU UUU CUG UGA AAA CGG CC 
Tnf CDE LM1 ACA UGU UUU CUC UGA AAA CGG AG 
Tnf CDE LM2 ACA UGU UUU CUG GGA AAA CGG AG 
Tnf CDE LM3 ACA UGU UUU CAC AGA AAA CGG AG 
Tnf CDE SM1 ACA UGU UUU UUG UAA AAA CGG AG 
Tnf CDE SM1 ACA UGU UUU GUG UCA AAA CGG AG 
Tnf CDE SM1 ACA UGU UCC CUG UGG GAA CGG AG 
ICOS CDE-like AGA AUG ACU GUA UCA GUC AAU GG 
Ox40 CDE-like CUA UGU AUG CUA UGC AUA CUA CC 
Ox40 SELEX-like UCC ACA CCG UUC UAG GUG CTG GG 
 
 
3.1.4.2 DNA Oligonucleotides 
DNA Oligonucleotides were purchased from Metabion (Planegg, Germany). 
 
Table 6: Primers for cloning and site directed mutagenesis 
Name	   Sequence	  (5’	  to	  3’)	   Purpose	  
Ox40 CDS for GAGGTCGACCATGTATGTGTGGGTTCAGC  Cloning Ox40 
Ox40 CDS rev CTCGCGGCCGCTCAGATCTTGGCCAGAG Cloning Ox40 
Ox40 3’UTR rev CTCGCGGCCGCTAGCATGTTTATTAGGAG  Cloning Ox40 
Ox40 3’UTR 1-40 rev CTCGCGGCCGCGGTTGTCCGTGCCCCAT  Shorten Ox40 
Ox40 3’UTR 1-80 rev CTCGCGGCCGCCTAGAACGGTGTGGAG Shorten Ox40 
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Name	   Sequence	  (5’	  to	  3’)	   Purpose	  
Ox40 3’UTR 1-120 rev CTCGCGGCCGCTGCATAGCATACATAG Shorten Ox40 
ICOS CDS for GAGGTCGACCATGAAGTCAGGCCTCTGG Cloning ICOS 
ICOS CDS rev GAGACTCGAGGGTTATAGGGTCACATCTGTGAG Cloning ICOS 
ICOS 3’UTR rev CTCGCGGCCGCTACTACTGTTAAAATCTC Cloning ICOS 
ICOS 2438 rev GAGACTCGAGTGGGGATGAGGATGTGTC Shorten ICOS 
Tnf CDE260 for CTCGAGGGAAGGCCGGGGTGTCC Cloning CDE260 
Tnf CDE260 rev CTCGAGCTCTCAATGACCCGTAGGG Cloning CDE260 
Ox40 QC SELEX for ACCCTCCACACCGTTCTACCAGCTGGGCTGGCT Mutagenesis  
Ox40 QC SELEX rev AGCCAGCCCAGCTGGTAGAACGGTGTGGAGGGT Mutagenesis  
Ox40 QC CDE for GGCTTTCCTATGTATGCTATCGTTACTACCTGCC
TGGTGGTG 
Mutagenesis  
Ox40 QC CDE rev CACCACCAGGCAGGTAGTAACGATAGCATACAT
AGGAAAGCC 
Mutagenesis  
Roquin-1 QC K220A for GGTTCTGCATTGTCTCGGGCAGTGTTGGTTCTCT
TCGTGG 
Mutagenesis 
Roquin-1 QC K220A rev CCACGAAGAGAACCAACACTGCCCGAGACAATG
CAGAACC 
Mutagenesis 
Roquin-1 QC K239A for CCTCAAGCCTCTGCTACCAGCATTGGGC Mutagenesis 
Roquin-1 QC K239A rev GCCCAATGCTGGTAGCAGAGGCTTGAGG Mutagenesis 
Roquin-1 QC R260A for GCTTCAAGGTCACCAAAGCTGATGAAGACTCTT
C 
Mutagenesis 
Roquin-1 QC R260A rev GAAGAGTCTTCATCAGCTTTGGTGACCTTGAAG
C 
Mutagenesis 
 
Table 7: Primers for SELEX 
Name	   Forward primer (5’ to 3’)	   Reverse primer (5’ to  3’)	  
N47Nε-TK 
AATTCTAATACGACTCACTATAGG- 
GAGGAGGAGAGATGTGAACTT GTCCTGTGGCATCCACGAAA 
N47Nε-Index1 ATCACGAGGAGAGATGTGAACTT ATCACGTGTGGCATCCACGAAA 
N47Nε-Index2 CGATGTAGGAGAGATGTGAACTT CGATGTTGTGGCATCCACGAAA 
N47Nε-Index3 TTAGGCAGGAGAGATGTGAACTT TTAGGCTGTGGCATCCACGAAA 
N47Nε-Index4 TGACCAAGGAGAGATGTGAACTT TGACCATGTGGCATCCACGAAA 
N47Nε-Index5 ACAGTGAGGAGAGATGTGAACTT ACAGTGTGTGGCATCCACGAAA 
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The basis for the random RNA library used in the SELEX assay was a single stranded 
DNA library synthesized by Metabion with 47 nucleotides (nts) random sequence 
flanked by primer sequences (5’- GGG AGG AGG AGA GAT GTG AAC TT- N47 -
TTT CGT GGA TGC CAC AGG AC -3’). 
 
Table 8: In vitro transcription templates 
Name	   Sequence	  (5’	  to	  3’)	  
P1_A1_Seq_104 GGAGAGATGTGAACTTGGACCGTAAGGTATGCAAAGTATGTACATGGAACTGCG 
TTTTAGGAGTTTCGTGGATGCCAC 
P2_A1_Seq_89 GGAGAGATGTGAACTTCGTTTTAGAAGGCTTGTCCATATCAATGAGTGTCATCAC 
GCGTTCTAGTTTCGTGGATGCCAC 
P3_A1_Seq_85 GGAGAGATGTGAACTTCTGGGAAGGAAAGAAATAAGCATGCAGAGCCGTTACGT 
TTTAGGAACAGTTTCGTGGATGCCAC 
P4_A1_Seq_82 GGAGAGATGTGAACTTACCGTGTAAGTCTCAATCAGTCGGCAAGCAAGGGGCTG 
CGTTGTAGTAGTTTCGTGGATGCCAC 
P5_A1_Seq_81 GGAGAGATGTGAACTTGCTACAGGTACAAAAGGGCATCGCAACGTGAGGAACTG 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P6_A1_Seq_79 GGAGAGATGTGAACTTTCCAAATAGAGGCGCGCATGAGAATGCACACGGGGCTG 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P7_A1_Seq_74 GGAGAGATGTGAACTTGGATAGCTTGAAAGTTGAATGATGGTAAAATGGAATTA 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P8_A1_Seq_74 GGAGAGATGTGAACTTACCGTGTATCATGGTGGATTTTGCAGTGGTATTTGCGAG 
GCGTTGTAGTTTCGTGGATGCCAC 
P9_A1_Seq_74 GGAGAGATGTGAACTTACGGTCTCTGTAGATGGTTGTAGGCACGACGAGCACTG 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P10_A1_Seq_73 GGAGAGATGTGAACTTAGGTTGCGTTATAGCAATCGCGCGAGGCTGGCGAGACG 
ATACGTTGTAGTTTCGTGGATGCCAC 
P11_A1_Seq_73 GGAGAGATGTGAACTTTAGGAATTGCGTATAAAGACTTGCAGAAACGAACACTG 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P12_A1_Seq_73 GGAGAGATGTGAACTTCCTGGAGCATCATAAGAATTTGCGAACGTGACTGCGTTT 
TAGGAGTTAGTTTCGTGGATGCCAC 
P13_A1_Seq_72 GGAGAGATGTGAACTTCCGTTATAGGAAGCAGTCAAGATCATCGATGAGTATCC 
GCGCGTTGTAGTTTCGTGGATGCCAC 
P14_A1_Seq_71 GGAGAGATGTGAACTTAGACATGACATCAGAAATCGTGTAGGTGGACGAGGCTG 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P15_A1_Seq_70 GGAGAGATGTGAACTTCGTTTTAGCAGTGCATTCGAGCTCTGTGTACGGGATCTG 
CGCGTTTTAGTTTCGTGGATGCCAC 
P16_A1_Seq_68 GGAGAGATGTGAACTTGCATTATTTCAAGTTAGTAGTTGTGAATTCATGGATTGC 
GTTGTAGGAGTTTCGTGGATGCCAC 
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Name	   Sequence	  (5’	  to	  3’)	  
P17_A1_Seq_66 GGAGAGATGTGAACTTGGGCGGCTTCATAACTAGTGATAGGACAATCGGAACTG 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P18_A1_Seq_64 GGAGAGATGTGAACTTGTAACAAGTTTAGGGAGAGGTGGTATACATACAAACTA 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P19_A1_Seq_64 GGAGAGATGTGAACTTCCAGGATTAGATAAGAACATAAGAGTATATAGCATTTG 
GGCCCGCGTAGTTTCGTGGATGCCAC 
P20_A1_Seq_64 GGAGAGATGTGAACTTCAAGAATAAGGAACAGAGTCCCAGGGCACGTGAAATTG 
CGTTTTAGGAGTTTCGTGGATGCCAC 
P34_A1_Seq_56 GGAGAGATGTGAACTTGCGTGTATCATGCAAAAAAGCTATAGGCAGATCGACGG 
ATGCGTTTTAGTTTCGTGGATGCCAC 
P43_A1_Seq_51 GGAGAGATGTGAACTTAGCTACCGTGTAGCCATGCCTAGTGGAGCCGGAACTAC 
TTTATGCGCAGTTTCGTGGATGCCAC 
P44_A1_Seq_51 GGAGAGATGTGAACTTACGGAGATTGCTTGTATCAAGTAATGCGGAGGCTGGCG 
AAACGTTGTAGTTTCGTGGATGCCAC 
ICOS_600-700 GGAGAGATGTGAACTTTATGGAACTCTGGCACCCAGGCATGAAGCACGTTGGCC 
AGTTTTCCTCAACTTGAAGTGCAAGATTCTCTTATTTCCGGGACCACGGAGAGTC 
TGACTTATTTCGTGGATGCCAC 
ICOS_700-800 GGAGAGATGTGAACTTACTACATACATCTTCTGCTGGTGTTTTGTTCAATCTGGA 
AGAATGACTGTATCAGTCAATGGGGATTTTAACAGACTGCCTTGGTACTGCCGAG 
TCCTCTTTTCGTGGATGCCAC 
mOX-40_UTR GGAGAGATGTGAACTTGCATTACTACAGGAGTGGATTTTATGGGGCACGGA 
CAACCCATATCCTGATGCCTGCCAGTACCCTCCACACCGTTCTAGGTGCTGG 
GCTGGCTCTGGGCTTTCCTATGTATGCTATGCATACTACCTGCCTGGTGGTGC 
TCCTTTTCGTGGATGCCAC 
mOX-40_UTR 
SELEX_mut 
GGAGAGATGTGAACTTGCATTACTACAGGAGTGGATTTTATGGGGCACGGA 
CAACCCATATCCTGATGCCTGCCAGTACCCTCCACACCGTTCTACCAGCTGG 
GCTGGCTCTGGGCTTTCCTATGTATGCTATGCATACTACCTGCCTGGTGGTGC 
TCCTTTTCGTGGATGCCAC 
mOX-40_UTR 
CDE_mut 
GGAGAGATGTGAACTTGCATTACTACAGGAGTGGATTTTATGGGGCACGGA 
CAACCCATATCCTGATGCCTGCCAGTACCCTCCACACCGTTCTAGGTGCTGG 
GCTGGCTCTGGGCTTTCCTATGTATGCTATCGTTACTACCTGCCTGGTGGTGC 
TCCTTTTCGTGGATGCCAC 
mOX-40_UTR 
SELEX_CDE_mut 
GGAGAGATGTGAACTTGCATTACTACAGGAGTGGATTTTATGGGGCACGGA 
CAACCCATATCCTGATGCCTGCCAGTACCCTCCACACCGTTCTACCAGCTGG 
GCTGGCTCTGGGCTTTCCTATGTATGCTATCGTTACTACCTGCCTGGTGGTG 
CTCCTTTTCGTGGATGCCAC 
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Table 9: Primers for qPCR 
Gene Forward primer (5’ to 3’) Reverse primer (5’ to 3’) Probe 
Bcl2l1 TGACCACCTAGAGCCTTGGA GCTGCATTGTTCCCGTAGA # 2 
Bcl3 GAACAACAGCCTGAACATGG TCTGAGCGTTCACGTTGG # 18 
Ctla4 TCACTGCTGTTTCTTTGAGCA GGCTGAAATTGCTTTTCACAT # 21 
Ebi3 GCTCCCCTGGTTACACTGAA ACGGGATACCGAGAAGCAT # 26 
Fbxo33 GCATCTACTTGGAGCTGGTGT TCCAAAAAGACTAAACTTCTGGAGAT # 89 
Icos CGGCAGTCAACACAAACAA TCAGGGGAACTAGTCCATGC # 6 
Irf4 AGCACCTTATGGCTCTCTGC TGACTGGTCAGGGGCATAAT # 3 
Lfng GCGCCACAAGGAGATGAC CCGAGGAGCAGTTGGTGA # 100 
Nfkbid TTTCTACCCTCCGTCAGACC TACAGCCGGGTATCCAGAGA # 9 
Pim2 GAGGCCGAATACCGACTTG GATTACTTTGATGGCCACCTG # 79 
Ppan GAACCTGTTCCCGTCCATC CTCTTGGGAGTCAGGGTTGT # 16 
Tm2d3 GCCCTCTGTTACCTGTGTCG AAACCTGCAAGTCATGTTGATG # 6 
Tnfrsf4 
(Ox40) 
GCTTGGAGTTGACTGTGTTCC GGGTCTGCTTTCCAGATAAGG # 79 
Ywhaz CGCTAATAATGCAGTTACTGAGAGA TGGAAGGCCGGTTAATTTT # 2 
Zc3h12a GAAGCAATGTGGCCATGAG CCTCGCTCCAGAAACCAG # 76 
 
3.1.5 Antibodies and cytokines 
Antibodies were used for different applications including immunoblotting (IB), 
immunoprecipitation (IP), flow cytometry and T helper cell cultures. Some monoclonal 
antibodies were obtained as hybridoma supernatants from an in-house antibody facility 
as indicated in Table 10. If not stated differently the antibodies are directed against 
mouse antigens. 
 
Table 10: Antibodies and cytokines 
Name	   Company	   Dilution	   Application	  
Anti-Ago2 (2D4) Wako 0.1 µg/µl IP 
Anti-B220 (RA3-6B2) eBioscience 1:200 Flow cytometry 
Anti-CAR (E1-1)  BD Biosciences 1:20 Flow cytometry 
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Name	   Company	   Dilution	   Application	  
Anti-CD134 (Ox40, clone OX-86) eBioscience 1:200 Flow cytometry 
Anti-CD278 (human ICOS, ISA-3) eBioscience 1:1000 Flow cytometry 
Anti-CD278 (Icos, 7E.17G9) eBioscience 1:200 Flow cytometry 
Anti-CD279 (PD-1, clone J43) eBioscience 1:200 Flow cytometry 
Anti-CD28 (37N) In-house production 1.0 µg/ml Th1 cell culture 
Anti-CD3 (145-2C11) In-house production 0.1 µg/ml Th1 cell culture 
Anti-CD3 (145-2C11) eBioscience 1:200 Flow cytometry 
Anti-CD4 (RM4-5) eBioscience 1:200 Flow cytometry 
Anti-CD44 (IM7) eBioscience 1:200 Flow cytometry 
Anti-CD62L (MEL-14) eBioscience 1:200 Flow cytometry 
Anti-CD8 (53-6.7) eBioscience 1:200 Flow cytometry 
Anti-CD90.1 (Thy1.1, OX-7) eBioscience 1:200 Flow cytometry 
Anti-CD95 (Jo2) eBioscience 1:200 Flow cytometry 
Anti-Ctla4 (UC10-4B9) eBioscience 1:100 Flow cytometry 
Anti-CXCR5 (2G8) In-house production 1:10 Flow cytometry 
Anti-FoxP3 (FJK-16s) eBioscience 1:100 Flow cytometry 
Anti-GL-7 BD Pharming 1:800 Flow cytometry 
Anti-hamster IgG MP Biochemicals 0.1 mg/ml Th1 cell culture 
Anti-IFN-γ (XMG1.2) eBioscience 1:200 Flow cytometry 
Anti-IL-4 (11B11) In-house production 10 µg/ml Th1 cell culture 
Anti-IL-4 PE (11B11)  eBioscience 1:200 Flow cytometry 
Anti-KLRG1 (2F1) eBioscience 1:200 Flow cytometry 
Anti-mouse IgG (HRP coupled) Cell signaling 1:3000 IB 
Anti-NK1.1 (PK136) eBioscience 1:200 Flow cytometry 
Anti-rat IgG (biotinylated) Jackson ImmunoResearch 1:200 Flow cytometry 
Anti-rat IgG (HRP coupled) Cell signaling 1:3000 IB 
Anti-Roquin (18F8) In-house production 2 mg/ml IP 
Anti-Roquin (3F12) In-house production 2 mg/ml 
1:10 
IP 
IB 
Anti-TCRβ (H57-597) eBioscience 1:200 Flow cytometry 
Anti-tubulin (B-5-1-2) Santa Cruz 1:2000 IB 
Fc-block (CD16/31; 2.4G2) In-house production 10 µg/ml Flow cytometry 
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Name	   Company	   Dilution	   Application	  
PBS57-loaded CD1d Tetramer National Institutes of Health 1:100 Flow cytometry 
Recombinant human IL-2 
(ProleukinS) 
Novartis 20 U/ml Th1 cell culture 
Recombinant mouse IL-12 BD Biosciences 10 ng/ml Th1 cell culture 
Streptavidin  eBioscience 1:200 Flow cytometry 
 
3.1.6 Chemicals, enzymes and kits 
Table 11: Chemicals and solutions 
Chemicals	  and	  solutions	   Company	  
2-Propanol Merck 
2log DNA ladder New England Biolabs 
Acrylamide 4K solution Applichem 
Albumin fraction V (Bovine serum albumin, BSA) Roth 
Amersham ECL Prime GE Healthcare 
Ammonium persulfate (APS) Serva 
Ampicillin Roche 
ATP [γ-32P] Hartmann Analytic 
Baker’s yeast tRNA Sigma 
Bio-Rad Protein assay (Bradford solution) Bio-Rad 
Biozym LE Agarose Biozym 
Boric acid Calbiochem 
Brefeldin A eBioscience 
Calcium chloride Merck 
Chloroform Sigma 
Chloroquin Sigma 
Coomassie brilliant blue R-250 Roth 
DETACHaBEAD® Mouse CD4 (L3T34) Invitrogen 
Dithiothreitol (DTT) Applichem 
dNTP set Thermo Scientific 
Doxycyclin Applichem 
Dynabeads® M-280 Streptavidin Invitrogen 
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Chemicals	  and	  solutions	   Company	  
Dynabeads® Mouse CD4 Invitrogen 
Dynabeads® MyOneTosylactivated Invitrogen 
Dynabeads® Protein G for Immunoprecipitation Invitrogen 
EDTA, pH 8.0, 0.5 M Roth 
Epsilon aminocaproic acid Applichem 
Ethanol Merck 
EZ-link PEG4-NHS-Biotin Pierce 
Formaldehyde solution 36.5-38% Sigma 
GlycoBlue Ambion 
H2O2 Applichem 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Sigma-Aldrich 
Kanamycin Roth 
Methanol Merck 
Nonfat dry milk powder Applichem 
Nonidet P-40 Sigma-Aldrich 
NOVEX loading buffer Invitrogen 
NTP set Thermo Scientific 
Paraformaldehyde (PFA) solution, 8% Merck 
Polybrene Sigma-Aldrich 
Protease inhibitor tablets, cOmplete Mini EDTA-free Roche Diagnostics 
Rotiphorese Gel 30 (polyacrylamide for EMSAs) Roth 
Saponin GPR Rectapur 
Sodium acetate 3M, pH 5.2 Ambion 
Sodium dodecyl sulfate (SDS) pellets Serva 
Spectinomycin Applichem 
Tamoxifen Sigma-Aldrich 
TEMED Applichem 
TRI reagent solution Ambion 
Trypsin-EDTA Gibco, life technologies 
Tween 20 Applichem 
UTP [α-32P] Hartmann Analytic 
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Table 12: Enzymes 
Enzyme	   Company	  
FastAP (Alkaline phosphatase) Fermentas 
Gateway® LR Clonase® II Enzyme Mix life technologies 
PNK (Polynucleotide kinase) Fermentas 
Proteinase K Roche 
RNase T1 Thermo scientific 
RNasin® Promega 
SuperScript® III Reverse Transcriptase Invitrogen 
T4 Polynucleotide Kinase Thermo scientific 
T4 RNA ligase Fermentas 
T7 RNA Polymerase Agilent technologies 
Taq Polymerase Invitrogen 
Turbo-DNase Ambion 
 
Table 13: Kits 
Kit	   Company	  
Foxp3 staining buffer set eBioscience 
GeneChip WT Terminal Labeling and Controls Kit Affymetrix 
LIVE/DEAD® Fixable Blue Dead Cell Stain Kit Invitrogen 
LR Clonase enzyme mix Invitrogen 
mMESSAGE mMACHINE® T7 Transcription Kit Ambion 
Nucleobond®Xtra Maxi Machery-Nagel 
One-Step RT-PCR Kit Qiagen 
pCR™8/GW/TOPO® TA Cloning® Kit life technologies 
PureYield™ Plasmid Miniprep System Promega 
QIA®quick Gel extraction Kit Qiagen 
QIA®quick Nucleotide removal Kit Qiagen 
QuantiTect Reverse Transcription Kit Qiagen 
QuikChange XL Site-Directed Mutagenesis Kit Agilent Technologies 
RNeasy® Mini Kit Qiagen 
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Kit	   Company	  
Universal Probe Library 
LightCycler® 480 Probes Master 
Roche Diagnostics 
WT Expression Kit Ambion 
 
3.1.7 Buffers 
Table 14: Buffers for standard procedures 
Name	   Composition	  
Blotting buffer 
25 mM Tris 
192 mM glycine 
20% methanol 
Coomassie destaining solution 
50% methanol 
40% H2O 
10% acetic acid 
Coomassie staining solution 
50% methanol 
40% H2O 
10% acetic acid 
0.25 g/l Coomassie brilliant blue R-250 
FACS buffer PBS with 2 % FCS 
HBS (2x) 
274 mM NaCl 
10 mM KCl 
1.4 mM Na2HPO4, pH 7.0 
Lysis buffer 
20 mM Tris-HCl pH 7.5 
150 mM NaCl 
0.25 % NP-40 
1.5 mM MgCl2 
PBS 
137 mM NaCl 
10 mM Na2HPO4, pH 7.4 
2.7 mM KCl 
Saponin buffer PBS with 0.5% saponin and 1% BSA 
SDS PAGE buffer 
25 mM Tris 
200 mM glycine 
0.1% SDS 
SDS sample buffer (4x) 
200 mM Tris-HCl, pH 6.8 
8% SDS 
4% glycerol 
0.1% bromophenol blue 
10% β-mercaptoethanol 
TAC lysis buffer 
13 mM Tris 
140 mM NH4Cl, pH 7.2 
TBE (1x) 
89 mM Tris-borate 
2 mM EDTA, pH 8.0 
TBS 50 mM Tris-HCl pH 8.0 150 mM NaCl 
TBS-T TBS with 0.05 % Tween-20 
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Table 15: Buffers for CLIP and PAR-CLIP assays 
Name	   Composition	  
5x PNDS buffer 
(High salt wash) 
5x PBS 
0.5% NP-40 
0.25% Deoxychelate 
0.1% SDS 
1 mM DTT 
EGTA wash buffer 
20 mM Tris-HCl pH 7.5 
20 mM EGTA 
0.2% Tween-20 
Mg wash buffer 
20 mM Tris pH 7.5 
10 mM MgCl2 
0.2% Tween-20 
1mM DTT 
PN8 0.1 M Na-Phosphate pH 8.0 0.01% NP-40 
PNDS lysis buffer 
1x PBS 
0.5% NP-40 
0.25% Deoxychelate 
0.05% SDS 
Proteinase K (PK) digestion buffer 
100 mM Tris-HCl pH 7.5 
50 mM NaCl 
10 mM EDTA 
RNA elution buffer 
1 M sodium acetate, pH 5.5 
1 mM EDTA 
 
Table 16: Buffers for SELEX and Filter binding assays 
Name	   Composition	  
Filter activation buffer 40 mM aminocaproic acid 20% Methanol 
PAA-loading buffer 9 M Urea 50 mM EDTA, pH 8.0 
Selection buffer 
20 mM HEPES, pH 7.4 
150 mM NaCl 
1 mM MgCl2 
1 mM DTT 
1µg/µl BSA 
Washing buffer 
20 mM HEPES, pH 7.4 
150 mM NaCl 
1 mM MgCl2 
1 mM DTT 
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3.1.8 Columns and consumables 
Table 17: Columns and consumables 
Name	   Company	  
Centrifugal filter units, Amicon Ultra, 30K Millipore 
Costar Spin-X centrifuge tube filter Sigma-Aldrich 
Disposable PD-10 Desalting Columns GE Healthcare 
Filter paper, 1 mm and 2 mm Whatman 
GeneChip Mouse Gene 1.0 ST Arrays Affymetrix 
His-Trap HP GE Healthcare 
Immobilon® PVDF Membrane Millipore 
Mesh, fine (41 µm) and rough (150 µm) Reichelt Chemietechnik 
MicroSpin Columns P30 Bio-Rad 
Nitrocellulose membrane (Protran®) Whatman 
Surgical disposable scalpels Braun 
 
3.1.9 Instruments 
Table 18: Instruments 
Instrument	   Company	  
96-well dotblotter SRC 96 D Minifold I (Schleicher und Schüller) 
Accuracy weighing machine KERN ABJ-220-4M (Kern und Söhne GmbH) 
KERN EW 220-3NM (Kern und Söhne GmbH) 
Agarose gel chambers Peqlab Biotechnologie GmbH 
Bacterial incubator Brutschrank BINDER BF 53 (Binder Labortechnik) 
Innova 4400 incubator shaker (New Brunswick Scientific GmbH) 
BD FACS AriaIII Cell Sorter BD Biosciences 
BD LSR Fortessa Cell Analyzer BD Biosciences 
Bead separation magnet DynaMagTM-5 Magnet (Invitrogen) 
Cell counting chamber Neubauer counting chamber (Marienfeld Superior) 
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Instrument	   Company	  
Centrifuges and rotors Beckman Coulter Avanti-J-26XP (Beckman Coulter); JA-10 
Rotor, Fixed Angle (Beckman Coulter) 
Allegra®X-12R Centrifuge (Beckman Coulter); Rotor SX 4750 
(Beckman Coulter) 
Eppendorf Centrifuge 5810R (Eppendorf); Rotor A-4-62 and F-
34-6-38 
CO2 incubator Forma Direct Heat CO2 Incubator HEPA Class 100 (Thermo 
Electron Corporation) 
Coasting mixer Tube Roller-Mixers, SRT1 (Stuart) (ScienceLab) 
Gel documentation Quantum ST4 (Vilber) 
Gel drying system SLAB Gel dryer Model GD2000 (Hoefer) 
Ice machine Scotsman AF 200 (Scotsman Ice system) 
Magnet stirrer RCT basic safety control (IKA) 
Magnetic phosphoimager screen Imaging plate BAS-IP MS 2025 (Fujifilm) 
Microscope Axiovert 40C (Zeiss) 
Microwave Bosch 
Mixing wheel Dynabeads® MX 12-tube Mixing Wheel (Applied biosystems) 
pH meter pH-Meter inoLab® pH 720 (WTW GmbH) 
Phospho-image reader FLA 5100 Image analysis system (Fujifilm) 
Power supply Stromgeber EC105 (Thermo Electron Corporation) 
Bio-Rad energy supplier (Bio-Rad) 
Sonification device Digital sonifier Model 250 D (Branson) 
Spectrophotometer Eppendorf Bio Photometers (Eppendorf) 
NanoDrop TM 1000 Spectrophotometer (Thermo Scientific) 
Sterile-working bench  BDK, Luft und Reinraumtechnik 
Table centrifuges Centrifuge 5415D (Eppendorf) 
Centrifuge 5417R (Eppendorf) 
Tank blotting chamber Trans-blot Cell, Bio-Rad 
Thermo cycler DNA Engine 48/48 Dual Alpha Unit (Bio-Rad) 
Light Cycler 480II (Roche) 
Thermo mixer Thermomixer comfort (Eppendorf) 
UV crosslinker Stratagene 
UV transilluminator TS-40 (Ultra-Violet Products Ltd.) 
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Instrument	   Company	  
Vacuum pump Diaphragm Vacuum Pump MZ 2C (Vacuubrand) 
Vertical Electrophoresis apparatus Vertical Electrophoresis apparatus (Bio-Rad) 
Vortexer Vortex Genius 3 (IKA) 
 
3.1.10   Software and databases 
Table 19: Software and databases 
Name	   Application	   Company/URL	  
Adobe Creative suite 5 Illustrator (Figures, Schemes) 
Photoshop (Image processing) 
Adobe 
AIDA Image Analyzer Quantification of 32P signals Raytest 
ClipZ Analysis of PAR-CLIP data http://www.clipz.unibas.ch/ 
Clustalw Multiple alignments http://www.ebi.ac.uk/Tools/msa/clustalw2/ 
FlowJo  version 9.4.10 FACS data analysis  FlowJo 
Graphpad Prism® Statistics and graphs Graphpad 
LightCycler software qPCR data analysis Roche Diagnostics 
MEME Sequence motif search http://meme.nbcr.net/meme/cgi-
bin/meme.cgi 
Mfold RNA folding  http://mfold.rna.albany.edu/?q=mfold 
Microsoft Office 2011 Data analysis (Excel) 
Writing (Word) 
Microsoft 
NCBI Nucleotide cDNA sequences http://www.ncbi.nlm.nih.gov/nucleotide/ 
ProbeFinder version 
2.49 (Mouse) 
qPCR primer design Roche Diagnostics 
QuickChange primer 
design 
Primer design for mutagenesis http://www.genomics.agilent.com/primerDe
signProgram.jsp 
RNAalifold RNA structure analysis http://rna.tbi.univie.ac.at/cgi-
bin/RNAalifold.cgi 
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3.2 Methods 
3.2.1 Molecular biological methods 
3.2.1.1 Polymerase chain reaction (PCR) 
Using heat-stable Taq DNA Polymerases and cycling temperature profiles, PCR allows 
exponential amplification of specific DNA fragments that are flanked by the respective 
primer sequences. In addition to PCR reactions for library preparations (3.2.5), the 
method was used to amplify Ox40 (NM_011659) full-length (fl) and CDS from murine 
T cell cDNA. Using the Taq Polymerase (Invitrogen) resulted in deoxyadenosine (A) 
overhangs, which were required in the subsequent TA cloning procedure. The reaction 
mix contained about 100 ng cDNA as template, 5 µl 10x reaction buffer, 1 µl dNTP 
Mix (10 mM each), 1 µl MgCl2 (50 mM), 2 µl forward and reverse primer (10 mM 
each) and 1 µl Taq Polymerase. Deionized water was added to reach the final volume of 
50 µl. The PCR was performed for 30 cycles with denaturation at 95°C for 30 sec, 
annealing at 52°C for 30 sec and elongation at 72°C for 45 sec. The reaction products 
were visualized and size separated by electrophoresis on a 1.5% (w/v) agarose gel in 1x 
TBE buffer. The band with the correct size was cut, and DNA was purified using the 
QIA®quick gel extraction Kit according to the given instructions. 
 
3.2.1.2 Cloning and bacterial culture 
Purified PCR products were transferred into the topoisomerase-I-activated entry vector 
pCR8-GW via TOPO®TA-cloning following the manual of the kit (life technologies). 
Amplification and cloning of the obtained plasmids was performed in bacterial cultures 
of the Dh5α E. coli strain. The bacteria were grown in LB medium or on LB agar plates 
supplemented with ampicillin (100 µg/ml), spectinomycin (100 µg/ml) or kanamycin 
(50 µg/ml) to select for bacteria with the respective plasmids. Plasmid DNA was 
purified using the PureYield™ Plasmid Miniprep System (Promega) kit for small-scale 
and the Nucleobond®Xtra Maxi (Machery-Nagel) kit for large-scale bacterial cultures.  
Cloned DNA sequences can be transferred into different destination vectors using the 
Gateway® technology that promotes lambda recombination (LR) via recombination 
sites within the entry vector (AttL1 and 2) and destination vector (AttR1 and 2) 
backbones. The LR reaction using the LR Clonase® II Enzyme Mix (life technologies) 
was performed for one hour at room temperature (RT) followed by Proteinase K 
treatment and heat-shock transformation of Dh5α E. coli. Correct recombination 
removes the toxin-encoding ccdB gene from the destination vector that also carries an 
antibiotic resistance gene different from the entry vector. Both features ensure that only 
bacteria transformed with the correct destination plasmid form colonies. 
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For site directed mutagenesis of plasmid DNA the QuickChange XL Mutagenesis Kit 
(Agilent) was used according to the manufacturer’s suggestions. Using specifically 
mismatching primers in a PCR that amplifies the whole plasmid causes nucleotide 
deletions, insertions or nucleotide exchanges that can result in amino acid exchanges in 
the encoded protein. A DpnI digest of the template plasmid ensures high mutation rates 
in the clones resulting from bacterial transformation. Primers for this method were 
designed using the manufacturer’s online tool (QuickChange primer design, Table 19). 
 
3.2.1.3 Recombinant protein expression and purification 
Expression of Roquin N-terminal proteins (Roquin-1 aa 2-440, Roquin-1 M199R aa    
2-440, Roquin-2 aa 2-438) from the respective pETM11 constructs was induced in 
transformed Rosetta (DE3) pLysS E. coli cultures. Having an optical density (OD) of 
0.6-0.8 the cultures were complemented with 1 mM IPTG and incubated over night, 
shaking at 12°C. Harvested bacteria pellets were resuspended in PBS complemented 
with protease inhibitors (Roche) and 1 mM DTT for sonification on ice (amplitude 
30%). The disrupted cells were further lysed by addition of 1% Triton-X100 and 30 min 
incubation on ice, and cell debris was removed by centrifugation. Recombinant Roquin 
proteins were then purified from the bacterial lysate using a HisTrap column (GE 
Healthcare) according to the instructions of the manufacturer. The eluted fractions 
containing the protein were combined and desalted via a PD10 gel filtration column 
(GE Healthcare). The proteins were kept in storage buffer (100 mM NaCl, 20 mM 
NaH2PO4, pH 7.5) and snap frozen in liquid nitrogen for storage at -80°C. 
Full-length Roquin-1 was expressed from a construct containing an N-terminal His6-tag 
and a C-terminal Strep-tag II in the E. coli strain Rosetta2 (DE3). The protein was 
purified using two consecutive affinity chromatography steps on a HiTrap chelating 
column (GE Healthcare) and a StrepTrap column (GE Healthcare). The purification 
buffer was 50 mM Tris-HCl pH 8.0, 300 mM NaCl and 0.01% (v/v) 1-thioglycerol. 
Full-length Roquin-1 protein was provided by Dr. Arie Geerlof, Helmholtz Zentrum 
München. 
The minimal ROQ domain (Roquin-1 aa 147-326) was defined and purified as 
described (Schlundt et al. 2014). Protein samples for EMSA experiments were obtained 
from Dr. Andreas Schlundt, Helmholtz Zentrum München. 
 
3.2.1.4 Monoclonal antibody production and coupling to magnetic beads 
A new monoclonal antibody for immunoprecipitations (IPs) of Roquin-1 and Roquin-2 
was produced in collaboration with Dr. Elisabeth Kremmer’s group, Helmholtz 
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Zentrum München. To do so, a rat was immunized with N-terminal Roquin-1 and 
Roquin-2 proteins (aa 2-440 and aa 2-438 respectively), and hybridoma cells lines were 
generated from B cells of the spleen. By testing the antibody containing hybridoma 
supernatants first in ELISA (Enzyme-linked immunosorbent assay) and then in an IP 
screening procedure the antibody clone 18F8 was found to be highly efficient and 
specific in Roquin-1 and Roquin-2 IPs. 
In-house produced monoclonal antibodies were purified from cell culture supernatants 
and coupled to tosyl-activated magnetic beads (Invitrogen) to achieve highly efficient 
IPs of endogenous Roquin proteins. For one coupling reaction, 4 mg of antibody were 
spin-concentrated (Centrifugal filter units) to a concentration of 2 mg/ml and combined 
with 50 mg magnetic beads in coating buffer according to the protocol provided with 
the beads. After completing the coupling protocol, the beads were stored in PBS 
(complemented with 0.1% BSA, 0.05% Tween-20, 0.02% sodium azide) at 4°C. 
 
3.2.1.5 Immunoprecipitation, SDS-PAGE and immunoblotting 
For protein analyses, MEFs and Th1 cells were harvested, washed once in PBS and 
lysed in lysis buffer (1 mM DTT and protease inhibitors added freshly), using three 
times the volume of the cell pellet. After 10 min incubation on ice and repeated mixing, 
the cell debris was removed by centrifugation (10,000 g, 10 min, 4°C), and the protein 
concentration of the lysate was determined using the Bio-Rad protein assay according to 
the manufacturer’s instructions. For SDS-PAGE (SDS polyacrylamide gel 
electrophoresis), the lysate was complemented with 4x SDS sample buffer and boiled 
for 5 min at 95°C. Depending on the expression level of the protein of interest 30-80 µg 
of protein were loaded onto an SDS polyacrylamide gel (8% to 10% depending on the 
size of the protein of interest) and separated by electrophoresis at 120V for about           
1 hour. 
Immunoprecipitations were performed using cell lysates (2-5 mg of protein) and 50 µl 
of antibody-coupled tosyl-activated beads. After 4 hours of incubation on a mixing 
wheel at 4°C, the lysate was removed from the beads using a magnetic separator. The 
beads were washed 5x with lysis buffer and finally resuspended in a small volume of 1x 
SDS sample buffer for elution at 95°C. The samples were separated by SDS PAGE as 
described above. 
For immunoblotting samples were transferred from the SDS polyacrylamide gel onto a 
PVDF membrane by tank blotting over night at 40 V and 4°C. Subsequently, the 
membrane was blocked using 5% nonfat dry milk in TBS for 1 hour at RT, followed by 
incubation in a dilution of the primary antibody to detect the protein of interest (2 hours 
RT for anti-tubulin or 2 hours 4°C and 1 hour RT for anti-Roquin 3F12). After three   
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10 min washing steps with 1% nonfat dry milk in TBS-T, the membrane was incubated 
in the corresponding HRP-coupled anti-IgG antibody solution for 1 hour at RT. 
Subsequently, the membrane was again washed three times (10 min each time), and 
protein bands were detected on an X-ray film using ECL substrate for the HRP to 
promote light emission. 
 
3.2.2 RNA methods 
3.2.2.1 In vitro transcription 
For in vitro transcription of large (>500 nts) RNAs to be used in Electrophoretic 
mobility shift assays (EMSAs), the mMessage mMachine kit was used according to the 
protocol provided by the manufacturer. To do so, pDest17 plasmids containing Ox40 fl 
or Ox40 CDS (NM_011659) as inserts were linearized in a NotI restriction digest and 
purified by ethanol precipitation. The obtained DNA was used as template in the T7 
RNA polymerase transcription reaction. 
Short RNAs (20-180 nts) for EMSAs or filter binding assays (FBAs) were in vitro 
transcribed from DNA templates that had been generated in a PCR adding a T7 
transcription start site to purchased DNA oligonucleotides. For the reaction, equimolar 
amounts of DNA template, NTPs (1.25 mM each), 10x reaction buffer, 17 mM MgCl2 
and an enzyme mix (2:1) of T7 RNA polymerase (Agilent technologies) and RNasin 
(Promega) were combined and incubated at 37°C for 4 hours. Radioactive labeling was 
achieved by adding α-32P-UTP to the transcription reaction.  
 
3.2.2.2 RNA purification and radioactive labeling 
To purify total RNA from Th1 cell samples, cell pellets were resuspended in 1 ml TRI 
reagent solution (Ambion). Upon addition of 200 µl of chloroform, the aquaeous phase 
was separated by centrifugation (12,000 g, 15 min, 4°C) and collected in a fresh tube. 
After isopropanol precipitation in the presence of 1 µl glycogen, the RNA pellet was 
washed in 75% ethanol and finally resuspended in RNase-free water. RNA yield and 
purity were determined by spectrophotometer measurements using the NanoDrop 
device. 
Radioactive labeling of purchased RNA oligonucleotides was performed using γ-32P-
ATP and the T4 Polynucleotide Kinase (PNK) in a forward reaction (30 min, 37°C). 
The mix contained 50 pmol RNA, 2 µl 10x reaction buffer (PNK buffer A), 20 pmol    
γ-32P-ATP, 1 µl T4 PNK and RNase-free water to a final volume of 20 µl. To terminate 
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the reaction, 1 µl 0.5 M EDTA (pH 8.0) was added and the sample was incubated 
another 10 min at 70°C.  
After the labeling reaction, RNAs were purified using the QIAquick nucleotide removal 
kit according to the instructions of the manufacturer. Assuming that no RNA was lost 
during the reaction and purification process, 50 µl of RNase-free water were used for 
elution to obtain a 1 µM RNA solution. The same purification procedure was applied to 
short RNAs from in vitro transcription reactions. For the purification of large RNAs 
after in vitro transcription (mMessage mMachine kit) the RNeasy® mini kit (Qiagen) 
was used according to the manufacturer’s protocol. RNA yield and purity were 
measured with the NanoDrop device. 
 
3.2.2.3 Reverse transcription and quantitative real-time PCR (qPCR) 
Reverse transcription of total RNA to obtain cDNA for qPCR measurements was 
performed using the QuantiTect Reverse Transcription Kit (Qiagen) according to the 
provided protocol. Primer sequences and the respective probes used for the assays are 
given in Table 9. 
For qPCR reactions, the Universal probe library was used together with the LightCycler 
480 probes Master (both Roche Diagnostics) according the instructions of the 
manufacturer. The assays were run on a Light Cycler 480II equipped with the Light 
Cycler 480 SW 1.5 software. The qPCR primer design was performed with the help of 
the assay design software (ProbeFinder version 2.49 for Mouse) provided by Roche. All 
reactions were run in duplicates to control for technical errors, Ywhaz served as 
reference gene in Th1 cell samples, and the relative expression was calculated with the 
equation: fold change=2^-(Ct(GOI)- Ct(RG)) (Ct: threshold cycle, GOI: Gene of 
interest, RG: reference gene). The Ct values were obtained from the Light Cycler 480 
SW 1.5 software.  
 
3.2.2.4 Filter binding assay (FBA) 
To probe many different RNAs at the same time for protein binding, FBAs were 
performed as described (Vogel et al. 2013). In short, radioactively labeled RNA was 
employed in a binding reaction with recombinant Roquin-1 and Roquin-2 N-terminal 
protein for 30 min at 37°C in 20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM MgCl2,      
1 mM DTT and 1 µg/µl BSA. After the binding, the samples were applied onto 
nitrocellulose filters in a dot blot device, and after five washing steps, protein-bound 
RNA could be detected on the membrane using a phosphoimager screen. To calculate 
the relative retention, the same amount of labeled RNA as in a binding reaction was 
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spotted onto the membrane, and radioactive signals were quantified using the AIDA 
Image analyzer software. 
FBAs with competitor RNA were performed as described above, yet with the addition 
of the respective amount of unlabeled competitor RNA (ICOS nts 600-700 or nts 700-
800, NM_012092.3) to the binding reaction. 
 
3.2.2.5 Electrophoretic mobility shift assays (EMSAs) 
Depending on the size of the RNA being probed in an EMSA experiment, different 
approaches were used. Short RNAs (20-180 nts) were labeled with 32P and gel shifts 
were investigated in acrylamide gels. Binding of Roquin to long RNAs (>500 nts) was 
visualized in agarose gels using ethidiumbromide. 
Shift assays in agarose gels were conducted as published (Glasmacher et al. 2010) with 
slight modifications. The binding buffer contained 150 mM NaCl, 20 mM HEPES (pH 
7.4), 1 mM MgCl2 and 1 mM DTT. After binding of recombinant Roquin-1 and 
Roquin-2 N-terminal protein and RNA for 30 min on ice, glycerol was added to the 
sample to achieve a final concentration of 16%. The electrophoresis was performed in a 
0.75% agarose gel in TBE buffer at 120 V for 1.5 hours. Subsequently, the gel was 
stained in an ethidiumbromide bath for 30 min, and the RNA bands were visualized on 
a UV transilluminator. 
EMSAs with short 32P-labeled RNAs were established on the basis of Leppek et al. and 
performed as published (Schlundt et al. 2014). The binding reaction containing           
2.5 µg/µl tRNA from baker’s yeast (Sigma), 1 pmol 32P-labeled RNA, 20 mM HEPES 
(pH 7.4), 50 mM NaCl, 1 mM MgCl2, 1 mM DTT, 1 µg/µl BSA and the indicated 
amount of recombinant protein was performed in a volume of 20 µl for 10 min at RT or 
for 20 min on ice. Subsequently, 4 µl 30% glycerol were added to load the samples onto 
a 6% polyacrylamide gel (5% glycerol, in 0.5x TBE) for PAGE (120 V, 40 min, RT) of 
the protein-RNA complexes. The gels were placed in fixing solution (20% methanol, 
20% acetic acid) for 30 min before drying and exposing them to a phosphorimager 
screen.  
The detected signals of the RNA were quantified using the AIDA Image Analyzer 
software. For calculation of the dissociation constant (Kd value), the bound fraction was 
normalized to the unbound fraction for each lane and plotted against the respective 
protein concentration. Using the Graphpad Prism software, a non-linear regression 
curve was fitted to the data points with the equation: y=Bmax*x^h/(Kd^h+x^h) (Bmax: 
maximum specific binding, Kd: dissociation constant, h: Hill coefficient).  
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3.2.3 Cell biological methods 
3.2.3.1 Calcium phosphate transfection and retrovirus production 
The calcium phosphate transfection method was used to introduce retroviral expression 
plasmids (pMSCV-IRES-Thy1.1 or pKMV-IRES-GFP) and packaging plasmids into 
HEK293T cells for retrovirus production. In detail, production of ecotropic retroviruses 
required 50 µg expression plasmid DNA and 5 µg eco-pac packaging plasmid to 
transfect a 15 cm cell culture dish of HEK293T cells (60-80% confluent). For 
amphotropic retroviruses, 16 µg expression plasmid DNA, 4 µg gag-pol and 2 µg 
ampho-env packaging plasmids were used per 15 cm dish. To increase the transfection 
efficiency, HEK293T cells were treated with 100 µM chloroquine in DMEM (10% 
FCS, 100 U/ml penicillin/streptomycin and 10 mM HEPES) for 1 hour before adding 
the transfection mix containing plasmid DNA, CaCl2 (125 mM) and HBS. 6-8 hours 
after transfection, the cells were provided with fresh DMEM (10% FCS, 100 U/ml 
penicillin/streptomycin and 10 mM HEPES). After 48 hours, the cell culture supernatant 
containing retrovirus particles was harvested, filtered through 0.45 µm-filter units and 
stored at -80°C. 
 
3.2.3.2 Retrovirus infection of MEFs and primary T helper cells 
Retroviral transduction of MEFs or primary CD4+ T cells was achieved by spin 
infection protocols. The retrovirus containing supernatants were used either pure or in 
dilution and complemented with polybrene (MEFs: 5 µg/ml; T cells: 9 µg/ml) before 
applying them to the cells. 
Best infection levels in MEFs were achieved with 30% confluent cells and spinning for 
1 hour at 300 g and 32°C. After centrifugation, the virus remained on the cells for        
6-8 hours and was then exchanged for fresh DMEM (10% FCS, 100 U/ml 
penicillin/streptomycin and 10 mM HEPES).  
Infection of primary T helper cell cultures was performed 40 h after plate-bound anti-
CD3/anti-CD28 activation of naïve CD4+ T cells by adding the prepared undiluted 
retrovirus-containing supernatants to the attached cells. Spinning was performed for      
1 hour at 820 g and 18°C, and the cells were rinsed from the plate and transferred to 
fresh T cell medium 6-8 hours after infection. 
Expression levels of virus-encoded genes were determined 2-3 days after infection by 
immunoblotting or flow cytometry. 
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3.2.3.3 CD4+ T cell isolation and Th1 cell culture 
For primary Th1 cell cultures, CD4+ T cells were isolated from spleen and lymph nodes 
of mice. To this end, the organs were collected and mashed through a 150 µm mesh to 
obtain a single-cell suspension. Upon erythrocyte lysis in TAC buffer (5 min on ice) and 
subsequent washing, the remaining leukocytes were filtered (fine mesh, 41 µm) and 
transferred to CD4 Dynabeads (Invitrogen) for selection of CD4+ cells (30 min, 4°C) 
according to the protocol provided by the manufacturer. Specific elution of CD4+ cells 
that were bound to the beads was achieved by incubating the beads in CD4 
DETACHaBEAD solution (Invitrogen) for 1 hour at RT. To set up a Th1 cell culture, 
CD4+ cells were seeded in T cell medium containing 0.1 µg/ml anti-CD3 and 1.0 µg/ml 
anti-CD28, 10 µg/ml anti-IL-4 and 10 ng/ml IL-12. For the first 48 hours, 5-6 million 
CD4+ cells/ml were cultured on anti-hamster IgG coated 6-well plates. The anti-hamster 
IgG binds the anti-CD3 and anti-CD28 antibodies and thereby renders T cell activation 
more efficient. Subsequently, the activated Th1 cells were removed from the 6-well 
plate and further expanded in T cell medium with 20 U/ml IL-2 for 3-4 days at a 
concentration of 1 million cells/ml.  
 
3.2.3.4 Cellular assay to monitor Ox40 regulation in response to Roquin-1 
overexpression 
To investigate the regulation of different Ox40 expression constructs by Roquin-1, a 
Rc3h1-2-/- MEF cell line was stably transduced with a doxycyclin (Dox)-inducible 
Roquin-1-p2A-mCherry construct. These cells were retrovirally infected with Ox40 
constructs of different 3’UTR length or mutation, which led to the expression of Ox40 
on the cell surface. 48 hours after infection, the cells were split, and one half of the cells 
was treated with doxycyclin (1 µg/ml) to induce expression of Roquin-1 and mCherry, 
connected via the self-cleaving peptide p2A. Thus, Roquin-expressing cells were 
marked by mCherry expression. 16-20 hours after induction, the cells were harvested, 
stained with APC-conjugated anti-Ox40 and analyzed by flow cytometry. To compare 
the Ox40 expression levels achieved by different constructs, the relative Ox40 mean 
fluorescence intensity (MFI) was determined by dividing the MFI of treated (mCherry+) 
cells by the MFI of untreated (mCherry–) cells. 
 
3.2.3.5 Cellular assay to monitor target regulation in response to acute 
Rc3h1-2 deletion 
To assess the post-transcriptional regulation of different target constructs mediated by 
endogenous Roquin-1 and Roquin-2 levels, an acute deletion assay was established in 
Cre ERT2; Rc3h1-2fl/fl; CAG-CARstop-fl MEFs. This transgenic cell line expresses a Cre 
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recombinase-ERT2 fusion protein that is translocated to the nucleus upon 
tamoxifentreatment. Thus, genomic deletion of Rc3h1-2 alleles and of the STOP 
cassette proceeding CAR is achieved, which induces CAR surface expression. The cells 
were transduced with ecotropic retroviruses expressing Ox40 and ICOS constructs and 
split 24 hours after infection to treat one half of the cells with tamoxifen (0.3 µM). After 
2-4 days of tamoxifen treatment, the cells were stained and analyzed by flow cytometry. 
Thereby, the reporter expression of untreated (CAR–) cells was compared to the reporter 
expression of treated (CAR+) cells.  
 
3.2.3.6 Cellular assays to monitor Roquin function 
The function of the Roquin-1 and different Roquin-1 mutants (obtained by 
QuickChange mutagenesis) was studied in Rc3h1-2-/- MEFs as published (Schlundt et 
al. 2014). ICOS fl, Ox40 fl or ICOS CDE260 expressing amphotropic retroviruses were 
used as reporters for Roquin-1 function. After primary infection with the reporter 
constructs, the cells were split and again spin-infected with different Roquin-1-
expressing viruses or an empty virus as control. For the secondary infection, the viruses 
were titrated to achieve infection levels of 50-70%. Expression levels of the different 
Roquin-1 variants were checked by immunoblotting, using the 3F12 monoclonal 
antibody against Roquin-1 and Roquin-2 compared to anti-tubulin as loading control.  
60 hours after the secondary infection, the expression of the infection markers GFP 
(primary infection) and Thy1.1 (secondary infection) as well as the expression level of 
the reporter ICOS or Ox40 was determined. To this end, the cells were stained with 
anti-mouse Thy1.1, anti-human ICOS or anti-mouse Ox40 antibodies and analyzed by 
flow cytometry. To compare different Roquin-1 variants, the relative MFI of 
Thy1.1+/Thy1.1– cells was calculated. 
 
3.2.4 Flow cytometry and cell sorting 
3.2.4.1 Cell surface staining 
MEFs were trypsinized prior to cell surface staining using antibodies diluted according 
to Table 10 in FACS buffer (PBS, 2% FCS). After 20 min incubation at 4°C, the cells 
were washed and fixed in 2% formaldehyde in PBS for 15 min at RT. The cells were 
washed again and analyzed using the LSR Fortessa flow cytometer (BD Bioscience). 
Splenocyte suspensions were prepared by mashing mouse spleens through a 150 µm 
mesh and performing TAC lysis (5 min on ice) followed by a washing step. Before 
staining, the cells were incubated with 10 µg/ml Fc-block in FACS buffer for 10 min on 
ice. The commercially available antibodies were diluted in FACS buffer (Table 10), 
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and cells were stained for 20 min on ice. Staining with the in-house produced anti-
CXCR5 antibody (1:10 dilution in FACS buffer) was performed for 1 hour at RT and 
followed by stainings with anti-rat IgG-biotin and strepatividin-APC. The PBS57-
loaded CD1d Tetramer to detect NKT cells was provided by the National Institute of 
Health and used in a 1:100 dilution. Shortly before analysis using the LSR Fortessa 
device, 10 µl of DAPI solution (5 mg/ml) were added to the sample for live/dead 
staining of the cells. 
 
3.2.4.2 Intracellular stainings 
Cell samples for intracellular staining were pre-incubated with fixable LIVE/DEAD® 
dye (Invitrogen, diluted 1:1000 in PBS) for 30 min on ice.  
After Fc-block treatment and surface staining, the cells were fixed using 4% 
paraformaldehyde in PBS for 10 min at RT and permeabilized by washing with Saponin 
buffer. Thus, the cells were prepared for intracellular staining of Ctla4 using the 
respective antibody diluted 1:100 in FACS buffer (20 min, on ice). 
Intracellular FoxP3 staining to identify peripheral Tregs required a specific fixing and 
permeabilization procedure using the Foxp3 Fixation/Permeabilization Concentrate and 
Diluent solutions (eBioscience). The solutions were used according to protocol provided 
by the supplier. In short, fixation (45 min, 4°C) and permeabilization (20 min, 4°C) 
were followed by FoxP3 staining (30 min 4°C, antibody diluted in permeabilization 
buffer). After washing, the cells were analyzed by flow cytometry. 
 
3.2.4.3 Flow cytometry data analysis 
Flow cytometry data was exported from the FACS Diva software and analyzed using 
FlowJo. The analysis of splenocytes from control mice (CD4 Cre or Rc3h1-2fl/fl), Ox40 
knockout mice (Ox40-/-; Rc3h1-2fl/fl), Roquin-1 and Roquin-2 double knockout mice 
(Rc3h1-2fl/fl; CD4 Cre) and Roquin and Ox40 triple knockout mice (Ox40-/-; Rc3h1-2fl/fl; 
CD4 Cre) followed a standardized gating strategy (Vogel et al. 2013). As an example, 
gating for Tfh cells is given in Figure 8. For statistical analysis, cell frequencies were 
obtained from FlowJo and further evaluated using GraphPad prism. 
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Figure 8: Gating strategy for Tfh cells using FlowJo. After choosing lymphocytes (FSC-A, SSC-A) for 
further analysis, doublet discrimination was accomplished and dead cells (DAPI+) were excluded. Tfh 
cells were identified as PD-1hi CXCR5hi subpopulation of CD4+ T cells. 
 
3.2.4.4 Cell sorting 
For cell sorting, primary Th1 cells were harvested, and cell surface staining was 
performed as described (3.2.4.1). Using the FACS Aria III Cell Sorter (BD Bioscience), 
Thy1.1+ CAR+ or Thy1.1hi cells were sorted for microarray experiments. The purity of 
the cell populations was checked by subsequent flow cytometric analysis. 
 
3.2.5 Structural analysis 
Methods concerning the crystal structure of the ROQ domain and the ROQ-Tnf CDE 
complex and NMR spectroscopy were performed by our collaborators Dr. Robert 
Janowski, PD Dr. Dierk Niessing’s group and Dr. Andreas Schlundt, Prof. Dr. Michael 
Sattler’s group (both Helmholtz Zentrum München). The work was published (Schlundt 
et al. 2014). 
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3.2.6 High throughput assays 
3.2.6.1 Microarray analyses 
For microarray analyses, primary Th1 cell cultures were set up from three Rc3h1-2fl/fl; 
CAG-CARstop-fl and three Rc3h1-2+/+; CAG-CARstop-fl mice as described in 3.2.3.3.       
40 hours after T cell activation, the cells were transduced with Cre recombinase-
expressing retrovirus to achieve acute deletion of Rc3h1-2 accompanied by CAR 
upregulation. After expansion of the Th1 cell culture in T cell medium with IL-2, the 
cells were harvested, stained and sorted to purify Thy1.1+ CAR+ cells. For each sample 
3 million sorted cells were obtained and resuspended in 1 ml TRI reagent for 
subsequent RNA purification. For a repeat of the experiment in animals lacking Icos, 
three Icos-/-; Rc3h1-2fl/fl and three Icos-/-; Rc3h1-2+/+ mice were used. Due to the lack of 
the CAG-CARstop-fl allele in these mice, Thy1.1hi cells (highest 25%) were sorted from 
the Th1 cultures upon Cre-mediated deletion of Rc3h1-2.  
RNA purification, quality check and processing of microarrays (GeneChip Mouse Gene 
1.0 ST Arrays, Affymetrix) using the respective reagents (WT Expression Kit, Ambion 
and GeneChip WT Terminal Labeling and Controls Kit, Affymetrix) was performed by 
Andrea Klanner from Dr. Helmut Blum’s group (Genzentrum, München). 
The bioinformatics data analysis was kindly performed by Dr. Dirk Repsilber 
(University of Örebro) based on Storey & Tibshirani, 2003. In short, he selected genes 
that show significant (q<0.05; the q-value is the false discovery rate analogue of the p-
value) differential expression in WT (Rc3h1-2+/+) compared to Roquin knockout 
(Rc3h1-2fl/fl) samples. Among these, genes with a fold change ≥1.5 were considered to 
be potential Roquin targets. To present the data in a heatmap he normalized the values 
according to Smyth & Speed 2003. 
 
3.2.6.2 CLIP and PAR-CLIP assays 
For cross-linking and immunoprecipitation (CLIP) and photoactivatable ribonucleoside-
enhanced CLIP (PAR-CLIP) assays (Ule et al. 2003; Hafner et al. 2010) (Figure 9), 
primary Th1 cell cultures from C57BL/6J mice were prepared according to 3.2.3.3 at 
the Biozentrum, Basel. 4 days after T cell activation, the cells were harvested, washed 
in PBS and irradiated with UV light. Half of the Th1 cells were treated with 100 µM    
4-thiouridine (4SU) 24 hours prior to UV cross-linking with 2x 0.15 J/cm2 and 365 nm 
(PAR-CLIP samples). The other half of the cells was irradiated with 254 nm UV light 
and 3x 0.1 J/cm2 (CLIP samples). 
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Figure 9: Schematic representation of the PAR-CLIP procedure. After incorporation of 4-thiouridine 
(4SU), the protein-RNA interactions were cross-linked by UV irradiation of the cells. Following cell lysis 
and partial RNase digest, protein-RNA complexes were immunoprecipitated and RNA fragments were 
purified for Illumina Solexa sequencing. 
 
The assays were performed together with Georges Martin, Prof. Dr. Mihaela Zavolan’s 
group (Biozentrum, Basel). 3F12 and 18F8 monoclonal antibodies coupled to tosyl-
activated magnetic beads (3.2.1.4) were used for Roquin-specific assays. A commercial 
anti-Ago2 antibody (Wako) bound in PN8 buffer to magnetic beads via protein G      
(20 µg antibody per 10 µl magnetic beads) served as control. Th1 cell lysates were 
prepared using PNDS lysis buffer complemented with protease inhibitors, Turbo-DNase 
(1:500), RNasin (10 µl/ml), DTT (1mM) and 1 µl RNase T1 (1:20 dilution). The cleared 
lysate was combined with magnetic antibody beads for IP (3 hours, 4°C, rotating). 
Subsequently, the beads were washed once with high salt buffer (5x PNDS buffer) and 
twice with PNDS buffer. RNase T1 was diluted 1:1000 in PNDS buffer for on-beads 
RNA digestion (15 min, 22°C), followed immediately by high salt and Mg washing 
steps. Next, the RNA in the complexes was dephosphorylated (20 min, 37°C, FastAP, 
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Fermentas), washed (Mg wash and EGTA wash), and 3’ adapter (5'-P-
uggaauucucgggugccaagg-block) ligation was performed at 16°C over night using the T4 
RNA ligase (Fermentas). On the next day, the beads were washed (5x PNDS, 3x Mg 
wash), the bound RNA was labeled with 32P, and after elution into NOVEX loading 
buffer the samples were separated by SDS PAGE. 
After blotting the protein-RNA complexes onto a nitrocellulose membrane, they were 
visualized using a phosphorimager. Bands corresponding to the size of the investigated 
proteins and up to 30 kDa higher were excised from the membrane and RNA fragments 
were eluted by Proteinase K digestion (4 mg/ml in 200 µl PK digestion buffer, 30 min, 
37°C). Upon addition of 200 µl 7 M urea, incubation (30 min, 55°C) and addition of   
50 µl 3 M sodium acetate, phenol-chloroform extraction was performed twice. By 
ethanol precipitation (30 min, -20°C), the RNA was purified and ligation of the PAGE-
purified 5’ adapter (5’-OH-guucagaguucuacaguccgacgauc-OH) was performed (over 
night, 4°C). The obtained RNA fragments were separated on a 10% TBE/Urea gel, and 
the gel pieces corresponding to 70-100 nts were excised. To extract the RNA from the 
gel pieces, they were incubated in 350 µl RNA elution buffer for 1 hour at 37°C.  After 
that, the supernatant was mixed with ethanol for RNA precipitation and purification.  
Finally, the RNA was reverse transcribed (Superscript III reverse transcriptase, 45 min, 
42°C) into cDNA, which served as template for barcoding PCRs and thus preparation of 
the cDNA library. To reduce adapter-adapter sequences, the samples were size 
fractionated on an agarose gel. DNA fragments between 130 and 170 nts of length were 
purified and applied to IlluminaSolexa sequencing analysis. The sequencing data was 
first processed automatically via the Clipz database (Khorshid et al. 2011). Dr. Andreas 
Gruber from Prof. Mihaela Zavonlan’s group (Biozentrum, Basel) performed further 
analyses. 
 
3.2.6.3 SELEX 
Selection of Roquin-bound RNAs from a random RNA library was performed in 
collaboration with Dr. Raymund Buhmann’s group (Clinical Cooperative Group, 
Helmholtz Zentrum München). Dr. Michael Blank provided the protocol and suggested 
to perform three rounds of selection with extending washing procedures (3x 100 µl, 4x 
100 µl and 5x 100 µl washing steps) and decreasing protein concentration (250 nM,  
150 nM and 50 nM) to increase stringency. 
Prior to selection, 100 µg recombinant Roquin-1 and Roquin-1 M199R N-terminal 
protein (N-term) (aa 2-440) were incubated for 30 min on ice with 10x molar excess of 
EZ-link PEG4-NHS-Biotin (Pierce) resolved in PBS (0.1 mg/ml). Subsequently, the 
biotinylated protein was purified via gel filtration (MicroSpin column P6, BioRad). 
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Since precipitation was observed, the loss of protein during the biotinylation procedure 
was estimated on an SDS gel by Coomassie staining. To prove the efficiency of the 
biotinylation reaction, three concentrations of biotinylated and non-biotinylated protein 
were spotted onto a nitrocellulose membrane. After blocking the membrane with 1% 
BSA in PBS, it was incubated in streptavidin-PE (R-Phycoerythrin) diluted 1:1000 in 
PBS for 30 min at RT. Subsequently, the membrane was washed 3x with PBS and 
fluorescence intensity of PE bound to biotinylated protein was determined by 
fluoroimaging (Raytest, FLA5000, 473 nm, Y510 filter). 
The RNA startpool with a 47 nts random sequence was in vitro transcribed from 
double-stranded random DNA according to Chang et al. (Chang et al. 2010) using 
common NTPs. Following the transcription reaction, the samples were mixed with 
PAA-loading buffer and fractionated via denaturing PAGE (8%). RNA containing gel 
pieces were excised and RNA was purified. 
Every round of selection started by combining the RNA pool (400 pmol) with 
biotinylated protein and incubating the mix for 30 min at 37°C. Subsequently, binding 
buffer-equilibrated streptavidin-magnetic beads were added, incubated (10 min, 37°C) 
to bind the protein-RNA complexes and washed. By boiling the beads in 0.2 mM EDTA 
in H2O for 3 min, protein and RNA molecules were released. After removal of the 
beads, the solution served as template for reverse transcription (One-Step RT-PCR Kit, 
Qia-gen), and from the obtained cDNA the RNA pool for the next round of selection 
was transcribed. 
The cDNAs from every selection round (startpool, round 1, round 2, round 3) were 
finally used for Index-PCRs to analyze the pool composition at every stage during 
selection. Comparable amounts of the PCR products were combined to one cDNA 
library and analyzed by Solexa Illumina sequencing. Dr. Michael Blank and Dr. Carsten 
Gröber (both AptaIT) performed the processing of the raw data, tested sequence 
statistics and identified enriched sequences in the third round of selection. Further 
analyses concerning motif search within enriched sequence patterns (hexamers) and 
structural implications were provided by Dr. Andreas Gruber, Prof. Dr. Mihaela 
Zavolan’s group (Biozentrum, Basel). 
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4 Results 
4.1 Identification of mRNAs targeted by Roquin 
Roquin binding to target mRNAs results in a decreased protein expression of the target 
as well as in a reduction of the mRNA levels. Although Roquin presumably targets a 
number of mRNAs, only few have been identified or characterized in detail to date. In 
this study, different methods that approach the protein-RNA interaction and its effect on 
different levels were used to identify new target mRNAs. Since Roquin function in T 
cells has been described in detail and the M199R mutant of Roquin-1 had a strong 
impact on T helper cells (Vinuesa et al. 2005), all assays were performed in primary 
murine T helper cells to identify T-cell-specific target candidates. 
The use of mRNA expression arrays allows the detection of mRNAs that show a high 
dynamic range in response to varying Roquin activity. Target candidates identified with 
this method are therefore supposed to also show a strong response to Roquin regulation 
on the protein level. However, there is no prove that Roquin directly binds these 
mRNAs and that their regulation is not due to secondary effects. This disadvantage can 
be overcome with immunoprecipitation (IP)-based methods. CLIP and PAR-CLIP 
assays are useful to identify mRNAs that are directly bound by Roquin within the T 
helper cells, but they do not give any information about the downstream effects of this 
binding. Combining both approaches was expected to yield the most comprehensive list 
of mRNA candidates targeted by Roquin in T helper cells. 
 
4.1.1 Microarray analyses of Th1 cells upon acute deletion of Rc3h1-2 
The strongest upregulation of the known Roquin target Icos and its mRNA was 
observed in T cells that completely lack Roquin-1 and Roquin-2 proteins (Vogel et al. 
2013). CD4+ T cells isolated from Rc3h1-2fl/fl; CD4 Cre mice were strongly activated 
(Vogel et al. 2013) and therefore not comparable to the mainly naïve CD4+ T cells from 
control mice. Thus, an in vitro deletion system using a Cre recombinase expressing 
retrovirus was established. The CAG-CARstop-fl allele was introduced into Rc3h1-2fl/fl 
mice to monitor the deletion efficiency. This was indicated by upregulation of the 
coxsackievirus and adenovirus receptor (CAR) as a result of Cre-mediated deletion of 
the stop cassette. RNA from Th1 cells upon acute deletion of Roquin was compared to 
control Th1 cells in mRNA expression array analyses. 
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4.1.1.1 Evaluation of the acute Roquin deletion in Th1 cells 
To identify the best time point for cell harvesting and RNA isolation, a time course 
experiment was performed (Figure 10). Purified CD4+ T cells from Rc3h1-2fl/fl; CAG-
CARstop-fl mice and Rc3h1-2+/+; CAG-CARstop-fl control mice were activated by CD3 and 
CD28 stimulation in Th1 polarizing T cell medium. 40 hours after activation, the cells 
were spin infected with a Cre recombinase-expressing retrovirus that also encoded 
Thy1.1 as infection marker. Eight hours after infection (48 hours after activation), the 
cells began to express Thy1.1 on their cell surface showing a transduction efficiency of 
70% (Figure 10A). An additional expression of CAR, demonstrating the ongoing Cre-
mediated deletion, was observed 72 hours after activation and further increased until 
144 hours after activation (Figure 10A). In parallel to observing deletion through CAR 
upregulation, cells were harvested at every time point and Roquin levels were 
investigated by immunoblotting (Figure 10B). Roquin levels were comparable for 
Rc3h1-2+/+and Rc3h1-2fl/fl cells during the first 72 hours after activation. Subsequently, 
a reduction of Roquin-1 and Roquin-2 proteins in the Rc3h1-2fl/fl cells was observed. 
Since only 50-60% of the cells used for immunoblotting were CAR+, it was assumed 
that the Thy1.1+ CAR+ population would show an even more prominent loss of Roquin. 
In addition to the virus infection and the Roquin levels, the abundance of Icos as 
representative target was monitored. Icos surface staining and flow cytometry gave an 
insight into the protein expression (Figure 10C), whereas the results of qPCR 
measurements reflected the changes on the mRNA level (Figure 10D). The mean 
fluorescence intensity (MFI) of Icos on the cell surface of Thy1.1+ CAR+ Rc3h1-2fl/fl 
cells continuously increased compared to Rc3h1-2+/+ cells and reached an eightfold 
higher expression (Figure 10C). On the mRNA level the differences only became 
obvious after 120 hours, when Icos expression was almost fourfold higher in Rc3h1-2fl/fl 
versus Rc3h1-2+/+ cells (Figure 10D). Taken together, the time course experiment 
suggested to use Th1 cells 120 hours after activation for the array experiment, since that 
was the earliest time point to observe differential expression of an mRNA targeted by 
Roquin.  
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Figure 10: Evaluation of the acute Roquin deletion in Th1 cells. After activation, Th1 differentiation 
and infection with a Cre recombinase expressing retrovirus (40 hours after activation), CD4+ T cells were 
analyzed in a time course experiment (h: hours). A Thy1.1 and CAR were gradually upregulated after 
retrovirus infection as assessed by flow cytometry. B Deletion of Rc3h1-2 resulted in reduced Roquin 
protein expression 96 hours after T cell activation as shown by immunoblotting. The band marked with 
an asterisk was derived from a Roquin degradation product. Tubulin detection served as loading control. 
C and D Upon Roquin deletion, Icos was increased on the protein level as assessed by flow cytometry 
(C) and on the mRNA level as determined by qPCR (D). 
82   Results  
4.1.1.2 Sample preparation for mRNA expression arrays 
Thy1.1+ CAR+ cells were purified by cell sorting for the final experiment to reduce 
background signals from inefficiently infected cells. The affymetrix mRNA expression 
arrays were run in triplicates using one mouse per array. The three samples showed very 
similar infection rates (Figure 11A), deletion efficiency (Figure 11A and B), and the 
upregulation of Icos on the surface of Thy1.1+ CAR+ Rc3h1-2fl/fl cells was also highly 
comparable (Figure 11C). Cell sorting resulted in 97% purity of Thy1.1+ CAR+ cells 
that were subsequently collected in TRI reagent solution for RNA preparation (Figure 
11D).  
To exclude candidates that were only regulated in response to the strong Icos 
upregulation upon Roquin deletion, the array experiment was repeated on an Icos-/- 
genetic background. Since Icos-/- and Icos-/-; Rc3h1-2fl/fl mice did not carry the CAG-
CARstop-fl allele, cell sorting had to be performed on the 25% percent cells with the 
highest Thy1.1 levels (Figure 12). Those cells are supposed to have high deletion 
efficiencies, since there were no CAR– Thy1.1high cells present in the first set of samples 
(Figure 11A). 
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Figure 11: Sample preparation for mRNA expression arrays. CD4+ T cells from three mice for each 
condition were cultured under Th1 conditions and infected with Cre recombinase-expressing retrovirus.  
A 120 hours after activation, all samples showed comparable Thy1.1 and CAR expression levels in flow 
cytometry measurement. B Immunoblotting analysis of Roquin expression in the treated cells 120 hours 
after activation. Tubulin detection served as loading control. C Flow cytometric measurement of Icos 
surface expression on Thy1.1+ CAR+ cells. D Representative dot plots of cell samples before and after 
cell sorting. 
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Figure 12: Preparation of Icos-/- samples for the second array experiment. CD4+ T cells from three 
mice of each genotype (Icos-/- and Icos-/-; Rc3h1-2fl/fl) were cultured under Th1 conditions and transduced 
with Cre-Thy1.1 retrovirus. After 120 hours of cell culture, Thy1.1 levels were analyzed by flow 
cytometry. The blue gates indicate the proportion of cells purified by cell sorting. 
 
4.1.1.3 Microarray hybridization and data analysis 
Next, the samples obtained by cell sorting of Th1 cell cultures (Figure 11 and Figure 
12) were handed over to the microarray hybridization facility of the Gene Center 
Munich. Andrea Klanner, Dr. Helmut Blum’s group, conducted the RNA preparation 
and the microarray procedure, and the overall quality of the array performance was 
irreproachable. The raw data was transferred to Dr. Dirk Repsilber (University of 
Örebro) who performed the bioinformatics data analysis. In short, he selected for 
mRNAs that were at least 1.5-fold up- or down-regulated in Rc3h1-2fl/fl versus     
Rc3h1-2+/+ samples. In the first set of arrays, 84 mRNAs were at least 1.5-fold, 17 
mRNAs at least 2.0-fold and 5 mRNAs at least 3.0-fold upregulated. 45 of these 
mRNAs were also found to be upregulated 1.5-fold or more in the Icos-/- arrays upon 
Roquin deletion (Table 20).  The heatmap in Figure 13 gives an overview of the 
obtained data. The dendrogram on top of the graph is the result of a clustering analysis 
showing that the triplicates are indeed most similar in their expression patterns for all 
samples. Also, the diagram shows that in cells with Roquin deletion (Rc3h1-2fl/fl and 
Icos-/-; Rc3h1-2fl/fl) the majority of differentially expressed mRNAs is upregulated 
(blue), whereas only few mRNAs are downregulated (yellow). Thus, derepression of 
mRNAs was the main effect of Roquin deletion. This is also underlined by the fact that 
upregulation of mRNAs is much more reproducible than downregulation in the Icos-/- 
samples. 
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Figure 13: Heatmap showing relative expression of Roquin target candidates. Listed are genes with a 
significant (q≤0.05) fold change of ±1.5 or more normalized to their mean expression. Blue indicates 
relative upregulation and yellow downregulation of gene expression. The dendrograms are derived from a 
hierarchical cluster analyses. This analysis was provided by Dr. Dirk Repsilber. 
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Table 20: Potential Roquin targets with ≥1.5-fold expression in the first set of arrays and their fold 
change in Icos-/- validation arrays. Dark turquoise: fold change ≥ 3, turquoise: fold change ≥ 2, light 
turquoise: fold change ≥ 1.5. The known target Icos is highlighted in red. 
 
 
Taking a more detailed look at the mRNAs that were significantly upregulated in Th1 
cells after Roquin deletion revealed that several groups of genes are represented. 
Interestingly, among the potential target mRNAs there are three activation-induced co-
stimulatory receptors. Ox40 (Tnfrsf4) and CD30 (Tnfrsf8), members of the Tnf receptor 
super family, are stimulatory co-receptors that support cytokine production and 
Results  87 
expansion of T cells (Watts 2005). In contrast, Ctla4 is an inhibitory co-receptor 
upregulated in the late stage of T cell activation. Another group of genes possibly 
targeted by Roquin are members of the Bcl-2 protein family (Bcl2a1a, Bcl2a1b, 
Bcl2a1d and Bcl2l1), known to be negative regulators of apoptosis in the mitochondrial 
pathway. Furthermore, a number of cytokines and chemokines (for example Ccl22, 
Ebi3, Cxcl10 and Il2) and T cell activation associated genes (for example Nfkbid, 
Cd24a, Bcl3 and Tnfrsf13c) were upregulated upon Roquin deletion in T cells. 
Unexpectedly, also the expression of several B cell specific genes, such as Cd86, Cd19 
and Cd40, was increased in this setting.  
The array data was evaluated by qPCR measurements of selected target candidates in 
the RNA samples (Figure 14). All tested candidates were confirmed yielding a higher 
fold change than measured in the arrays. Also, the qPCR data showed that most of the 
candidates are upregulated in an Icos-independent manner. Only Ctla4 exhibited a 
weaker deregulation upon Roquin deletion in the Icos-/- sample indicating that high Icos 
levels contribute to the deregulation of Ctla4 (Figure 14). In summary, the microarray 
analyses identified an interesting set of putative target mRNAs that can be further 
validated to decipher their role in Roquin-mediated regulation. However, due to time 
constraints and previous experiments with this candidate, further investigations in this 
study were focused on the costimulatory receptor Ox40. 
 
 
Figure 14: Evaluation of Roquin target candidates by qPCR. The expression of potential Roquin 
target mRNAs relative to Ywhaz is shown normalized to the respective control sample. Black and white 
bars represent samples from the first set of arrays and the grey bars are derived from measurements of 
Icos-/- samples. 
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4.1.2 The mRNA of the costimulatory receptor Ox40 is bound and 
regulated by Roquin 
Due to its functional overlap with Icos, Ox40 is a particularly interesting target 
candidate of Roquin. Therefore, it was investigated whether Ox40 mRNA is directly 
bound by Roquin and if this interaction results in a regulation of Ox40 expression. 
Analyzing CD4+ T cells from Rc3h1-2fl/fl; CD4 Cre mice compared to control animals 
revealed that the lack of Roquin indeed resulted in increased Ox40 expression (Figure 
15A). Even though this costimulatory receptor is only induced upon T cell activation 
(Mallett et al. 1990; al-Shamkhani et al. 1996), low expression was observed on naïve 
(CD62Lhi CD44lo) CD4+ T cells of Rc3h1-2fl/fl; CD4 Cre mice. In effector-like 
(CD62Llo CD44hi) CD4+ T cells lacking Roquin, the upregulation of Ox40 was even 
more prominent. To exclude that high Ox40 levels resulted from the excessive T cell 
activation in Roquin knockout mice, a cell culture assay was established to monitor 
Roquin function. To this end, a Roquin-1-p2A-mCherry-inducible Rc3h1-2-/- MEF cell 
line was transduced with ecotropic retroviruses expressing Ox40 fl or Ox40 CDS. 
Subsequently, the Ox40 surface expression in response to doxycyclin (Dox)-induced 
Roquin-1 overexpression was determined by flow cytometry (Figure 15B). Whereas 
expression from the Ox40 CDS barely changed after doxycyclin treatment, Ox40 
expression from the full-length construct was strongly reduced in Roquin-1-p2A-
mCherry-expressing cells. This indicated that Ox40 is post-transcriptionally regulated 
by Roquin-1 via its 3’UTR.  
Next, the specificity of the Roquin-Ox40 3’UTR interaction was investigated on the 
molecular level. In a filter binding assay (FBA), recombinant Roquin N-terminal 
proteins  (Roquin-1 aa 2-440 and Roquin-2 aa 2-438) were used for binding reactions 
with 32P-labeled Ox40 3’UTR and unlabeled competitor RNAs comprising 100 nts of 
the ICOS 3’UTR (Figure 15C and D). The specific competitor (ICOS, nts 700-800) 
clearly reduced Ox40 3’UTR binding with increasing molar excess, whereas an 
unspecific competitor RNA (ICOS, nts 600-700) only had minor effects. Roquin-2 (aa 
2-438) seemed to bind the Ox40 3’UTR with higher affinity than Roquin-1 (aa 2-440), 
since the same amount of competitor RNA did not reduce binding of Roquin-2 to the 
same extent as binding of Roquin-1. The combination of methods to analyze Roquin-
mediated post-transcriptional regulation on different levels, such as measuring target 
protein expression in response to Roquin-1 overexpression and in vitro binding assays 
to detect the direct interaction of protein and RNA, proved that Ox40 is a direct mRNA 
target of Roquin-1 and Roquin-2. 
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Figure 15: Validation of Ox40 as Roquin target mRNA. A Ox40 expression on naïve (CD62Lhi 
CD44lo) and effector-like (CD62Llo CD44hi) CD4+ T cells as determined by flow cytometry. B Ox40 
expression on Rc3h1-2-/- MEFs with and without Dox-induced expression of Roquin-1-p2A-mCherry.    
C Competitive FBA with Roquin-1 and Roquin-2, the 32P-labeled Ox40 3’UTR and unlabeled specific 
(ICOS 700-800) and unspecific (ICOS 600-700) competitor RNA. 4 technical replicates are shown for 
each condition. D Quantification of C, error bars show standard deviation (SD) of 3 (Roquin-2) or           
4 (Roquin-1) independent experiments. 
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4.1.3 Analysis of a combined Roquin and Ox40 knockout in mice 
The next aim was to investigate how Ox40 upregulation on CD4+ T cells in Rc3h1-2fl/fl; 
CD4 Cre mice contributes to the phenotype of these mice. Therefore, Ox40-/-;      
Rc3h1-2fl/fl; CD4 Cre mice were bred and analyzed comparing them to the conditional 
Roquin-1 and Roquin-2 knockout mice and Ox40-/- mice as well as control animals. The 
age of the analyzed mice was in the range between 7 and 18 weeks, with the majority of 
animals at the age of 9 to 12 weeks. 
The most prominent phenotype of the Rc3h1-2fl/fl; CD4 Cre mice (termed double 
knockout) was the splenomegaly, which was quantified by spleen weight. The 
combined Ox40 and conditional Roquin-1 and Roquin-2 knockout (termed triple 
knockout) resembles this phenotype, however to a significantly lesser extent (Figure 
16A right side). As opposed to the double knockout, the splenomegaly could not be 
explained by higher numbers of splenocytes in the triple knockout, since those numbers 
were not increased compared to the control animals (Figure 16B). In contrast, there was 
a mild reduction of splenocytes in the Ox40-/- control samples, which could possibly 
manifest in the triple knockout. 
 
 
Figure 16: Analysis of spleens from mice with a combined Roquin and Ox40 knockout in T cells. 
Spleen weight (A) and number of splenocytes (B) of 8 control mice (4 CD4 Cre and 4 Rc3h1-2fl/fl as 
indicated), 7 Ox40-/-; Rc3h1-2fl/fl mice, 6 Rc3h1-2fl/fl; CD4 Cre mice and 8 Ox40-/-; Rc3h1-2fl/fl; CD4 Cre 
mice. Error bars show SD and statistical analysis was performed by one-way ANOVA and subsequent 
Tukey’s multiple comparison test (ns: not significant, *p<0.05, **p<0.01, ***p<0.005). 
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4.1.3.1 Analysis of CD4+ and CD8+ T cells from triple knockout mice 
Using the conditional CD4-Cre allele causes a deletion of Rc3h1-2 in T cells during the 
CD4+ CD8+ double positive stage of thymic development. Therefore, CD4+ and CD8+ T 
cells as well as other T cell subsets were investigated in more detail. Like the double 
knockout mice, the triple knockout animals showed a significant reduction of CD4+ T 
cells in percentage as well as in total cell numbers (Figure 17A). The activation status 
of these T cells revealed that the reduced number of total CD4+ T cells was mainly due 
to significantly lower numbers of naïve (CD62Lhi CD44lo) T helper cells, which in turn 
resulted in a relative increase in activated CD62Llo CD44hi CD4+ T cells (Figure 17B 
and C). A slightly but not significantly increased frequency of central memory-like 
cells (CD62Lhi CD44hi) was observed in the triple knockout (Figure 17C). The increase 
of CD8+ T cells in double knockout animals was ameliorated in the triple knockout, 
particularly on the level of total cell numbers (Figure 18A). Excessive T cell activation 
(CD62Llo CD44hi) and loss of naïve T cells (CD62Lhi CD44lo) was apparent in CD8+ 
double knockout cells and did not change upon additional lack of Ox40 (Figure 18B 
and C). The only difference between double and triple knockout cells was observed in 
the total numbers of CD8+ central memory-like T cells, which was slightly lower in the 
triple knockout than in the double knockout or the control samples (Figure 18C).  
Taken together, the excessive activation of CD4+ and CD8+ T cells observed in double 
knockout mice was not prevented in triple knockout mice despite the abrogation of 
Ox40 expression. 
92   Results  
 
Figure 17: CD4+ T cells are reduced and highly activated in triple knockout mice. A Relative (left) 
and absolute (right) numbers of CD4+ T cells. B Representative contour plots of CD62L and CD44 
stainings, gated on CD4+ cells. C Relative (upper panel) and total (lower panel) numbers of naïve 
(CD62Lhi CD44lo), effector memory-like (CD62Llo CD44hi) and central memory-like (CD62Lhi CD44hi) T 
helper cells in all analyzed mice. Error bars show SD and statistical analysis was performed by one-way 
ANOVA and Tukey’s multiple comparison test or one-way ANOVA Kruskal-Wallis Test followed by 
Dunn’s multiple comparison test (ns: not significant, *p<0.05, **p<0.01, ***p<0.005). 
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Figure 18: CD8+ T cells are excessively activated in triple knockout mice. A Relative (left) and 
absolute (right) numbers of CD8+ T cells. B Representative contour plots of CD62L and CD44 stainings, 
gated on CD8+ cells. C Relative (upper panel) and total (lower panel) numbers of naïve (CD62Lhi 
CD44lo), effector memory-like (CD62Llo CD44hi) and central memory-like (CD62Lhi CD44hi) CD8+ T 
cells in all analyzed mice. Error bars show SD and statistical analysis was performed by one-way 
ANOVA and Tukey’s multiple comparison test or one-way ANOVA Kruskal-Wallis Test followed by 
Dunn’s multiple comparison test (ns: not significant, *p<0.05, **p<0.01, ***p<0.005). 
 
 
94   Results  
4.1.3.2 Analysis of autoimmunity-associated lymphocyte subsets 
Next, other lymphocyte subsets having been connected to the development of 
autoimmunity were analyzed in conditional double and triple knockout mice. 
Follicular T helper cells (Tfh cells) are a subset of CD4+ T cells that is involved in the 
germinal center reaction and thus might promote high-affinity autoantibody production. 
Tfh cells were increased in double knockout mice, and this phenotype was not rescued 
but rather enhanced in mice that additionally lack Ox40 (Figure 19A and B). Since Tfh 
cells support germinal center B cell (GC B cell) formation, an increase in Tfh cells 
might result in increased levels of GC B cells. This was found in conditional double 
knockout and triple knockout mice, the latter having slightly higher total numbers of 
GC B cells (Figure 19A and B). 
Regulatory T cells (Tregs) are a T helper cell subset that plays a role in preventing 
autoimmunity and is marked by the expression of the transcription factor Foxp3. 
Whereas control, Ox40-/- and double knockout samples had similar levels of peripheral 
Tregs in the spleen, this cell subset was significantly increased in triple knockout mice 
compared to the Ox40 single knockout (Figure 20A and B). A tendency to higher Treg 
levels was also apparent in double knockout mice, however there are strong variances 
between the four animals. This suggests that double knockout T helper cells might have 
an intrinsic preference for Treg differentiation that is suppressed by the high expression 
levels of Ox40 in those cells. 
Short-lived effector cells (SLECs) are a subset of activated CD8+ T cells characterized 
by the killer cell lectin-like receptor G1 (KLRG1) expression and their inability to 
become memory cells. Increased numbers of SLEC-like T cells have been associated 
with the development of autoimmune diseases (Chang et al. 2012). The percentage of 
SLECs was significantly increased in spleens from double knockout as well as from 
triple knockout mice, indicating that Ox40 signals are not required for the excessive 
formation of SLECs in double knockout mice (Figure 20C). 
Finally, natural killer cells (NK cells) and natural killer T cells (NKT cells), that were 
both reduced in the double knockout mice, were investigated in the triple knockout 
samples (Figure 20D). Although it was shown that NK cells as well as NKT cells 
express Ox40 (Croft 2010), the loss of this costimulatory receptor did not alter their 
frequency compared to control or double knockout mice (Figure 20E). 
 
Results  95 
 
Figure 19: Double knockout and triple knockout mice have increased levels of Tfh cells and GC B 
cells. A Representative contour plots of Tfh stainings (upper panel) and GC B cell stainings (lower 
panel). B Relative (upper part) and total (lower part) numbers of Tfh cell and GC B cells in spleens of the 
respective mice. Error bars show SD and statistical analysis was performed by one-way ANOVA and 
Tukey’s multiple comparison test and one-way ANOVA Kruskal-Wallis Test followed by Dunn’s 
multiple comparison test for total number of GC B cells (ns: not significant, *p<0.05, **p<0.01, 
***p<0.005). 
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Figure 20: Frequency of different lymphocyte subsets in triple knockout mice. A Representative 
contour plots of FoxP3+ peripheral regulatory T cells. B Overview of Treg percentages among CD4+ T 
cells. C Relative numbers of SLECs among CD8+ T cells. D Representative contour plots of NK1.1+ NK 
cells (upper panel) and of PBS57-loaded CD1d tetramer+ NKT cells (lower panel). E Frequency of NK 
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and NKT cells. Error bars show SD and statistical analysis was performed by one-way ANOVA and 
Tukey’s multiple comparison test for SLECs and one-way ANOVA Kruskal-Wallis Test followed by 
Dunn’s multiple comparison test for all other subsets (ns: not significant, *p<0.05, **p<0.01, 
***p<0.005). 
 
4.1.3.3 Expression of Roquin targets in triple knockout T cells 
To find out whether the known Roquin targets Ox40 and Icos influence each other’s 
expression in addition to the post-transcriptional regulation by Roquin, the Icos MFI 
was quantified on different CD4+ and CD8+ T cells. In all CD4+ subsets, the relative 
Icos level was equally high in double knockout and triple knockout samples and 
increased compared to Ox40-/- or control animals (Figure 21A upper panel). A similar 
tendency was observed in CD8+ cells with the most prominent effects in the effector-
like population (Figure 21A lower panel). Interestingly, the costimulatory receptor 
Ctla4, suggested to be a Roquin target in the microarray analyses, showed a similar 
expression pattern in CD4+ T cells from the different mice (Figure 21B), indicating that 
it is regulated by Roquin-1 and Roquin-2. 
In summary, the analysis of Ox40-/-; Rc3h1-2fl/fl; CD4 Cre in comparison to Rc3h1-2fl/fl; 
CD4 Cre animals did not reveal a certain phenotypical feature to be rescued by the loss 
of Ox40 on double knockout T cells. Most probably, the double knockout phenotype 
results from derepression of multiple Roquin target mRNAs acting together in T cell 
activation and differentiation. 
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Figure 21: Icos and Ctla4 MFI are increased in different T cell subsets of double as well as triple 
knockout mice. A Relative Icos expression levels (normalized to control animals) on naïve (right), 
effector-like (middle) and memory-like (left) CD4+ (upper panel) and CD8+ (lower panel) T cells.           
B Relative expression of Ctla4 (normalized to control animals) in the same CD4+ T cell subsets as in A. 
Error bars show SD and statistical analysis was performed by one-way ANOVA Kruskal-Wallis Test 
followed by Dunn’s multiple comparison test (ns: not significant, *p<0.05, **p<0.01). An asterisk above 
one group indicates statistically significant difference to the control group (dashed line). 
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4.1.4 Roquin CLIP and PAR-CLIP assays in primary Th1 cells 
As a second approach to identify Roquin-targeted mRNAs, CLIP and PAR-CLIP assays 
were performed in collaboration with the Group of Prof. Dr. Mihaela Zavolan 
(Biozentrum Basel). To be able to identify T-cell-specific targets and to use Icos, which 
is only expressed in T cells, as a positive control, PAR-CLIP and CLIP analyses were to 
be done in primary T helper cells. Moreover, previous experiments had shown that high 
Roquin concentrations exhibit an unspecific RNA affinity in vitro (Glasmacher et al. 
2010) and cells did not tolerate Roquin overexpression for more than a few days 
(unpublished observation). Therefore, the assay was performed in primary T helper cells 
on the endogenous Roquin-1 and Roquin-2 proteins, which limited the availability of 
cells and the amount of Roquin protein in the starting lysate. 
 
4.1.4.1 CLIP and PAR-CLIP assay procedure 
The first step towards PAR-CLIP and CLIP assays was to test different antibodies in 
Roquin immunoprecipitations (IPs) from primary Th1 cell lysates to achieve a high 
pull-down efficiency. Specificity of the antibodies was confirmed comparing IPs from 
wild-type and Rc3h1-/- Th1 cell lysates. Two different antibodies were tested in this 
experiment, namely clone 3F12 that recognizes Roquin-1 and Roquin-2 (Vogel et al. 
2013) and a newly generated monoclonal antibody, clone 18F8, which also recognizes 
both Roquin paralogs. The antibodies were purified from hybridoma cell culture 
supernatants and coupled to tosyl-activated magnetic beads. IPs using these beads 
exhibited a strong enrichment of Roquin proteins compared to the input control   
(Figure 22). Surprisingly, Roquin proteins in IP samples seemed to be slightly different 
in size, which might be due to dissimilar salt concentrations in the IP samples, or due to 
varying affinity of the two antibodies for certain post-translationally modified Roquin 
variants. The control IPs from Roquin-1 knockout Th1 cells showed that the upper 
prominent band represents Roquin-2, whereas the lower prominent band in the wild-
type IPs is derived from Roquin-1. Since the clones 3F12 and 18F8 achieved similar 
enrichment of Roquin-1 and Roquin-2, they were both used in CLIP and PAR-CLIP 
experiments. The anti-Ago2 antibody 2D4 was bound to magnetic protein G beads and 
used for a reference IP. 
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Figure 22: Immunoprecipitation (IP) of Roquin-1 and Roquin-2 from Th1 cell lysates. Immunoblot 
of IPs performed with different anti-Roquin-1/2 antibodies. The 3F12 antibody, which recognizes both 
Roquin paralogs, was used for detection. 
 
With the help of Georges Martin, Prof. Dr. Mihaela Zavolan’s group, three CLIP assays 
(samples 4-6) using 254 nm UV light for irradiation were performed together with three 
PAR-CLIP assays (samples 1-3) using 4SU treatment of the Th1 cells and irradiation 
with 365 nm UV light. After cell lysate preparation and IP, the 32P-labeled samples 
were separated in SDS PAGE (Figure 23A right) and then blotted to a nitrocellulose 
membrane (Figure 23A left). Whereas there were almost no bands visible within the 
SDS gel, clear signals were observed after blotting to the nitrocellulose membrane for 
the Roquin 3F12 and the Ago2 samples, most probably because the procedure reduced 
background signals. Unexpectedly, the 18F8 antibody seemed to have performed much 
worse, even though it was comparable to the 3F12 antibody in Roquin IPs (Figure 22). 
However, since the autoradiographic signals on the membrane do not provide 
information about the quality of the bound RNA, all samples were further processed. 
The parts of the membrane corresponding to the protein size (about 135 kDa for Roquin 
and about 100 kDa for Ago2) and up to 30 kDa above were cut and RNA fragments on 
those membrane pieces were purified. After linker ligation and size selection of the 
RNA fragments (Figure 23B), a cDNA library was prepared by reverse transcription 
(Figure 23C). At this step, all samples showed comparable PCR product amounts, 
which is in contrast to the picture observed after SDS PAGE and blotting. The cDNA 
library was analyzed using the Illumina Solexa sequencing technology. 
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Figure 23: Documentation of the PAR-CLIP assays (samples 1-3). A Left: autoradiography of SDS 
gel after PAGE of 32P-labeled IP samples. Right: as on the left side after blotting the content of the gel 
onto a nitrocellulose membrane. Parts of the membrane that were cut for sample purification are indicated 
in red. B Autoradiography of a denaturing RNA gel, run for size separation of the RNA fragments after 
linker ligation. The gel was cut to purify fragments between 70 and 140 nts as indicated by the red boxes. 
C Agarose gel visualizing PCR products. For cDNA library preparation DNA was purified from gel 
pieces covering 130-170 basepairs (bp) length as indicated in red. CLIP assays were performed and 
documented in the same way (data not shown). 
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4.1.4.2 CLIP and PAR-CLIP sequencing data analysis 
An overview of the sequencing results obtained from the Clipz database (Khorshid et al. 
2011) is presented in Table 21. The number of reads ranged between 24 and 50 million 
per sample, and only the Ago2 PAR-CLIP sample had less than 10 million reads. 
However, only about 5% of these reads mapped to mRNAs, whereas half of the reads 
were based on an excessive number of degraded 5’ adapter sequences (defined as vector 
in the Clipz database). Therefore, the overall quality of the libraries was rather poor, and 
those adapter sequences had to be excluded for further data evaluation. Customized 
bioinformatics analyses of the CLIP and PAR-CLIP data sets were performed by Dr. 
Andreas Gruber, Prof. Dr. Mihaela Zavolan’s group.  
 
Table 21: Number of reads and read annotation in CLIP and PAR-CLIP samples according to 
standard analysis procedure of the Clipz database pipeline. 
	   Antibody	   Assay	   Number	  of	  
reads	  
%	  reads	  mapping	  
to	  mRNAs	  
%	  reads	  mapping	  
to	  vector	  
1	   Roquin	  3F12	   PAR-­‐CLIP	   24,959,528	   5.18	   51.56	  
2	   Roquin	  18F8	   PAR-­‐CLIP	   49,801,557	   4.66	   46.82	  
3	   Ago2	  2D4	   PAR-­‐CLIP	   8,714,767	   4.24	   44.64	  
4	   Roquin	  3F12	   CLIP	   27,044,116	   4.76	   48.78	  
5	   Roquin	  18F8	   CLIP	   25,062,000	   5.08	   46.29	  
6	   Ago2	  2D4	   CLIP	   31,164,857	   4.07	   49.07	  
 
Table 22: Number of total reads and reads mapping to mRNAs after removal of linker sequences. 
This analysis was performed by Dr. Andreas Gruber. 
	   Antibody	   Assay	   Number	  of	  
unique	  
mappers	  
Reads	  mapping	  
to	  mRNAs	  
%	  reads	  mapping	  
to	  mRNAs	  
1	   Roquin	  3F12	   PAR-­‐CLIP	   2,844,920	   231,055	   8.12	  
2	   Roquin	  18F8	   PAR-­‐CLIP	   5,518,583	   328,781	   5.96	  
3	   Ago2	  2D4	   PAR-­‐CLIP	   828,595	   105,596	   12.74	  
4	   Roquin	  3F12	   CLIP	   2,908,436	   244,933	   8.42	  
5	   Roquin	  18F8	   CLIP	   2,528,968	   379,627	   15.01	  
6	   Ago2	  2D4	   CLIP	   3,413,487	   212,334	   6.22	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Upon removal of adapter sequences, reads mapping uniquely to the genome were 
defined as the total number of reads. Thus, the frequency of reads mapping to mRNAs 
was increased up to 15% (Table 22). The results of mutation analyses revealed that 
PAR-CLIP samples had the expected high T to C conversion rates (Figure 24, 1-3), 
whereas CLIP samples exhibited increased rates of T deletion and insertion and A to C 
conversion (Figure 24, 4-6). Subsequently, sequence preferences next to the 200 most 
abundant T positions that show T to C conversions in mRNAs were investigated for the 
PAR_CLIP samples 1 and 2 (Figure 25). Surprisingly, no position 25 nts upstream or 
downstream of the T to C conversion showed a bias for a certain base, suggesting that 
Roquin binding to these RNAs might be non-sequence-specific. 
 
 
Figure 24: Mutation plots of all CLIP and PAR-CLIP samples. T to C conversions are highlighted in 
PAR-CLIP samples (1-3) and other frequent mutations are highlighted in CLIP samples (4-6). The data 
was provided by Dr. Andreas Gruber. 
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Figure 25: Sequence patterns of the area next to T to C conversion sites. The size of the letters at 
every nucleotide position reflects the frequency within the analyzed sequences. The analysis was       
performed by Dr. Andreas Gruber. 
 
An RNA stem-loop structure, named constitutive decay element (CDE), was proposed 
to be specifically recognized by Roquin-1 (Leppek et al. 2013). Therefore, the number 
of sequence reads in the proximity of such putative CDE stem-loops was determined for 
all Roquin samples. Figure 26 shows sequence profiles 100 nts upstream and 
downstream of three example CDE sites located in the mRNAs of Tnf, Nfkbid and Ier3. 
Interestingly, samples 2 and 5 had higher numbers of clipped sequences in all analyzed 
areas, indicating that the antibody clone 18F8 was more efficient in IPs of specific 
Roquin-RNA complexes. Tnf, harboring the prototypic CDE stem-loop, represented a 
mixed picture of clipped sites (Figure 26A). Only sample 2 showed a cluster of clipped 
sequences at the position of the CDE. Apart from that, clipped sequences were present 
throughout the 200 nts stretch in all samples with an accumulation about 60 to 70 nts 
upstream of the stem-loop structure. Nfkbid, a target candidate from the previously 
described array analyses (Table 20), supposedly has two CDE stem-loops in a tandem 
conformation with 13 nts as spacer sequence (Leppek et al. 2013). The histograms in 
Figure 26B were centered on the more downstream CDE and they revealed a 
preference for clipped sequences 50 nts upstream and downstream of this stem-loop. 
The third example, Ier3, is a Roquin-1 target suggested by Leppek et al. due to a CDE 
in its 3’UTR. For this candidate the CLIP and PAR-CLIP samples exhibited the highest 
read numbers and also a very uniform picture (Figure 26C). Clipped Ier3 sequences are 
exclusively located at the position of the stem-loop with a less stringent endpoint on the 
upstream side of the sequence cluster. Comparing the given examples for clipped 
sequences in the area of CDE stem-loops showed high variability and did not reveal a 
clear bias to upstream or downstream regions. 
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Figure 26: Number of clipped sequences in the proximity of CDE stem-loops. A Clipped sequences 
in samples 1,4 (Roquin 3F12) and 2,5 (Roquin 18F8) in the area 100 nts upstream and downstream of the 
Tnf CDE. B As in A for sequences flanking the more downstream CDE in the Nfkbid 3’UTR. C As A and 
B for a CDE within the Ier3 3’UTR. The analysis was performed by Dr. Andreas Gruber. 
 
The newly identified Roquin target Ox40 does not have a consensus CDE in its 3’UTR 
and was therefore analyzed separately. Clipped sequences covering the Ox40 mRNA 
from all four Roquin samples were extracted from the Clipz database and aligned. 
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Unexpectedly, the largest sequence cluster was located at the 3’ end of the Ox40 CDS 
(data not shown), whereas two smaller clusters of clipped sequences were identified in 
the Ox40 3’UTR (Figure 27A). To get an idea of the structural composition of the 157 
nts spanning Ox40 3’UTR, mfold structure prediction was performed. The 
thermodynamically most stable structure (initial ΔG = -55.00) suggests the formation of 
two hairpin structures, one with a hexaloop and one with a triloop, which is reminiscent 
of the CDE stem-loop structure (Figure 27B). Those putative stem-loop structures are 
in close proximity to the described sequence clusters. 
 
 
Figure 27: Two sequence clusters are clipped in the Ox40 3’UTR. A Alignment of all clipped       
sequences in the Ox40 3’UTR (violet). Two putative structural features are shown in green (hexaloop) 
and red (CDE-like stem-loop). Mutated positions in the clipped sequences are marked in orange.             
B Secondary structure prediction of the Ox40 3’UTR as obtained from the mfold Web Server. Numbers 
indicate position relative to the first nucleotide of the CDS. 
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4.2 Molecular analysis of the Roquin-RNA interaction 
4.2.1 Selection of Roquin-bound RNAs from a random library 
SELEX (Systematic evolution of ligands by exponential enrichment) is a method to 
select for single stranded nucleic acids that bind with high affinity to the ligand used 
during the selection procedure. By employing a random RNA library in combination 
with an RNA-binding protein such as Roquin, it is an unbiased approach to identify 
RNA sequences that are preferentially bound by the protein. Ideally, SELEX helps to 
identify high-affinity cis-elements for the respective trans-acting factor. 
 
4.2.1.1 Selection experiments 
For the SELEX experiment, recombinant Roquin-1 N-terminus (aa 2-440) was 
biotinylated and used to perform three rounds of selection from an RNA library with a 
random sequence of 47 nts. With every round of selection the protein concentration was 
reduced and the washing procedure was intensified to increase the stringency of the 
selection. The output of the biotinylation step was estimated on a coomassie gel and 
showed a slight loss of material during the procedure (Figure 28A left). The efficiency 
of the reaction was then analyzed in a filter spot assay using PE-coupled streptavidin to 
detect biotinylated protein by fluoroimaging. Increasing signal strength correlated with 
higher protein amounts, and the negative control did not show any signal (Figure 28A 
right). 
After transcription of the random RNA library, the first round of selection was 
performed, the selected RNAs were reverse transcribed and the cDNA served as 
template for the first RNA pool (Figure 28B). In total, three rounds of selection were 
successfully performed, and the cDNAs of every round were used as template in the 
Index PCR reactions. The experiment was repeated using Roquin-1 M199R (aa 2-440) 
in addition to Roquin-1 (aa 2-440). The obtained PCR products were analyzed by 
Illumina Solexa sequencing to identify sequences that were enriched during the three 
rounds of selection. 
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Figure 28: Documentation of the SELEX experimental procedure. A Left: Coomassie gel showing 
Roquin-1 (aa 2-440, 50 kDa) after spin concentration (conc.), after the biotinylation reaction (biotinyl.) 
and after purification of the biotinylated protein (purified). Right: Fluorography of biotinylated protein 
detected and visualized using streptavidin-PE. B Schematic representation of the selection procedure. Left 
side: Agarose gels showing the RNA pools resulting from in vitro transcription reactions (S: sample, M: 
marker). Right side: Final PCR products for the Illmina Solexa sequencing on agarose gel (M: marker). 
 
4.2.1.2 SELEX data analysis 
A first data analysis was performed by Dr. Michael Blank and Dr. Carsten Gröber (both 
AptaIT) and revealed that the RNA startpool consisted to almost hundred percent of 
unique sequence reads (Figure 29A). This changed after three rounds of selection with 
about eighty percent of unique reads, indicating that certain sequences had been 
enriched during the selection process. Unexpectedly, the first round of selection was 
covered by twice as many reads, although similar amounts of the Index PCR products 
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were to be combined for the final library. The random sequence stretch of the startpool 
showed an almost equal distribution of bases at every position (Figure 29B), being 
clearly different from the RNA pool after three rounds of selection (Figure 29C). Most 
prominently, the 3’ end of the sequences showed a bias to thymine and guanine after the 
selection, and cytosine was less prevalent in the middle part of the sequence. Based on 
the co-occurrence of two frequent motifs of defined length, enriched sequences were 
identified and grouped in so-called patterns with highly homologous sequences. In total, 
5559 enriched sequence patterns were identified in the first experiment.  
 
 
Figure 29: Sequence statistics of the Roquin-1 SELEX experiment (replicate 1). A Number of total 
and unique reads for every selection round. B Distribution of nucleotides for every position of the random 
sequence as found in the startpool. C Frequency of nucleotides at every position of the random sequence 
after three rounds of selection with Roquin-1 (aa 2-440). The analysis was performed by AptaIT. 
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To validate those patterns, the most frequent sequences were tested in a filter binding 
assay (FBA) using increasing amounts of recombinant Roquin-1 N-terminus (aa 2-440) 
to retain the 32P-labeled RNA on a nitrocellulose filter (Figure 30). Without Roquin-1 
there was no binding of RNA to the membrane, and patterns clearly exhibited     
Roquin-1-specific binding, since they did not bind to 250 nM and 500 nM streptavidin 
(data not shown). However, the patterns differed in their affinity to Roquin-1, with P1, 
P9, P12 and P15 being the strongest binders, and P19 showing a result similar to the 
random RNA pool, which served as negative control.  
 
 
Figure 30: SELEX patterns bind to Roquin-1 N-terminus (aa 2-440). FBA analysis of enriched 
sequences with increasing protein concentrations as indicated. Startpool (Pool) RNA served as negative 
control. Error bars represent SD of 2 or 3 independent experiments. 
 
In a second binding experiment, P9 and P12 were investigated more closely concerning 
their specific affinity to Roquin-1 (Figure 31). Here, the minimal ROQ domain (aa  
147-326) was used in EMSA experiments and exhibited half maximal binding to those 
patterns in the lower nanomolar range. In addition, the same shift assays using an RNA-
binding-deficient mutant of the ROQ domain (K239A R260A) showed no binding. This 
supports the hypothesis that the SELEX-enriched RNAs use the same protein interface 
like the Tnf CDE stem-loop for binding to Roquin-1. The definition of the minimal 
ROQ domain and the screening for binding-deficient mutants is described in paragraphs 
4.2.2 and 4.2.3 respectively. 
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Figure 31: High-affinity patterns are specifically bound by the ROQ domain. EMSA experiment 
with pattern 9 and 12 and the minimal ROQ domain (aa 147-326; upper panel) or an RNA-binding-
deficient mutant (aa 147-326, K239A R260A; lower panel). Kd values are obtained from curve fitting to 
the relative bound fraction per lane (not shown). 
 
Dr. Andreas Gruber, Prof. Dr. Mihaela Zavolan’s group, performed additional 
bioinformatics analyses to elucidate similarities between the enriched sequences. 
Searching for hexamer enrichment, he identified sequences that were strongly enriched 
in the first experiment (Roquin-1, replicate 1) and exhibited a similar tendency for 
Roquin-1 and Roquin-1 M199R in the second set of experiments (Figure 32A). 
Comparing the two replicates of Roquin-1 concerning their z-scores for all possible 
hexamers revealed a correlation of 0.56 and identified four candidates with the strongest 
enrichment in both data sets (Figure 32B). Sequence logos embedding the enriched 
hexamers clearly demonstrated that the common motif was rather a 12-mer                
(5’-TGCGTTTTAGGA-3’) with reduced strictness at position two (G), seven (T) and 
eleven (G) (Figure 32A). The distribution of the enriched hexamers within the random 
sequence stretch was surprisingly homogenous with a strong bias to the 3’ end 
(Appendix I), which raised the question whether those areas are prone to form 
secondary structures. Indeed, the sequence motif most probably folds into a hexaloop 
that is closed via a C-G base pair followed by a double-stranded stem structure (Figure 
33). Interestingly, the Ox40 3’UTR contains a sequence stretch closely resembling the 
SELEX sequence motif and structure. Binding and functional analyses of this Ox40 
SELEX-like stem-loop are shown in 4.2.5. 
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Figure 32: Analysis of enriched hexamers within the SELEX patterns. A Enrichment of hexamers in 
Roquin-1, replicate 1 (bold headline) and in the second set of samples (fold changes given below). The 
sequence logo shows the nucleotide distribution around the enriched hexamers. B Correlation analysis of 
hexamer enrichment in Roquin-1 replicate 1 and replicate 2. The most frequent hexamers in both samples 
are highlighted in red. This analysis was performed by Dr. Andreas Gruber. 
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Figure 33: Secondary structure prediction of the SELEX motif. Left side: Boxplot analysis showing 
base paring probabilities as the size of black boxes for each nucleotide combination. Right side: 
Schematic representation of the putative RNA structure of the SELEX sequence motif. The boxplot was 
provided by Dr. Andreas Gruber. 
 
4.2.2 Crystal structures of the ROQ domain and the ROQ-RNA complex 
An accurate picture of Roquin interactions with its target mRNAs on a molecular level 
can be obtained by solving the protein structure and the structure of the protein-RNA 
complex. This was successfully done in collaboration with Prof. Dr. Michael Sattler’s 
group and Prof. Dr. Dierk Niessing’s group (both Helmholtz Zentrum München) and 
enabled a mutational analysis of amino acids located within the binding interface as 
well as a validation of the Tnf CDE RNA. The results of this project (paragraphs 4.2.2 
to 4.2.4) are published in Schlundt et al., 2014.  
The first step in this analysis aimed at the re-definition of the ROQ domain, which was 
so far only defined by sequence homology and domain prediction (Vinuesa et al. 2005). 
Using limited proteolysis, Dr. Andreas Schlundt, Prof. Dr. Michael Sattler’s group, 
identified a stable minimal domain spanning Roquin-1 aa 147-326, a region completely 
conserved in the human homolog. To make sure this minimal ROQ domain is fully 
capable of binding the Tnf CDE, the best-characterized Roquin-bound RNA element, 
dissociation constants (Kd values) for Roquin-1 full-length (fl), N-terminus (aa 2-440) 
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and ROQ (aa 147-326) recombinant proteins were determined in EMSA experiments 
(Figure 34). All three proteins yielded comparable Kd values (120-240 nM), with the 
full-length protein being remarkably comparable to the minimal domain, indicating that 
the ROQ domain is sufficient for Tnf CDE binding. Dr. Andreas Schlundt confirmed the 
stem-loop structure of the Tnf CDE (Figure 34B) in a 2D imino proton NOESY, 
visualizing the present hydrogen bonds and thus the base pairing of the RNA stem (data 
not shown). 
 
 
Figure 34: Definition of the minimal ROQ domain by RNA binding. A Three length variations of the 
Roquin-1 protein, namely Roquin-1 full-length (fl, showing the domain organization of the protein; ZnF: 
zinc finger, PRS: proline-rich sequence, CC: coiled coil region), N-terminus (N-term), and ROQ, as used 
for RNA binding analysis. B Tnf CDE stem-loop as used in EMSA and crystallization experiments.         
C Band shift assays with different Roquin-1 proteins and the Tnf CDE RNA. D Quantification of C and 
curve fitting to determine dissociation constants, Kd±s.e. (standard error) (given in C). 
 
Determining the atomic structure of the ROQ domain (aa 147-326) was achieved by 
successful protein crystallization experiments. Dr. Robert Janowski, Prof. Dr. Dierk 
Niessing’s group, subsequently solved the crystal structure to a resolution of 1.9 Å. The 
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domain adopted a canonical Winged Helix (WH) fold involving α-helices 2, 3, 4 and β-
strands 2, 3, 4 (Figure 35). The regions N- and C-terminal to the WH domain contain 
α-helices that contact each other and form a second domain-like fold.  
 
 
Figure 35: Crystal structure of the ROQ domain. A Cartoon presentation of the ROQ protein 
structure. α-helices, β-sheets and loops (W) are numbered according to their sequential order from N- to 
C-terminus. Blue color highlights the winged helix (WH) domain. B Schematic domain topology of the 
crystal structure shown in A. The figures were obtained from Dr. Andreas Schlundt. 
 
Next, the ROQ-Tnf CDE complex was crystallized and again Dr. Robert Janowski 
solved the structure (Figure 36A). The conformation of the ROQ domain within the 
complex was very similar to the structure of the protein alone, yet with a more compact 
folding of the W1 region located between β3 and β4. The Tnf CDE RNA showed a 
triloop structure with six Watson and Crick base pairs forming the stem (Figure 36A). 
Interestingly, the interaction between the WH fold of the ROQ domain and the Tnf CDE 
was mainly non-sequence-specific via electrostatic contacts to the phosphate backbone 
of the RNA stem (Figure 36B and C). ROQ binding did not involve the 3’ half of the 
Tnf CDE stem. The W1 region recognized the loop of the RNA structure and showed 
base specific interactions for all nucleotides forming the triloop. U11 and U13 were 
flipped out and thus more exposed to the protein interface, and G12 was found in a tight 
coordination with the surrounding amino acids (R219 and Q247) (Figure 36D). 
Another base-specific contact was observed for U4, which was flipped out of the stem 
and interacts with the amino acids W184, R188 and F194 (Figure 36D). 
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Figure 36: Crystal structure of the ROQ-Tnf CDE complex. A Cartoon presentation of the ROQ 
domain (aa 174-325, blue) and the bound Tnf CDE RNA stem-loop (magenta). B Scheme of the RNA 
stem- loop and the contacting amino acids in the ROQ-Tnf CDE complex. Different types of interactions 
are indicated. C Close-up of the 5’ arm of the stem within the complex structure. D Close-ups of base-
specific protein-RNA contacts. Figures provided by Dr. Robert Janowski and Dr. Andreas Schlundt. 
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4.2.3 Mutational analysis of the ROQ-RNA interaction site 
4.2.3.1 Binding assays 
The impact of specific protein-RNA contacts for the binding was studied in a mutational 
analysis using EMSA experiments to monitor the complex formation. Based on the 
crystal structure and on NMR (Nuclear magnetic resonance) data from Dr. Andreas 
Schlundt, amino acids were chosen for mutagenesis. Key residues being directly or 
indirectly influenced by Tnf CDE interactions were identified through strong chemical 
shift perturbations upon RNA binding and plotted on the crystal structure of the 
complex (Figure 37A). In total, fifteen amino acids of the ROQ domain, most of them 
positively charged, were mutated into alanine, whereas one was mutated into tyrosine, 
and the recombinant proteins were then applied to binding reactions with the Tnf CDE 
(Figure 37B, Appendix II and III). Most mutations had minor effects on the complex 
formation, yet mutations of certain lysine residues (K220A, K239A and K259A) 
resulted in a strong reduction of affinities. Binding was also considerably impaired by 
the R260A mutation that affected the W1 region of the WH fold. Combining K239A 
and R260A within one protein further reduced binding to almost undetectable levels in 
the probed concentration range (Figure 37B and C), which underlines that the 
interaction of the ROQ domain with the Tnf CDE depends on several contacts at the 
same time. Interestingly, mutations of amino acids forming base-specific contacts to the 
Tnf CDE RNA (R219, R251, S253, S265) had minor or no effects on RNA binding 
(Appendix II and III). 
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Figure 37: Mutational analysis of the ROQ RNA-binding interface. A Amino acids with large 
chemical shift perturbations as determined by NMR analysis of ROQ and ROQ-Tnf CDE were plotted on 
the crystal structure of the complex. The scheme was provided by Dr. Andreas Schlundt.                          
B Autoradiographies of EMSA experiments using ROQ mutants with a strong impact on Tnf CDE 
binding. C Binding curves of ROQ mutants (B) compared to ROQ wild-type (WT). Overview of 
dissociation constants of ROQ WT and all protein mutants tested in Tnf CDE binding assays. The plotted 
values are Kd±s.e. (see also Appendix II and III). Asterisks indicate extrapolated Kd values >1000 when 
calculation was not possible from the EMSA quantification. 
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4.2.3.2 Cell-based functional assays 
To assess whether impaired RNA binding results in compromised post-transcriptional 
regulation of Roquin-1 targets, a functional cell culture assay was established. Thereby, 
Rc3h1-2-/- MEFs were transduced to express different reporter genes, namely ICOS fl or 
Ox40 fl. Furthermore, ICOS CDE260 was used, which is a chimeric construct consisting 
of the ICOS CDS and an artificial 3’UTR of 260 nts from the Tnf 3’UTR. The CDE260 
contains the CDE but lacks AU-rich elements (AREs). The expression levels of those 
reporter genes were determined by cell surface staining of ICOS or Ox40 and flow 
cytometric analysis. In a second retroviral infection, Roquin-1 wild-type (WT) or the 
RNA-binding-impaired mutants were overexpressed from retroviral expression 
constructs containing the Thy1.1 marker gene to monitor infection rates. Comparable 
Roquin-1 expression levels were achieved by carefully titrating the virus supernatants to 
infection rates between 30% and 70% in a preliminary experiment (Figure 38 and 
Appendix IV). Half-maximal infection also made it possible to investigate infected 
(Thy1.1+) and non-infected cells (Thy1.1-) within one sample and to calculate the 
relative MFI of the reporter. Thus, the results from different combinations of reporters 
and protein mutants could be compared. 
 
 
Figure 38: Comparable overexpression of Roquin-1 wild-type (WT) and RNA-binding-impaired 
mutants. Roquin-1 proteins (WT, K220A, K239A, R260A and K239A R260A as indicated) were 
expressed in Rc3h1-2-/- MEFs by retroviral transduction and detected in the cell lysates by 
immunoblotting with the 3F12 monoclonal antibody that recognizes Roquin-1 and Roquin-2. Detection of 
tubulin served as loading control. 
 
Functional assays using the ICOS fl reporter are shown as contour plots in Figure 39A, 
top, and a quantification of all experiments is presented in Figure 39B, left. As 
expected, overexpression of Roquin-1 WT induced a strong reduction of ICOS on the 
cell surface. Roquin-1 mutants harboring one amino acid exchange (K220A, K239A 
and R260A) exposed impaired regulation but were still able to reduce ICOS levels by 
30-60%. Furthermore, the K239A R260A double mutant no longer reduced ICOS 
expression. This is in line with the prominent deficiency of the double mutants in RNA 
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binding being observed in EMSA experiments (Figure 37). When Ox40 fl was used as 
reporter gene, Roquin-mediated regulation followed a similar pattern (Figure 39A, 
middle). While Roquin-1 WT overexpression reduced Ox40 to 30% relative to 
uninfected cells, the single mutants of Roquin-1 had an intermediate regulatory 
capacity.  However, the K239A R260A double mutant did not repress Ox40 protein 
expression. 
Finally, Roquin-1 function on a Tnf CDE-containing 3’UTR was analyzed using the 
ICOS CDE260 reporter construct (Figure 39A, bottom). Compared to ICOS fl and Ox40 
fl, the ICOS CDE260 was even more effectively repressed by Roquin-1 WT, suggesting 
that the CDE260 3’UTR is highly responsive to Roquin-1 regulation. Accordingly, the 
single mutants (K220A, K239A and R260A) that were strongly compromised in Tnf 
CDE binding in vitro still repressed ICOS expression. The Roquin-1 K239A R260A 
mutant showed functional impairment but still reduced ICOS levels by 40%. Taken 
together, these experiments show that Roquin-1-mediated post-transcriptional 
regulation directly correlates with its RNA binding affinity. 
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Figure 39: Functional analysis of Roquin-1 ROQ domain mutants. A Flow cytometry analysis of 
ICOS or Ox40 reporter expression in Rc3h1-2-/- MEFs upon overexpression of Roquin-1 variants. Thy1.1 
serves as marker for transduction with Roquin-1-expressing retroviruses (WT or mutants as indicated). 
ICOS fl (top), Ox40 fl (middle) and ICOS CDS with a truncated Tnf 3’UTR (260 nts) containing the Tnf 
CDE (bottom). B Relative reporter MFI (Thy1.1+/Thy1.1-) of A. Error bars indicate range of two    
measured values (K220A) or SD of four independent experiments. Statistical significance was determined 
by one-way ANOVA Kruskal-Wallis test and Dunn’s multiple comparison test (**p<0.01). 
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4.2.4 Investigating the spectrum of CDE stem-loops 
From the crystal structure of the ROQ-Tnf CDE complex it was deduced that the 
protein-RNA contacts are mainly non-sequence specific. Hence, different Tnf CDE 
mutants were generated to test which parts of the stem-loop structure allow for 
deviation from the CDE consensus sequence in EMSA experiments. In addition, more 
distantly related triloops were proposed and tested as functional Roquin cis-elements. 
 
4.2.4.1 Mutational analysis of the Tnf CDE 
Inverting the purine (Pu) and pyrimidine (Py) order of the triloop from Py-Pu-Py to Pu-
Py-Pu (loop mutant 3: LM3) had the strongest impact and completely abolished binding 
of the ROQ domain (Figure 40B and E). However, inverting single positions as in 
G12C (LM1) or U13G (LM2) was well tolerated. LM1 exhibited the same affinity as 
the WT Tnf CDE and LM2 binding was only mildly affected. Next, different stem 
mutants (SM) were probed in ROQ binding assays (Figure 40C and E). The closing 
base pair of the loop structure was mutated from C-G to U-A (SM1), which increased 
the dissociation constant three-fold. Compared to that, SM2 with an inversion of C10 
and G14 was less affected, implying that a C-G base pair is preferred at this position. 
Exchanging the upper two U-A base pairs for C-G (SM3) resulted in a slightly 
attenuated complex formation. Extending the stem of the Tnf CDE by two possible G-C 
pairs also decreases ROQ binding (Figure 40D). The mutational analysis of the Tnf 
CDE RNA revealed that a number of different variants have reduced affinities for the 
ROQ domain but are nevertheless tolerated in binding. This finding indicates that the 
ROQ domain might be able to recognize a broader spectrum of RNA stem-loop 
structures than anticipated by Leppek et al., 2013. 
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Figure 40: Mutational analysis of the Tnf CDE RNA. A EMSA showing binding of ROQ domain to 
the Tnf CDE (scheme on the right). B ROQ binding analysis of three loop mutants (LM). Nucleotides 
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different from Tnf CDE are highlighted in blue. C Stem mutants (SM) probed for ROQ binding. 
Differences from Tnf CDE are marked in orange. D EMSA experiment with extension mutant (EXT).     
E Binding curves of the Tnf CDE RNA and indicated mutants. Kd±s.e. values are calculated from the 
respective curve fitting to the relative bound fraction per lane. 
 
4.2.4.2 CDE-like stem-loops 
In the 3’UTRs of ICOS and Ox40 there are triloops predicted that differ from the Tnf 
CDE in several positions. Those CDE-like stem-loops were probed in EMSAs and 
exhibited binding to the ROQ domain, yet with clearly reduced affinities (Figure 41).  
 
 
Figure 41: Binding of CDE-like RNA stem-loops from ICOS and Ox40 3’UTR. A Autoradiographies 
of EMSAs using ICOS CDE-like (nts 740-762) (left) and Ox40 CDE-like (nts 924-946) (right) RNA and 
the ROQ domain. Nucleotide positions different from the Tnf CDE or the CDE consensus sequence are 
marked in grey or orange respectively. B Binding curves of CDE-like stem-loops compared to Tnf CDE. 
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To test whether those low-affinity stem-loops can be functional cis-elements, a cell-
based assay was established by Dr. Stephanie Edelmann, Prof. Dr. Vigo Heissmeyer’s 
group, to monitor target expression upon acute deletion of Roquin-1 and Roquin-2. To 
this end, Cre-ERT2; Rc3h1-2fl/fl; CAG-CARstop-fl MEFs were treated with tamoxifen, and 
CAR surface expression served as marker for efficient genomic deletion in flow 
cytometry analyses (Figure 42A right). By immunoblotting it was confirmed that 
Roquin-1 and Roquin-2 proteins are almost completely eliminated after four days of 
tamoxifen treatment (Figure 42A left). To decipher the role of CDE-like stem-loops in 
post-transcriptional gene regulation, different ICOS and Ox40 reporter constructs were 
tested (Figure 42B and C). Overexpression of ICOS and Ox40 full-length constructs 
and subsequent tamoxifen treatment resulted in an upregulation of ICOS and Ox40 on 
the surface of CAR+ cells. This derepression upon Rc3h1-2 deletion was not observed 
for constructs containing only the CDS of ICOS and Ox40. The ICOS 3’UTR contains 
one consensus CDE stem- loop at its 3’ end and one CDE-like stem-loop located at the 
5’ end. Truncation of the 3’UTR to remove the CDE stem-loop did not reduce the 
responsiveness of the ICOS ΔCDE construct compared to the ICOS full-length 
construct. This suggests that the presence of a consensus CDE stem-loop is not required 
for Roquin-mediated ICOS regulation. On the other hand, the Ox40 3’UTR only 
contains a CDE-like stem-loop. When this was removed by shortening the 3’UTR, 
Ox40 upregulation due to Roquin deletion was drastically reduced, indicating that 
Roquin-mediated Ox40 regulation requires the presence of a CDE-like stem-loop 
structure. 
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Figure 42: CDE-like stem-loops are functional cis-elements in Roquin-mediated regulation.            
A Tamoxifen induced deletion of Roquin-1 and Roquin-2 in Cre-ERT2;Rc3h1-2fl/fl; CAG-CARstop-fl MEFs 
was monitored by immunoblotting (left) and by upregulation of CAR on the cell surface as assessed by 
flow cytometry (right). B Schematic representation of ICOS constructs with different 3’UTR lengths (top) 
and expression levels of ICOS in response to tamoxifen treatment measured by flow cytometry. C As in 
B with different Ox40 constructs. The ICOS data (B) was provided by Dr. Stephanie Edelmann. 
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4.2.5 Cis-element analysis of the Ox40 3’UTR 
Combining the findings of the different analyses creates a comprehensive picture of 
Roquin-mediated Ox40 regulation. Roquin-1 and Roquin-2 specifically bound to the 
3’UTR (Figure 15C and D) and substantial regulation of Ox40 protein expression 
required the presence of the 3’UTR (Figure 15B and Figure 42C).  
Secondary structure prediction of the Ox40 3’UTR sequence suggested the presence of 
a triloop (Figure 27B) that was shown to be a functionally active CDE-like cis-element 
(Figure 42C). Interestingly, also a hexaloop was proposed, which closely resembles the 
RNA stem-loop that was independently identified in SELEX experiments (Figure 33). 
Those structures do not only have the same shape but also share the SELEX sequence 
motif within the hexaloop (Figure 43A and B). By multiple sequence alignment 
(Clustalw) and subsequent structural analysis (RNAalifold) of Ox40 3’UTRs from 
different species, conservation of the SELEX-like stem-loop was investigated (Figure 
43C). Whereas the overall sequence conservation of the Ox40 3’UTR is rather poor, the 
region of the SELEX-like stem-loop (position 128-137 of the 3’UTR) shows high 
conservation. Interestingly, only the position being less well-defined in the sequence 
motif of the SELEX patterns shows some variation. The structural analysis shows that 
this region is most likely forming a hexaloop with two C-G pairs at the top of the stem. 
Another highly conserved part is located at position 171-185 of the 3’UTR. This part 
forms the previously described CDE-like stem-loop (Figure 41A). Again, the twelve 
nucleotides forming the stem are fully conserved, whereas the three nucleotides in the 
loop allow some variation. 
To prove that the SELEX-like stem-loop is bound by Roquin-1 comparable to other 
known cis-elements, EMSA experiments were performed using the ROQ domain and 
some of the mutants described in section 4.2.3.1. The Ox40 SELEX-like stem-loop was 
recognized and bound by Roquin-1 ROQ with a slightly higher Kd value (∼370 nM) 
than the Tnf CDE (∼120 nM), and mutations that reduced binding to the Tnf CDE also 
impaired the Ox40 SELEX-like stem-loop binding (Figure 44). However, some 
differences became evident. ROQ K220A seemed to be less impaired compared to the 
Tnf CDE experiment, but Y250A and S265Y clearly decreased Ox40 SELEX-like 
binding to a larger extent. Meanwhile, crystallization of the ROQ Ox40 SELEX-like 
RNA complex was successful, and Dr. Robert Janowski was able to solve the crystal 
structure. Together with NMR data from Dr. Andreas Schlundt it proves that the ROQ 
domain uses the same interface to contact the SELEX-like hexaloop from the Ox40 
3’UTR and the Tnf CDE (data not shown). 
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Figure 43: Motif and conservation analysis of the Ox40 3’UTR. A A SELEX-like sequence in the 
Ox40 3’UTR closely resembles the MEME motif found in SELEX-enriched RNA sequences.                  
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B Schematic representation of the predicted SELEX stem-loop and the Ox40 SELEX-like stem-loop as 
used for binding analyses. C Multiple alignment of Ox40 3’UTR sequences from different species 
demonstrates sequence conservation (grey boxes) and structural conservation (obtained from Clustalw2 
and subsequent RNAalifold analysis). The darker the color of the nucleotide position the more likely it 
forms the indicated (top row, brackets and dots) structure. Here, the SELEX-like stem-loop is located at 
position 128-137 and the CDE-like stem-loop is located at position 171-185. 
 
 
Figure 44: Ox40 SELEX-like RNA binding analysis with ROQ domain mutants. Autoradiographies 
visualizing the binding of ROQ WT and of different ROQ mutants to the Ox40 SELEX-like RNA stem-
loop. Kd±s.e. for ROQ WT binding was calculated by curve fitting to the relative bound fraction per lane. 
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In the last part of this study, the contribution of the two Ox40 stem-loops to the protein-
RNA interaction and the Roquin-mediated post-transcriptional regulation was 
examined. Different Ox40 constructs were designed to investigate the necessity of the 
SELEX-like and the CDE-like stem-loop within their sequence context (Figure 45). 
Truncation of the Ox40 3’UTR in a retroviral expression vector abolished both stem- 
loops (Ox40 3’UTR 1-40 and 1-80) or destroyed the CDE-like stem-loop alone (Ox40 
3’UTR 1-120). In addition to that, parts of the sequence were mutated to prevent stem 
formation of the SELEX-like or the CDE-like element or both at the same time   
(Figure 45 and Appendix V).  
 
 
Figure 45: Ox40 3’UTR constructs as tested in binding and functional analyses. Green boxes: 
SELEX-like stem-loop, red boxes: CDE-like stem-loop, grey boxes: truncations and mutations that 
prevent stem- loop formation. 
 
EMSA experiments using the complete Ox40 3’UTR and recombinant Roquin-1         
N-terminus (aa 2-440) for binding revealed two high-affinity binding modes as seen 
from the two band shifts (75nM) (Figure 46). Only one high-affinity band shift was 
observed for the SELEX-like and the CDE-like single mutants, indicating that the 
second band depended on the presence of a second binding element. In line with this, 
high-affinity binding of Roquin-1 (aa 2-440) to the Ox40 3’UTR was completely 
abolished when both stem-loops were mutated. In all four EMSAs a supershift was 
observed for protein concentrations of 400 nM and higher, which seemed to be 
independent from the presence of specific cis-elements. 
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Figure 46: Binding analysis of the Ox40 3’UTR in band shift assays. EMSA experiment with the 
complete Ox40 3’UTR and the indicated mutated versions binding to Roquin-1 (aa 2-440). Arrowheads 
indicate specific high-affinity band shifts. 
 
The Ox40 constructs with shortened 3’UTRs or the mutant variants (Figure 45) were 
probed in a functional assay using the previously described Roquin-1-inducible     
Rc3h1-2-/- MEFs (see section 4.1.2). After expression of Ox40 via retrovirus 
transduction, half of the cells were treated with doxycyclin to induce Roquin-1 and 
mCherry overexpression. Roquin-1 overexpression in turn reduced Ox40 surface 
expression depending on the provided 3’UTR (Figure 47A). Calculation of the relative 
MFI and normalization to the Ox40 CDS revealed a clear correlation between the 
presence of specific cis-elements and the ability of Roquin-1 to regulate Ox40 
expression (Figure 47B). The two truncated 3’UTRs 1-40 and 1-80 do not contain an 
intact SELEX-like or CDE-like stem-loop and were not substantially regulated by 
Roquin-1 overexpression. The SELEX-like stem-loop, present in 3’UTR 1-120, allows 
intermediate repression as compared to the Ox40 full-length construct. Specific 
mutations of the SELEX-like or the CDE-like motif in the context of the full-length 
construct also resulted in an intermediate regulation upon Roquin-1 induction. Finally, a 
construct with mutations destroying both stem-loops was no longer a target of    
Roquin-1-mediated regulation. Instead, this constructs exhibited a relative Ox40 protein 
expression, which was comparable to the Ox40 CDS. These functional experiments 
clearly indicate that Roquin-1 post-transcriptionally regulates the Ox40 mRNA via 
recognition and binding of two distinct stem-loop structures within its 3’UTR. 
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Figure 47: Functional analysis of truncated and mutated Ox40 3’UTRs. A Representative dot plots 
showing expression levels of Ox40 depending on the expression construct (indicated above each plot) and 
on Dox-induced expression of Roquin-1-p2A-mCherry in Rc3h1-2-/- MEFs. B Relative Ox40 MFI 
normalized to expression levels from the Ox40 CDS construct. Error bars show SD of 7 (CDS, 1-40,      
1-80, 1-120, full-length), 6 (SELEX mut, CDE mut) or 3 (SELEX/CDE mut) independent experiments. 
Statistical significance was calculated by one-way ANOVA Kruskal-Wallis test followed by Dunn’s 
multiple comparison test (**p<0.01). 
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5 Discussion 
5.1 Roquin target identification 
5.1.1 Microarray analyses of Th1 cells upon acute deletion of Roquin 
5.1.1.1 Microarrays as tools for Roquin target identification 
Microarrays are an established tool to detect mRNAs that are differentially regulated in 
two groups of samples. Our well-controlled Th1 cell culture system of retrovirus-
mediated Roquin-1 and Roquin-2 deletion and simultaneous upregulation of CAR on 
the cell surface allowed the identification of Roquin-regulated mRNAs. Since deletion 
of Rc3h1-2 is only induced in vitro in Th1 cell cultures that contain similarly activated 
T cells, we circumvented the massive T cell activation difference observed in       
Rc3h1-2fl/fl; CD4 Cre mice compared to controls (Vogel et al. 2013). 
In a time course experiment, progressive Roquin deletion and upregulation of its target 
Icos was monitored to find the best time point for microarray analyses. No differences 
in Roquin-1 and Roquin-2 protein levels were observed comparing wild-type and 
Rc3h1-2fl/fl samples until 72 hours after T cell activation (Figure 10B). However, after 
72 hours the Roquin degradation bands were less prominent than after 48 hours, 
indicating that cleavage of Roquin specifically happens shortly after T cell activation. 
This is in line with recent findings of our group (Jeltsch et al. 2014). 96 and 120 hours 
after activation, Roquin protein levels were reduced in the Rc3h1-2fl/fl samples. The 
remaining Roquin protein was presumably derived from the 40% of cells that did not 
experience efficient virus infection and thus Cre-recombinase activity resulting in an 
upregulation of CAR (Figure 10A). Therefore, we enriched Thy1.1+ CAR+ cells by cell 
sorting to prepare RNA for the microarray analysis. To avoid secondary effects of 
Roquin deletion, I wanted to harvest the cells as early as possible after T cell activation. 
Since Icos mRNA levels only increased massively 120 hours after T cell activation, this 
time point was chosen for the analysis.  
Using the Icos-/- background in a repeat experiment allowed excluding targets that were 
only regulated in response to high Icos levels and thus strengthened the obtained data. 
Yet, no such targets were present among the top 20 candidates. Nevertheless, the 
method detects both primary, directly bound mRNA targets and mRNAs that are 
regulated as a secondary effect, for example in response to changes in T helper cell 
activation or differentiation. Only some of those false positive candidates can be 
excluded via the Icos-/- control arrays. 
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As microarrays only detect mRNAs included in the analysis they do not represent a 
completely unbiased and global approach. RNA sequencing is a method offering global 
investigation of the transcriptome with a very high sensitivity. The technique even 
enables the discovery of unknown or non-coding transcripts and splice variants. 
However, this was not required, since the study aimed at identifying known mRNAs 
that are targeted by Roquin. Moreover, RNA sequencing would also detect indirect 
Roquin targets and is considerably more cost-intensive. 
Another drawback of microarray analyses and other methods investigating the 
transcriptome of target cells is their dependency on altered mRNA expression levels. 
Hence, mRNA targets bound by Roquin and only regulated on the translational level 
will not be identified in these assays. A connection of translational regulation and 
Roquin was found in the time course experiment to evaluate the retrovirally induced 
deletion of Roquin-1 and Roquin-2 in Th1 cells (Figure 10). Expression of the known 
target Icos in response to Roquin deletion was measured both on the protein and on the 
mRNA level (Figure 10C and D). Whereas Icos mRNA amounts only changed 
drastically after 120 hours of Th1 cell culture (80 hours post retroviral infection), the 
amount of Icos protein on the cell surface was already strongly increased 96 hours after 
T cell activation as determined by flow cytometry. This suggests that Roquin regulation 
involves translational inhibition as well as mRNA destabilization and decay. 
Nevertheless, the microarray analyses provided a comprehensive list of target 
candidates. As expected, most of the differentially regulated mRNAs were upregulated 
in the samples lacking Roquin-1 and Roquin-2, and only a few genes showed decreased 
expression (Figure 13). The high reproducibility of upregulated but not downregulated 
genes further underlined the reliability of the data. Differential expression of selected 
target candidates was confirmed by qPCR measurements, which offer a broad dynamic 
range for mRNA quantification (Provenzano & Mocellin 2007; Wang et al. 2006). 
Hence, the qPCR data revealed that fold changes obtained from the array data analysis 
rather underrated the extent of differential regulation. Consequently, the list (Table 20) 
of mRNAs contains promising candidates with strongly increased expression levels in 
response to Rc3h1-2 deletion in Th1 cells. 
 
5.1.1.2 Roquin target candidates 
The target candidate with the highest fold change was Ccl22 (Table 20), a secreted 
chemokine, which is mainly expressed in macrophages and monocyte-derived DCs 
(Vulcano et al. 2001). As a chemoattractant, it seems to play a role in trafficking 
activated/effector T cells to sites of inflammation (Chantry et al. 1999; Chang et al. 
1997). However, there is no evidence that T cells themselves are a major source of 
Ccl22. 
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Another strongly regulated factor was Ebi3, which associates as heterodimer with p28 
to form IL-27 and with IL-12p35 to form IL-35. IL-27 has been shown to induce 
proliferation of naïve CD4+ T cells and to promote the production of the Th1 cytokine 
IFN-γ in cell culture (Pflanz et al. 2002). IL-35 has been involved in 
immunosuppression by direct action on effector T cells or by promoting Treg cell 
proliferation (Olson et al. 2013). Yet, there is poor evidence that Th1 cells themselves 
produce IL-27 or IL-35. 
The serine-threonine protein kinase Pim2 is a target candidate mainly expressed in 
spleen, thymus and brain of mice (Allen et al. 1997). According to the ImmGen 
database Pim2 is highly expressed in most lymphocytes, including T cells. Pim2 is 
described as a proto-oncogene, since overexpression through proviral insertion or 
transgenic alleles increases the incidence of lymphoid tumors (Breuer et al. 1989; Allen 
et al. 1997). On a molecular level, Pim2 stabilizes c-myc, reduces apoptosis via Bad and 
increases survival and proliferation of cells by phosphorylation of different target 
proteins (Yan et al. 2003; Zhang et al. 2008; Hammerman et al. 2005). Thus, high Pim2 
levels in T cells lacking Roquin-1 and Roquin-2 might promote increased T cell 
survival and proliferation. In addition, T cell proliferation is supported by the IL-2 
cytokine, which is also a target candidate in our array analyses. 
Costimulatory receptors of T cells form a group of genes that appears to be affected by 
Roquin deletion. This is particularly interesting, since Icos functions as an inducible co-
stimulator on T cells and thus promotes prolonged T cell activation and supports Tfh 
cell differentiation (Hutloff et al. 1999; Choi et al. 2011). Similarly, the expression of 
the costimulatory molecules Ox40 (Tnfrsf4), CD30 (Tnfrsf8) and Ctla4, which are 
among the top 20 Roquin target candidates, is only induced by T cell activation (Croft 
2010; Carreno & Collins 2002; Watts 2005). Ctla4 is expressed in the late phase of T 
cell activation and is an inhibitor of T cell immune responses, since it antagonizes CD28 
costimulation (Rudd & Schneider 2003). This is not in line with the hypothesis that 
targets of Roquin promote T cell activation and autoimmunity. CD30 is a costimulator 
mainly described in the context of lymphocyte malignancies. It is expressed on 
activated T cells, and it was shown to promote Th2 and Th17 differentiation 
(Romagnani et al. 1995; Sun et al. 2010). Interestingly, we also observed increased 
Th17 differentiation of Rc3h1-2-/- T cells in vivo and in cell culture (Jeltsch et al. 2014). 
Recently, is has been shown that CD30 is increased on CD8+ T cell from SLE patients 
(Cabrera et al. 2013), indicating that CD30 might be involved in the development of 
autoimmunity. Moreover, the deletion of both CD30 and Ox40 in FoxP3-deficient mice 
prevented tissue infiltrations and autoimmunity in these animals (Gaspal et al. 2011). 
Increased Ox40 signaling has been involved in autoimmunity by different other studies 
(Bansal-Pakala et al. 2001; Murata et al. 2002). Since the target candidate Ox40 was 
investigated in more detail throughout this thesis work, it is discussed separately in 5.3.  
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Surprisingly, a number of target candidates are only expressed in lymphocytes other 
than T cell as for example CD19, a prominent B lymphocyte antigen. Other candidates 
are CD86, a ligand of the T cell costimulator CD28 also known as B7, as well as 
CD180, CD24a and CD79a/b. According to the ImmGen database (Kim & Lanier 2013) 
these genes are exclusively expressed on B cells, DCs, macrophages or monocytes, 
which raises the question how they can be differentially expressed in Th1 cells. One 
possible explanation is the purity of CD4+ cells isolated from spleen and lymph nodes. 
Surface staining and flow cytometry show that >94% of the cells are CD4+ after five 
days of Th1 cell culture (data not shown). Subsets of DCs express CD4 and could 
contaminate the T cells culture. However, DCs are short-lived cells and do not survive 
five days in cell culture. Also, it is not clear whether contaminating cells are retrovirally 
infected. Only upon efficient infection and Cre-recombinase activity, the cells express 
CAR on their surface, which was a prerequisite for our cell sorting protocol. Non-T-
cell-specific target mRNAs could also be explained by an upregulation of those genes in 
response to Roquin deletion causing a loss of tissue identity. In this scenario, Roquin 
proteins would be required to control the integrity of T cells by suppressing the 
expression of B cell- and DC-specific genes. Yet, Roquin proteins are also expressed in 
these lymphocytes, raising the question how cell-type-specific regulation of target 
mRNAs is achieved. In addition to differential expression upon acute Roquin deletion in 
the Th1 cell culture, one also has to consider the expression levels of the respective 
mRNAs. To test this, qPCR measurements of Syk, one predominantly B-cell-expressed 
gene (Chan et al. 1994) among the target candidates, was performed (data not shown). 
Upregulated mRNA levels in Rc3h1-2-/- cells were confirmed, but Syk exhibited low 
overall expression levels. Thus, Syk is an unlikely target candidate of Roquin. 
Other functional groups of Roquin target candidates are negative regulators of the 
mitochondrial apoptotic pathway, like Bcl2a1a/b/d and Bcl2l1 (Bcl-XL), and factors 
involved in the NF-κB signaling pathway, like Ox40, CD30, Nfkbid, Bcl-3, Il-2 and 
Icos. Interestingly, Bcl2a1 and Bcl2l1 are induced upon NF-κB signaling to promote 
cell survival (Zong et al. 1999; Chen et al. 2000). Therefore, upregulation of Bcl2a1 and 
Bcl2l1 might be a downstream effect of non-canonical NF-κB signaling, which is 
strongly activated in T cells lacking Roquin-1 and Roquin-2 (Vogel et al. 2013). 
 
5.1.1.3 Potential Roquin targets in the context of Roquin-related mouse 
phenotypes 
Roquin deficiency and the M199R mutation of Roquin-1 have been found to promote 
different immune diseases. Sanroque mice that are homozygous for the M199R 
mutation of Roquin-1 have increased numbers of Tfh cells and GC B cells and produce 
high-affinity ANAs, resembling the human disease SLE (Vinuesa et al. 2005; 
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Linterman, Rigby, R. K. Wong, et al. 2009). Furthermore, plasmacytoid infiltrations in 
liver, lung and kidneys were found in those mice (Vinuesa et al. 2005). In different 
models for autoimmune diseases, such as autoimmune diabetes and antibody-induced 
arthritis, sanroque mice exhibited enhanced disease parameters (Silva et al. 2011; 
Pratama et al. 2013). In this context, co-stimulatory receptors like Icos, Ox40 and CD30 
are promising target candidates. Also, factors that promote T cell activation and 
survival, such as Bcl2l1, Bcl2a1, Il-2, Nfkbid and Bcl-3, are likely to be involved in 
excessive immune responses and autoimmunity. Interestingly, heterozygosity for the 
Rc3h1san allele strongly increased the frequency of angioimmunoblastic T cell 
lymphomas in mice (Ellyard et al. 2012). Pim2, a proto-oncogene, induced T cell 
lymphomas when overexpressed from a lymphoid-cell-specific transgene (Allen et al. 
1997) suggesting that dysregulation of this gene due to a lack of Roquin could promote 
tumorigenesis. 
Taken together, the array data show that the lack of both Roquin-1 and Roquin-2 leads 
to the upregulation of numerous genes involved in T cell activation and survival. On the 
one hand, those targets are likely to reduce the threshold for T cell activation resulting 
in autoimmunity as in sanroque mice and in the accumulation of activated T cells as 
observed in Rc3h1-2fl/fl; CD4 Cre mice. On the other hand, increased proliferation and 
survival of T cells might be the underlying cause for the development of T cell 
lymphomas in heterozygous Roquinsan mice. 
 
5.1.2 Roquin CLIP and PAR-CLIP assays in primary Th1 cells 
As a second approach of target identification, CLIP and PAR-CLIP assays were 
performed for Roquin. In contrast to microarrays, this method is designed to identify 
RBP-bound RNAs by UV cross-linking of protein-RNA contacts within the cell and 
subsequent IP (Ule et al. 2005; Hafner et al. 2010). Therefore, CLIP assays with 
Roquin-specific antibodies are a possibility to isolate Roquin-bound RNAs independent 
of the regulatory effect of Roquin on the respective mRNA or protein amount. In 
addition, sites of protein-RNA interaction can be investigated, because UV cross-
linking results in mutagenesis during reverse transcription of the purified RNAs. 
Treatment with 4SU and irradiation with 365 nm UV light specifically induces T to C 
conversions at positions where the protein had close contact to a 4SU molecule 
(Meisenheimer & Koch 1997; Hafner et al. 2010). 
Unfortunately, the performed assays did not yield very conclusive results due to various 
reasons. One important factor is that my experiments were performed with primary Th1 
cells and therefore lower cell numbers than suggested for cell lines. Also, Roquin 
proteins, which are not highly expressed in cells, were not overexpressed as most 
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publications suggest. My decision for endogenous protein levels was based on the 
observation that cells only tolerate Roquin overexpression for about 24 hours without 
obvious signs of cellular stress. Thus, the starting conditions were not optimal, which 
was reflected by weak protein and RNA bands throughout the procedure (Figure 23). In 
addition, the sequencing data revealed a high frequency of multimeric adapter 
sequences, suggesting a failure to fully remove the adapter RNAs used during cDNA 
library preparation. This reduced the number of unique reads to 5.5 million per sample 
or less (Table 22), which is still comparable to published PAR-CLIP data ranging from 
1 to 10 million reads per sample (Hafner et al. 2010). Optimizing the adapter ligation 
and using for example the Roquin-1-inducible Rc3h1-2-/- MEFs to obtain higher 
Roquin-1 protein levels could help to increase the number and quality of specifically 
clipped sequences. However, MEF lysates will not provide any information about        
T-cell-specific targets. 
For the performed assays, reads mapping to mRNAs were analyzed with respect to T to 
C conversions and to their flanking sequence preferences. To our surprise, clipped 
sequences did not show any nucleotide bias upstream and downstream of cross-linked  
U sites (Figure 25). An explanation could be that Roquin proteins recognize and bind 
mRNA mainly in a non-sequence-specific manner. This hypothesis is supported by our 
own data (Schlundt et al. 2014) and by a publication showing that the CDE stem-loop 
structure within the Tnf 3’UTR is specifically bound by Roquin (Leppek et al. 2013). 
Based on that, Dr. Andreas Gruber plotted the number of reads mapping to the vicinity 
of putative CDE stem-loops. The data exposed spots of high read frequency close to 
CDE sequences, yet with various patterns, which does not indicate a clear preference for 
upstream or downstream sequences (Figure 26). Therefore, the observed clusters 
possibly reflect the accessibility of a CDE-neighboring sequence for cross-linking rather 
than a pattern of Roquin-RNA interaction. 
By now, our own investigations of the crystal structure of the ROQ domain and the 
ROQ-Tnf CDE complex show that indeed recognition and binding of CDE stem-loops 
is mainly not sequence- but shape-specific (see 4.2.2). Most interactions target the 
phosphate backbone of the double-stranded RNA stem. Another publication confirms 
our ROQ domain interaction with the CDE stem-loop and additionally describes a 
second RNA-binding site for Roquin, which binds double-stranded RNA without 
sequence specificity (Tan et al. 2014). The dispensability of base-specific interactions in 
RNA binding could explain the missing sequence bias nearby sites of T to C 
conversion. Moreover, these structural analyses give a possible explanation for the poor 
outcome of the CLIP and PAR-CLIP assays, since double-stranded RNA is less 
efficiently cross-linked to protein by UV irradiation (Liu et al. 1996). In addition, the 
data evaluation would have to be changed for PAR-CLIP assays on proteins like 
Roquin. Instead of starting with a search for enriched nucleotide sequences within the 
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clipped RNAs, a more structure-based approach would be required. Although protein 
binding-site identification recently also implemented structural features of RNA (Hu et 
al. 2014; Lambert et al. 2014), it is still not a standardized procedure. This is due to 
increasing complexity when sequence restrictions are absent or when structural 
requirements are unknown. 
Nevertheless, clipped sequences for known targets or target candidates can be extracted 
from the CLIP and PAR-CLIP data sets. Thus, an analysis of certain read clusters is 
possible, which supports the discovery of unknown Roquin cis-elements as shown for 
the newly identified target Ox40 (Figure 27). The largest sequence cluster was found at 
the 3’ end of the Ox40 CDS, which raised the question whether Roquin could also 
mediate post-transcriptional regulation via cis-elements in the CDS of an mRNA. Other 
CLIP data sets indicate that RBPs do not exclusively bind to 3’UTRs (Hafner et al. 
2010), but the functional impact of these interactions has not been investigated. Yet, 
miRNA binding in the CDS of mRNAs inducing post-transcriptional regulation is well-
accepted by now (Brümmer & Hausser 2014; Hausser et al. 2013). Thus, it is possible 
that mediators of post-transcriptional regulation, such as Roquin, recognize their target 
elements within the CDS of an mRNA. However, there were also two sequence clusters 
within the Ox40 3’UTR among the clipped sequences. Comparing the positions of these 
two clusters with a prediction of the Ox40 3’UTR folding revealed that the clusters are 
in close proximity of two putative stem-loop structures (Figure 27). One of these stem-
loops is a triloop and resembles a CDE-like structure, which suggests that the sequence 
clusters indeed are indicative of specific Roquin-RNA interactions. Similarly, several 
clipped sequence clusters could be identified within the Icos 3’UTR, one also covering 
the area of the proposed CDE stem-loop (data not shown) (Leppek et al. 2013). Even 
though a global analysis of the obtained CLIP and PAR-CLIP data sets was not 
possible, they contain valid information about sites of Roquin-mRNA interaction in Th1 
cells. 
 
5.1.3 Conclusions on Roquin target identification 
For the identification of Roquin-regulated mRNAs, different methods with certain 
advantages and disadvantages are available (see Table 23). They detect either the 
protein-RNA interaction directly or the downstream effects of this interaction, such as 
altered mRNA levels. CLIP and PAR-CLIP experiments offer a global view on the 
Roquin-RNA interaction, but the quality of the data is strongly dependent on the 
binding mode and thus the efficiency of UV cross-linking. The microarray analyses 
provided a more reliable list of target candidates, however, with a certain false positive 
rate due to secondary effects and poorly expressed non-T-cell targets. Therefore, the 
microarray data requires follow-up evaluation on the mRNA and on the protein level. 
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To account for the finding that Roquin also involves translational regulation, another 
method can be applied, which is known as ribosome profiling (Ingolia et al. 2009; 
Ingolia et al. 2012). Ribosomes are fixed in their position on mRNAs by cycloheximide 
treatment, and partial RNase digest removes RNA that is not protected by ribosome 
binding. The protected RNA fragments can be analyzed by high-throughput sequencing 
to obtain a picture of the ribosome occupancy of individual mRNAs. A change of this 
pattern upon deletion of Roquin would indicate translational regulation of the respective 
mRNA by Roquin. Since the Icos protein amount increased faster to acute Roquin 
deletion than mRNA levels (Figure 10), ribosome profiling would be the method of 
choice to identify targets earlier after T cell activation. Yet, it is unclear whether 
translational inhibition and mRNA destabilization are promoted by Roquin on the same 
target mRNAs to the same extent, or whether one or the other mechanism is preferred in 
certain situations. Therefore, performing different target identification assays at 
different time points after T cell activation could yield an extended set of mRNA 
candidates. 
My analyses clearly show that Roquin not only targets a few mRNAs but rather a large 
set of mRNAs. These mRNAs belong to different gene families indicating that Roquin-
mediated post-transcriptional regulation alters T helper cell homeostasis simultaneously 
on the level of activation, proliferation and apoptosis. Since Roquin proteins are 
expressed in various organs and cell types (Vogel et al. 2013), they might also regulate 
cell type-specific sets of target mRNAs. Thus, Roquin proteins might be able to fulfill a 
wide range of tasks in different cells. To get a comprehensive picture of Roquin-
mediated post-transcriptional regulation in Th1 cells or other cell types, different 
approaches for target identification ideally have to be combined and performed at 
different stages of cell activation and differentiation. 
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Table 23: Comparison of methods for Roquin target identification and summary of the subsequent 
target validation procedure 
Scheme	  
	  
Method Microarrays CLIP/PAR-CLIP Ribosome profiling* 
*not done in this study 
Technology mRNA expression arrays 
(Affymetrix) 
Deep sequencing   
(Illumina Solexa) 
Deep sequencing   
(Illumina Solexa) 
Targeted 
Roquin 
function 
mRNA destabilization 
à Differential mRNA 
expression depending on 
Roquin levels 
mRNA binding 
à Roquin-bound 
mRNA fragments 
Translation regulation 
à Differential ribosome 
occupancy depending on 
Roquin levels 
Maximum 
output 
Target mRNAs Target mRNAs and site 
of Roquin binding 
Target mRNAs and 
mechanistic insight  
False 
positives 
Secondary effects and 
expression levels 
Background signals Secondary effects and 
background signals 
Sensitivity + + + +  
Loss of material due to 
multistep experimental 
procedure 
+  
Loss of material due to 
multistep experimental 
procedure 
Costs + + + + + + + + 
 
Validation	   	  
ü Differential	  expression	  of	  targets	  on	  the	  protein	  level	  in	  response	  to	  
Roquin	  overexpression	  or	  deletion	  (Immunoblotting	  or	  flow	  cytometry)	  
ü Requirement	  of	  the	  3’UTR	  for	  Roquin-­‐mediated	  regulation	  of	  the	  target	  
mRNA	  (Reporter	  assay	  upon	  Roquin	  induction	  or	  deletion)	  
ü Direct	  and	  specific	  binding	  of	  Roquin	  (ROQ	  domain)	  to	  the	  target	  mRNA	  
via	  the	  3’UTR	  in	  vitro	  (EMSA	  or	  FBA)	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Having found target candidates by high-throughput methods, further validation is the 
important next step in Roquin target identification (see Table 23). Since the described 
methods investigate the mRNA level, it is necessary to prove that Roquin also alters the 
protein expression of a putative target gene. By immunoblotting or flow cytometry, an 
increase of the target protein as a result of Roquin deletion in primary CD4+ T cells or 
MEFs can be detected. Subsequently, Roquin-mediated regulation of the putative target 
mRNA needs to be attributed to the presence of cis-regulatory RNA elements, which 
are likely to be located in the 3’UTR. To this end, reporter assays in Roquin-inducible 
cells can be performed either comparing the full-length target mRNA to the respective 
CDS or fusing the target 3’UTR to a reporter gene. The 3’UTR of a direct Roquin target 
will confer post-transcriptional regulation of the reporter gene, whereas the 3’UTR of an 
indirect target most likely has no effect in response to Roquin induction. Similarly, 
reporter assays can be performed in MEFs upon acute deletion of Roquin (Figure 42). 
In addition to cell based analyses, the direct interaction of the putative target mRNA 
with Roquin has to be shown using in vitro binding assays. The specificity of the 
Roquin-RNA contact can be determined by addition of specific competitor RNAs or by 
using an RNA-binding-deficient Roquin mutant (Figure 15C, D and Figure 37). 
The combination of functional assays and in vitro binding analyses is required and 
sufficient to clearly identify mRNAs that are directly targeted and regulated by Roquin. 
Unfortunately, not all suggested Roquin targets were validated with this accuracy, as for 
example IFN-γ, for which deregulation in sanroque mice but no direct binding of 
Roquin proteins to the mRNA was shown (Chang et al. 2012). Since Roquin interferes 
with many cellular processes, validation is essential to distinguish primary, direct target 
from genes that are indirectly regulated due to aberrant Roquin function. 
 
5.2 Molecular requirements for the Roquin-RNA interaction 
5.2.1 Identification of high-affinity Roquin binding sites by SELEX 
5.2.1.1 Selection of RNAs bound by Roquin from a random RNA library 
To identify RNAs bound by Roquin in an unbiased approach, I performed SELEX 
experiments with recombinant Roquin-1 N-terminal protein (aa 2-440). A similar 
experimental approach has been successfully used to identify RNA binding sites, for 
example using the STAR protein QKI (Galarneau & Richard 2005) or Fox-1 and Fox-2 
splicing factors (Jin et al. 2003; Ponthier et al. 2006). For our selection, a single-
stranded RNA library with a 47 nts random sequence was used to potentially provide 
the protein with high-affinity binding sites. After three rounds of selection, enriched 
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sequences were identified, clustered into groups of sequence patterns and 
experimentally validated in FBAs. Indeed, most of the tested patterns were confirmed, 
since they bound to Roquin-1 N-term stronger than the starting pool of RNAs     
(Figure 30). Pattern 9 and 12, which were among the strongest binders in the FBA 
validation, were further analyzed to determine the dissociation constant. In radioactive 
EMSAs, both patterns showed a distinguished band shift upon addition of the minimal 
ROQ domain (aa 147-326) with a Kd value of about 80 nM (Figure 31, upper panel). 
This is the same order of magnitude as for ROQ binding to the Tnf CDE (Kd~120 nM) 
(Figure 34C) and underlines that SELEX succeeded in identifying RNAs that are 
bound by Roquin with high affinity. In a second set of EMSAs using a ROQ mutant that 
was impaired in binding the Tnf CDE (K239A R260A), I confirmed the SELEX 
patterns to target the same protein interface like the Tnf CDE (Figure 31, lower panel). 
 
5.2.1.2 Sequence motif and structural preference in SELEX patterns 
Using a bioinformatics approach, the enriched patterns were further analyzed to identify 
shared sequence motifs. Hexamer enrichment analysis revealed that SELEX patterns 
share certain hexamer sequences, which were also enriched in a repeat experiment using 
Roquin-1 N-terminus and Roquin-1 M199R N-terminus for selection (Figure 32). Thus, 
during the in vitro selection process from random RNA sequences, Roquin-1 does 
exhibit a preference for a sequence motif. This is in contrast to the finding that   
Roquin-1 predominantly binds RNA in a sequence-independent manner in our CLIP 
and crystal structure analyses. One explanation for this paradox is the fact that the 
selection was performed in vitro and from a pool of artificial RNA sequences. Here, 
artificial RNA elements could bind to Roquin-1 with higher than natural affinities and 
could bring out a sequence-specificity that is not used in natural targets. In fact, this 
might not be favorable in cells, because very tight macromolecular interactions would 
interfere with the dynamics of regulatory processes. The drawbacks of artificial RNA 
elements can be overcome by designing an RNA library based on naturally occurring 
mRNAs as in Reid et al., 2009, yet with the disadvantage of creating a selection bias. 
Interestingly, the enriched sequence motif was predominantly located at the 3’ end of 
the random RNA sequence (Appendix I). This prompted us to check whether the RNA 
context flanking the sequence motif shows a particular structural preference that was 
selected by Roquin-1. Indeed, Dr. Andreas Gruber found that the sequence motif is 
embedded in a stem-loop structure (Figure 33). Therefore, the SELEX experiments 
discovered a potential Roquin cis-element, which combines sequence-specific binding 
with structural preferences. 
The clear preference for the 3’ end of the random RNA sequence indicates that the 
adjacent primer sequence can influence the selection process. Selection can be 
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performed in a different RNA library to exclude a bias due to fixed primer sequences. In 
addition, the importance of the combined sequence-structure motif has to be addressed 
in further binding studies. Removing the flanking RNA context and mutational analyses 
are required to determine the specificity of the motif recognition. A first experiment 
using the Roquin-1 M199R N-terminus exhibited comparable hexamer enrichment, 
indicating an unchanged RNA binding preference of the sanroque protein. This is in 
line with the finding that the amino acid M199 does not form close contacts to the Tnf 
CDE in our crystal structures (Figure 36) and thus might not be directly involved in 
RNA binding. Yet, further binding experiments are necessary to draw final conclusions. 
Moreover, the importance of the SELEX stem-loop for natural Roquin-RNA 
interactions in cells needs to be determined. To address this, the mouse genome was 
screened for SELEX stem-loop elements and the resulting list of genes was compared to 
the list of Roquin target candidates from the microarray analysis. However, among the 
target candidates with a high fold change (Table 20), only the early B cell factor 1 
mRNA (Ebf1) harbors a sequence able to form a SELEX stem-loop (data not shown). 
Further experimental validation is required to clearly define the conformation of the 
SELEX stem-loop motif for Roquin binding. Nevertheless, I identified a SELEX-like 
hexaloop within the Ox40 3’UTR by in situ RNA folding analysis. The functional 
impact of this SELEX-like stem-loop in the context of Ox40 regulation is discussed in 
5.3.3. 
 
5.2.2 Structural analysis of the Roquin-RNA interaction 
5.2.2.1 Crystal structures of the ROQ domain and the ROQ Tnf CDE complex 
In collaboration with Dr. Robert Janowski, Prof. Dr. Dierk Niessing’s group, and Dr. 
Andreas Schlundt, Prof. Dr. Michael Sattler’s group, we were able to obtain the crystal 
structures of the minimal ROQ domain (aa 147-326) and of the ROQ-Tnf CDE 
complex. These structures were published together with a mutational screening of the 
RNA-binding interface of ROQ and mutational analyses of the CDE RNA stem-loop in 
Schlundt et al., 2014. In the same issue of the journal, a second structural investigation 
of Roquin-1-RNA interactions was published by Tan et al., 2014. A comparison of the 
two studies is given in Table 24 and will be discussed in the following passages. 
The crystal structure of the ROQ domain adopted an extended winged-helix (WH) fold. 
This domain type is predominantly involved in DNA binding, with the Fox family of 
transcription factors being prominent representatives (Gajiwala & Burley 2000; 
Benayoun et al. 2011). However, there are also examples of WH domains recognizing 
RNA either in a single-stranded or stem-loop conformation (Teplova et al. 2006; 
Yoshizawa et al. 2005; Soler et al. 2007; Harami et al. 2013). The WH fold of the ROQ 
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domain was not altered upon binding of the Tnf CDE stem-loop RNA except for a more 
compact conformation of the W1 fold. Tan et al. solved the crystal structure of a larger 
human ROQUIN-1 construct (aa 90-400) with additional sequences flanking the ROQ 
domain, and they identified three subdomains within this structure. Domain II and III 
together resemble our ROQ domain, whereas domain I is the additional part (see Table 
24). In addition to the WH fold in domain III, Tan et al. described in more detail a 
second helix-turn-helix (HTH) motif in domain II, which is similar to the WH fold 
except for the missing β-sheets to form the wing. Domain I consists of three N-terminal 
and three C-terminal α-helices packed together.  
Tan et al. identified two RNA interaction sites in crystal structures of Roquin-1 with 
different RNAs. The A site recognized a canonical CDE RNA stem-loop (Hmg19) from 
the 3’UTR of HMGXB3 (HMG box domain containing 3), whereas the B site bound to 
an artificial Tnf CDE RNA duplex. Comparing the A site binding of the Hmg19 stem-
loop to binding of the Tnf CDE stem-loop in our study shows identical protein-RNA 
interactions. The main contacts were non-sequence-specific interactions with the 
phosphate backbone of the 5’ stem (Figure 36). Moreover, sequence-specific contacts 
were observed for the flipped-out Us in the loop (U11 and U13 or U8 and U10 
respectively), the G in the center of the loop (G12 or G9) and for a U (U4 or U1) that is 
sticking out from the stem and interacts with W184. The remarkable identity of two 
different Roquin-1-RNA complex structures underlines the specific recognition of CDE 
RNA stem-loop folds by Roquin-1. Surprisingly, the Tnf CDE adopted a double-
stranded duplex conformation in crystal structures by Tan et al. and was bound to the   
B site, the groove between domain I and domain II. Protein-RNA interactions appeared 
to be weak and rather non-sequence-specific. In our hands, the Tnf CDE formed a stem-
loop structure in solution, as proven in NMR measurements, and it also seemed to adopt 
this conformation in binding assays performed by Tan et al.. Therefore, the double-
stranded Tnf CDE duplex observed in the complex structure is most likely a 
crystallization artifact. Nevertheless, it indicated that Roquin-1 is able to bind double-
stranded RNA and raised several questions. Does the B site RNA binding occur under 
physiological conditions, such as in solution or in cells? Can B site and A site binding 
take place simultaneously on one Roquin molecule? Are the RNA stem-loop for the     
A site and the double-stranded RNA for the B site present within the same mRNA in 
cells? What is the functional impact of RNA binding by the B site? Some of these 
questions are addressed in the manuscript of Tan et al.. Presence of a ternary complex 
consisting of Roquin-1 (aa 90-400), Hmg19 CDE and a double-stranded Tnf RNA was 
shown in a binding assay, suggesting that in vitro both RNA binding sites can be used at 
the same time. However, it remains elusive whether this also happens within cells and if 
so whether both binding sites are provided by one mRNA.  
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Taken together, both studies confirmed specific recognition of CDE stem-loop 
structures by the ROQ domain of Roquin-1 as suggested by Leppek et al. (Leppek et al. 
2013). Since we showed that full-length Roquin-1 and our minimal ROQ domain bound 
the Tnf CDE with similar affinities (Figure 34C and D), the quantitative involvement 
of other domains of Roquin in CDE stem-loop binding can be neglected. Nevertheless, 
they might support RNA recognition or binding through different mechanisms on 
composite cis-elements.  
Roquin-1 has a RING finger domain as found in E3 ubiquitin ligases. Whereas E3 
ligase activity was observed for Roquin-2 (Maruyama et al. 2014), it is not known 
whether the Roquin-1 RING finger is functional, even though RING-less Roquin 
mutants seemed to be impaired in immune regulation (Pratama et al. 2013). A whole 
group of RNA-binding E3 ubiquitin ligases has been described by now, but the 
connection of ubiquitination and RNA binding remains unclear (Cano et al. 2010). 
MEX-3C, one such protein, has been studied in more detail showing that its E3 
ubiquitin ligase function is required for degradation of target mRNAs but not for 
translational inhibition (Cano et al. 2012). The Roquin-1 N-terminus also contains a 
CCCH-type zinc finger C-terminal to the ROQ domain. This type of protein domain is 
known to bind to AU-rich RNA elements (AREs), best described for the RNA-binding 
protein TTP (Hall 2005). Although CCCH zinc fingers mostly occur in tandem or even 
higher numbers of modules, specific interaction with AREs was also observed with a 
single CCCH zinc finger (Michel et al. 2003). Thus, the Roquin-1 CCCH zinc finger 
might bind to AREs as an independent form of Roquin-1-RNA interaction in addition to 
the ROQ-mediated CDE stem-loop binding. The C-terminus of Roquin-1 contains a 
proline-rich sequence (PRS) and a putative coiled-coil domain (Vinuesa et al. 2005). 
PRSs are important sites for protein-protein interactions and can be found in a large 
number of proteins (Williamson 1994). Different domain types are known to interact 
preferentially with PRSs, such as WW domains and Src homology (SH) domains (Kay 
et al. 2000). Coiled-coils are abundant structural elements found in proteins with diverse 
functions, such as transcription factors or structural proteins, and they serve as 
oligomerization domains, spacers or building blocks in the cytoskeleton (Mason & 
Arndt 2004; Burkhard et al. 2001). Thus, the functional elements in the C-terminus of 
Roquin-1 are most likely involved in protein-protein interactions. 
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Table 24 Comparison of Roquin structure investigations from Schlundt et al. and Tan et al. 
Feature	   Schlundt	  et	  al.	   Tan	  et	  al.	  
Species Mouse and human Roquin-1 are 
identical in this region  
Human Roquin-1 
Model 
  
Domains                                                 
ROQ domain: aa 174-325 
Domain III+II+I: aa 89-398        
Domain III+II: aa 175- 324         
Domain III: aa 195-271 
Motifs WH: aa 195-271 WH: aa 195-271, HTH: aa 274-324 
RNA-binding 
interfaces 
One: stem-loop binding A site: stem-loop binding                      
B site: dsRNA binding 
RNA structure Tnf  CDE as triloop A site: Hmg19 as triloop                         
B site: Tnf CDE as duplex 
RNA binding 5’ stem, phosphate backbone A site: 5’ stem, phosphate backbone                                 
B site: weak 5’ and 3’ interactions  
RNA loop 
contacts 
U11 and U13: flipped out       
G12: stacking and R219, Q247 
U8 and U10: flipped out                    
G9: stacking and R219 
RNA stem 
contacts 
U4 flipped out, contact to W184 
and F194 
U1 flipped out, contact to W184 
Protein mutants K220A, K239A, R260A, 
K239A/R260A, R188A, R219A, 
R229A, R233A, S238A, Y250A, 
R251A, S253A, K259A, S264A, 
S265Y, E293A, K314A 
A site: K239A/T240A, 
Q247A/Y250A/R251A 
B site: Q318A/S319A, 
R135E/K136E/R164E, 
R135E/K136E/D322A/K323A 
RNA mutants Extension mutant, loop mutants 1-
3, stem mutants 1-3  
CDE-like RNA stem-loops 
none 
Functional 
assays 
Protein expression levels 
measured by flow cytometry 
mRNA half-life measured by qPCR 
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5.2.2.2 Mutational analysis of the ROQ RNA-binding interface 
The contribution of single amino acids within the RNA-binding interface of the ROQ 
domain was determined by mutational analyses in shift assays. K220, K239 and R260 
were identified as major players in the ROQ-RNA interaction (Figure 37), and 
therefore the respective mutants were investigated in cell-based functional assays. 
Importantly, combining two mutations (K239A and R260A) further reduced binding to 
the Tnf CDE. This indicated that changes in the amino acid composition of the RNA-
binding interface of ROQ reduced the RNA affinity and two changes at once had a 
stronger effect. In fact, Tan et al. only tested Roquin variants with two or more 
mutations in binding assays. Amongst others, they target the amino acids K239, Y250 
and R251, which were also included in our mutational screening. Since titration 
experiments are not shown, it is unclear whether there were gradual differences between 
a double mutant (K239A T240A) and a triple mutant (Q247A Y250A R251A) in RNA 
binding. To test functionality of the Roquin-1 mutants, Tan et al. knocked down 
endogenous Roquin by si-RNAs and re-expressed wild-type or mutant Roquin-1. 
Roquin-1 function was determined by qPCR measurements of RNA stability upon 
actinomycin D treatment. Interestingly, A site as well as B site mutations completely 
abolished Roquin-1-mediated reduction of the HMGXB3 mRNA half-life. In contrast, 
our cell-culture-based functional assay used surface expression of Roquin target 
proteins (ICOS or Ox40) as read-out for Roquin function in cells. This is advantageous 
because the result of Roquin-1-mediated regulation on the protein-level is monitored 
and thereby effects on mRNA stability and translational efficiency are integrated. 
As reporter constructs, I used the two natural Roquin targets ICOS fl, Ox40 fl and a 
chimeric ICOS CDE260, which has a shortened Tnf 3’UTR (260 nts) containing the CDE 
stem-loop sequence. Instead of knocking down Roquin-1 and Roquin-2 with siRNAs, I 
used Rc3h1-2-/- MEFs and introduced the reporter constructs and the different Roquin-1 
variants by retroviral transduction. The two natural Roquin targets ICOS fl and Ox40 fl 
showed comparable regulation patterns with the strongest reduction upon 
overexpression of wild-type Roquin-1. The single mutants K220A, K239A and R260A 
exhibited substantial residual activity, and the double mutant K239A R260A did no 
longer reduce ICOS and Ox40 expression compared to uninfected cells (Figure 39). 
This again highlights how single mutations reduce RNA affinity of the protein and how 
this adds up to a loss of function in the double mutant. Interestingly, the ICOS CDE260 
construct exhibited the strongest regulation in response to Roquin-1 WT. Accordingly, 
the single mutants caused a considerable reduction of ICOS on the cell surface, and 
even expression of the double mutant resulted in a downregulation of ICOS by 40%. 
Hence, reporter genes with different 3’UTRs (ICOS fl and ICOS CDE260) exhibited 
different responsiveness to Roquin-1 overexpression. As a consequence, mutations 
reducing the affinity of the protein-RNA interaction also affect the Roquin-1 mediated 
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post-transcriptional regulation to different degrees. This shows that Roquin proteins are 
able to confer different modes of post-transcriptional regulation. High-affinity target 
sequences like the CDE260 3’UTR experience an on-off regulation, if graded Roquin-1 
expression levels are compared, whereas targets like the Ox40 mRNA are rather subject 
to a modulation of expression. Thus, my findings provide different Roquin-1 mutants 
for functional assays and thereby enable an investigation and comparison of complex 
cis-regulatory RNA elements concerning their affinities and modes of regulation. 
 
5.2.2.3 CDE-like stem-loops as Roquin-1 cis-elements 
Having found that ROQ-Tnf CDE binding is mainly non-sequence-specific prompted us 
to perform a mutational analysis of this RNA stem-loop (Figure 40). Loop mutants with 
only one nucleotide exchange did not show strongly reduced ROQ binding affinity 
(Figure 40B). However, a Pu-Py-Pu sequence instead of Py-Pu-Py in the loop was no 
longer bound by the ROQ domain. This indicated that despite the tolerance for single 
nucleotide changes a certain sequence composition within the loop is required for 
Roquin binding. Different mutations of the stem (SM1-3 and EXT) reduced the ROQ 
binding affinity but did not abolish the protein-RNA interaction (Figure 40C and D). 
Thus, Roquin-1 seems to accept a much greater variety of RNA stem-loops than 
anticipated from the consensus CDE published by Leppek et al., 2013. Based on this 
hypothesis, I identified two CDE-like stem-loops, one in the ICOS 3’UTR and one in 
the Ox40 3’UTR, with considerable deviation from the CDE consensus sequence. As 
expected, both CDE-like stem-loops were bound by the ROQ domain even though with 
strongly reduced affinities (Figure 41).  
Moreover, these CDE-like stem-loops also functioned as cis-elements in Roquin-
mediated post-transcriptional regulation. This was shown in cellular assays monitoring 
the expression of different ICOS and Ox40 reporter constructs in response to acute 
deletion of Roquin-1 and Roquin-2 (Figure 42). In contrast to the functional assay 
using overexpression of Roquin-1 in Rc3h1-2-/- MEFs, the acute deletion system 
enabled us to study the effects of endogenous Roquin amounts. Roquin deletion 
increased the expression of ICOS and Ox40 from full-length mRNA constructs, 
whereas expression from CDS constructs was not altered. Shortening of the 3’UTRs 
selectively removed stem-loop sequences and revealed the contribution of CDE-like 
stem-loops to Roquin-mediated regulation.  
Binding analyses using CDE mutants together with the information from the ROQ-Tnf 
CDE complex structure suggested a broad range of CDE-like RNA stem-loops to be 
accepted by Roquin-1. Even more, the conformation of the protein-RNA contact 
indicated that stem-loop structures with larger loops might be bound as well. In SELEX 
experiments, a hexaloop structure was identified as potential Roquin cis-element 
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(Figure 33) and I found an analog RNA sequence in the Ox40 3’UTR (Figure 43). The 
crystal structure of the ROQ-Ox40 SELEX-like complex revealed that the ROQ domain 
is indeed capable of binding an RNA hexaloop through an enlarged protein-loop 
interface compared to the Tnf CDE binding (data not shown). Furthermore, in shift 
assays I observed binding of two SELEX patterns and of the Ox40 SELEX-like stem 
loop, which was abolished using the double-mutant K239A/R260A ROQ domain 
(Figure 31 and 44).  
Taken together, the crystal structures provided an insight into Roquin-RNA interaction 
that revealed binding to be achieved mainly via non-sequence-specific contacts 
recognizing the stem-loop fold throughout the protein-RNA interface. Mutational 
analyses of protein and RNA as well as functional assays further underlined that 
Roquin-RNA recognition accepts a broad range of affinities resulting in gradual post-
transcriptional regulation of target mRNAs. 
 
5.3 The inducible costimulator Ox40 is a target of Roquin 
5.3.1 Ox40 is specifically bound and regulated by Roquin 
Ox40 was 2-fold upregulated in the microarray analyses of Th1 cells after acute deletion 
of Rc3h1-2 and showed a similar regulation on the Icos-/- background. As a member of 
the Tnf receptor super family (Tnfrsf), Ox40 is induced on the cell surface in response 
to T cell activation and serves as a costimulator to promote cytokine expression as well 
as T cell proliferation and memory formation (Croft 2010). Moreover, excessive Ox40 
signaling was associated with different autoimmune diseases and impaired peripheral 
tolerance (Bansal-Pakala et al. 2001; Murata et al. 2002). Thus, Ox40 shares a lot of 
characteristics with the costimulatory receptor Icos, which was the first Roquin target 
being described (Yu et al. 2007; Athanasopoulos et al. 2010; Glasmacher et al. 2010). 
To prove that Roquin directly and specifically binds the Ox40 mRNA and that binding 
results in changes of Ox40 protein expression, different experiments were applied. 
Ox40 levels on CD4+ T cells from Rc3h1-2fl/fl; CD4 Cre and wild-type mice were 
investigated by flow cytometry (Figure 15A). Indeed, CD4+ T cells lacking Roquin-1 
and Roquin-2 had higher Ox40 levels in the naïve (Figure 15A, left) and more 
prominently in the effector-like (Figure 15A, right) compartment. Ox40 expression on 
naïve cells was particularly striking, since it is only induced upon activation in wild-
type T cells (Mallett et al. 1990; al-Shamkhani et al. 1996). In MEFs, Ox40 regulation 
was directly connected to Roquin-1 activity. Upon induced expression of Roquin-1, 
Ox40 expression from a full-length construct was strongly downregulated (Figure 15B, 
right), whereas the Ox40 CDS construct lacking the 3’UTR only showed a minimal 
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response (Figure 15B, left). Thus, Roquin-1 regulates Ox40 protein expression levels in 
the presence of the Ox40 3’UTR, suggesting that it targets this part of the Ox40 mRNA. 
In vitro binding assays were performed to prove the direct interaction of Roquin with 
the Ox40 mRNA. FBAs with specific and unspecific competitor RNAs thereby 
demonstrated the specificity of Roquin binding to the Ox40 3’UTR. In view of the fact 
that Roquin-1 overexpression also slightly reduced Ox40 expression from a Ox40 CDS 
construct (Figure 15B, left), Roquin might also functionally target the Ox40 CDS to a 
certain extend. This was supported by finding a cluster of clipped sequences mapping to 
the Ox40 CDS in our CLIP and PAR-CLIP assays (4.1.4.2). Nevertheless, Roquin 
binding via the Ox40 3’UTR resulted in a more prominent regulation of Ox40 protein 
levels (Figure 15B, right). Taken together, my experiments showed that the Ox40 
mRNA is a direct target of Roquin-mediated post-transcriptional regulation, which was 
published in Vogel et al., 2013. Roquin clearly binds to the Ox40 3’UTR, while the 
CDS might provide further target elements for Roquin-mediated regulation. 
 
5.3.2 Ox40 contribution to the Roquin knockout phenotype in T cells 
Having identified Ox40 as a direct target of Roquin-mediated post-transcriptional gene 
regulation, I aimed at determining its contribution to the phenotype of mice with a T-
cell-specific Roquin-1 and Roquin-2 knockout. To this end, splenocytes of Rc3h1-2fl/fl; 
CD4 Cre mice (termed double knockout mice) and Ox40-/-; Rc3h1-2fl/fl; CD4 Cre mice 
(termed triple knockout mice) were isolated and analyzed. In addition, Ox40-/-; Rc3h1-
2fl/fl mice were analyzed and CD4 Cre or Rc3h1-2fl/fl mice served as controls. 
Macroscopic analyses of the spleens indicated that the lack of Ox40 indeed ameliorates 
the phenotype of the double knockout mice. The number of splenocytes in the triple 
knockout mice showed no increase compared to the control animals, and the spleen 
weight was just slightly higher in triple knockout than in control mice (Figure 16). The 
increased weight in combination with unchanged numbers of splenocytes can possibly 
be explained by an increased number of erythrocytes, since the organs of triple 
knockout mice exhibited a darker red color compared to the other animals (Maekawa et 
al. 2013). 
Flow cytometric investigation of the CD4+ and the CD8+ T cell compartment (Figure 
17 and 18) did not show considerable differences between the double and the triple 
knockout mice, and the same result was obtained from the analysis of Tfh cells and GC 
B cells (Figure 19), SLECs, NK cells and NKT cells (Figure 20C and D). The only 
significant difference was observed for the frequency of peripheral Tregs, which 
increased to 25% in the triple knockout mice. In contrast, in double knockout mice and 
in control mice only about 10% of the CD4+ T cells expressed FoxP3. It was described 
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that Ox40 is important for Treg cell expansion and responsiveness to IL-2, whereas 
development of Ox40-/- Tregs is normal (Xiao et al. 2012). In line with this Ox40-/-; 
Rc3h1-2fl/fl mice had normal levels of peripheral Tregs. However, in the triple knockout 
mice the lack of Ox40 in addition to Roquin-1 and Roquin-2 seemed to increase the 
numbers of peripheral Treg cells either due to increased expansion or survival. It would 
be interesting to determine the suppressive capacity of those peripheral Tregs. 
Moreover, the expression of Roquin targets was determined in the different knockout 
mice. As expected, Icos expression was high in effector-like CD4+ and CD8+ T cells 
lacking Roquin-1 and Roquin-2 (Figure 21A). An additional lack of Ox40 did not 
influence Icos levels. Ctla4 is a further costimulatory receptor identified as potential 
Roquin target in the described microarray analyses (Table 20). Comparable to Icos but 
less prominent, Ctla4 expression is increased in cells that lack Roquin proteins and 
similarly high in triple knockout cells (Figure 21B). 
In summary, abolishing high Ox40 levels in mice with a T-cell-specific deletion of 
Roquin by introduction of Ox40-/- alleles did not rescue any of the prominent 
phenotypes. T cells were equally activated and showed strong Icos expression, and the 
numbers of Tfh cells and GC B cells were increased. This is in line with the microarray 
data showing that Roquin targets various mRNAs. Since many factors that drive T cell 
activation and expansion are highly expressed, the lack of one Roquin target gene is 
likely to only have a minor impact. However, the study can be extended to assays on T 
cell function. Ox40 is an activation-induced costimulator, and it will be interesting to 
see how triple knockout T helper cells respond to T cell activation signals. In vitro 
differentiation experiments (Th1, Th2, Th17 and Tregs) will reveal whether triple 
knockout cells have the same intrinsic preferences as double knockout cells, which 
showed increased Th17 differentiation (Jeltsch et al. 2014). The effect of Ox40 on 
memory formation in the context of the double knockout mice can be investigated by in 
vivo immunization experiments. Recently, it was described that an Ox40 agonistic 
antibody promotes massive infiltration of mononuclear cells into the lung (Xiao et al. 
2012). Moreover, it was shown that Ox40L-transgenic mice develop autoimmune-like 
disease due to constitutive Ox40 ligation. In the lungs from double knockout mice, we 
also observed lymphocyte infiltrates (Jeltsch et al. 2014), suggesting that high levels of 
Ox40 could cause T cell infiltration in these animals. To prove this, the lungs of triple 
knockout mice should be analyzed with respect to lymphocyte infiltrations. 
Taken together, double knockout mice with an additional deletion of Ox40 maintained 
their prominent phenotypic features, suggesting that Ox40 is just one target within a 
whole network of mRNAs regulated by Roquin. Nevertheless, further investigations of 
T cell function and differentiation are likely to identify characteristics of double 
knockout T cells caused by high Ox40 levels. 
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5.3.3 Roquin recognizes two distinct cis-elements in the Ox40 3’UTR 
The data collected in structural analyses, the different binding studies and functional 
assays increased our knowledge on Roquin-mRNA interactions but also pointed out the 
complexity of this regulatory process. The ROQ domain recognized a variety of RNA 
stem-loop structures from CDE triloops to SELEX hexaloops and it remains elusive 
whether and how different cis-elements cooperate in Roquin-mediated regulation. The 
newly identified Roquin target Ox40 has a rather short 3’UTR (∼ 150 nts) with two 
putative stem-loop structures. In addition to the CDE-like stem-loop described in 
4.2.4.2, I found a hexaloop, which closely resembles the SELEX hexaloop regarding 
shape and nucleotide sequence (Figure 43B). A conservation analysis of the Ox40 
3’UTR combining RNA sequence and structure revealed that both stem-loops are highly 
conserved (Figure 43C). Interestingly, the nucleotide sequence within the loop was 
slightly less conserved, indicating that the integrity of the RNA folding was of greater 
importance than the sequence motif. Moreover, conservation of the two stem-loops 
implies an involvement of both structures as functional elements. 
Specific recognition of the Ox40 SELEX-like stem-loop by the ROQ domain was 
shown in binding experiments with RNA-binding-deficient ROQ mutants. Amino acid 
exchanges that reduced binding to the Tnf CDE also affected binding to the Ox40 
SELEX-like element (Figure 44). Together with the crystal structure of the ROQ-Ox40 
SELEX-like complex this underlined that CDE stem-loops and SELEX stem-loops use 
the same interface for binding to Roquin-1. However, compared to the SELEX patterns 
9 and 12, the Ox40 SELEX-like RNA stem-loop has an almost 5-fold higher Kd value 
for Roquin-1 binding. This might be due to the larger sequence context or a potentially 
more stable secondary structure of the SELEX patterns. It might indicate that binding 
sites with lower affinity are favorable in natural 3’UTRs due to a larger flexibility in 
regulatory processes.  
The influence of both RNA structures in the Ox40 3’UTR in Roquin-mediated Ox40 
regulation was tested using mutants, in which one stem-loop or both were abrogated by 
an exchange of the stem forming nucleotides. In EMSA experiments with the complete 
Ox40 3’UTR and recombinant Roquin-1 N-terminus (aa 2-440), two high-affinity band 
shifts were dependent on the presence of two RNA stem-loops (Figure 46). A 
supershift induced by higher protein concentrations was independent from the integrity 
of CDE-like and SELEX-like stem-loop structures. This experiment indicated that the 
presence of two cis-elements provides two high-affinity binding sites for Roquin 
proteins, whereas disruption of either stem-loop resulted in the binding of just one 
Roquin protein. The observed supershift could be caused by an unspecific RNA affinity 
of the Roquin-1 N-terminus at higher concentrations, which has already been observed 
in EMSAs using the complete ICOS CDS (Glasmacher et al. 2010). Also, the Ox40 
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3’UTR could obtain a fold in vitro that allows binding of high concentrations of 
Roquin-1 N-terminal protein. The presence of the CDS and other RBPs involved in 
translation and stabilization of the mRNA might prevent such a folding in cells.  
The responsiveness of Ox40 constructs with different 3’UTR lengths and mutations was 
tested in functional assays using the Roquin-1-inducible Rc3h1-2-/- MEFs (Figure 47). 
The experiment nicely showed that Roquin-mediated Ox40 regulation via the 3’UTR is 
dependent on the presence of the SELEX-like as well as the CDE-like RNA stem-loop. 
Mutations and truncations leaving one stem-loop intact resulted in a partial Roquin-
response. Furthermore, an Ox40 full-length construct without intact cis-elements 
exhibited the same responsiveness to Roquin-1 overexpression as the Ox40 CDS. 
Therefore, Roquin-mediated post-transcriptional regulation of Ox40 can be attributed to 
two distinct RNA stem-loop structures within the Ox40 3’UTR that act as Roquin-1 cis-
elements. Unfortunately, the experiments did not clarify whether both cis-elements have 
the same impact on Roquin-mediated regulation. Binding affinities within the context of 
the complete mRNA, accessibility of the 3’UTR and responsiveness to changing 
amounts of Roquin proteins simultaneously influence the regulatory process. This 
complexity has to be considered in continuative studies. 
 
5.4 Conclusions and perspectives for Roquin-mediated post-
transcriptional gene regulation 
Using the Ox40 mRNA and mutated variants thereof in binding analyses and functional 
assays, I was able to show that Roquin-1 binds two independent and entirely different 
RNA stem-loops as functional cis-elements within one 3’UTR. This was possible due to 
the low complexity of the short Ox40 3’UTR, comprising only 150 nts. Investigating 
Roquin-mediated regulation via large 3’UTRs such as the ICOS 3’UTR (2 kb), which 
might harbor several Roquin-responsive elements, will be even more challenging. Every 
artificial alteration of the 3’UTR sequence by truncations or nucleotide exchanges could 
bring about changes in the folding and stability of RNA structures. This could in turn 
change binding of trans-acting factors and post-transcriptional regulation, even though 
the nucleotides forming the cis-element are still present. For many target mRNAs, these 
circumstances complicate the analysis of single regulatory elements within their natural 
context, which is required to obtain a clear picture of Roquin-mediated regulation. 
Therefore, experiments screening 3’UTRs for Roquin cis-elements and subsequently 
testing their functional impact have to be designed with great accuracy. Using different 
approaches that complement each other, like 3’UTR truncation, scanning and 
mutational analyses, will help to obtain reliable results. 
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In line with this, the extent of physiologic regulation by Roquin also depends on the 
accessibility of target 3’UTRs in terms of protein occupation and RNA structure. If an 
RNA stem-loop cannot fold due to steric hindrance, it will not serve as Roquin cis-
element. Moreover, 3’UTR shortening, as it broadly occurs upon cell activation 
(Sandberg et al. 2008), could abolish Roquin-responsive RNA elements and thus reduce 
Roquin-mediated repression of target mRNAs. Also, the interplay of different cis-
elements recruiting trans-acting factors within one 3’UTR has to be considered. Post-
transcriptional regulation of Tnf has mainly been attributed to the presence of an ARE in 
its 3’UTR (Anderson 2000). Yet, ARE-independent regulation also takes place via the 
CDE, forming a stem-loop structure that is targeted by Roquin-1 (Stoecklin et al. 2003; 
Leppek et al. 2013). Currently, it is unclear how these two mechanisms interfere with 
each other or whether they regulate Tnf expression at different stages of cell activation 
or differentiation. Similarly, all kinds of trans-acting factors such as RBPs, miRNAs 
and other non-coding RNAs act together on 3’UTRs to control protein expression. This 
also provides a basis for differential regulation of various Roquin targets within one cell 
at the same time. Unraveling these regulatory networks is essential to understand the 
impact of Roquin for post-transcriptional gene regulation. 
Furthermore, 3’UTRs with more than one Roquin cis-element could serve as platforms 
for Roquin binding and thereby be sensors for varying Roquin amounts. On the one 
hand, Roquin expression is regulated on the transcriptional level. A recent publication 
shows that Roquin levels increase upon IL-10 treatment in murine EL4 T cells 
(Schaefer et al. 2014). This is due to an IL-10-mediated induction of the transcription 
factors STAT1, STAT3, GATA2 and c-Rel, which bind to the Roquin-1 promoter 
region and drive Roquin-1 transcription. Interestingly, our own observations show that 
c-Rel levels are increased in Th1 cells upon acute deletion of Roquin and that the c-Rel 
3’UTR is targeted by Roquin-1 (Jeltsch et al. 2014). This indicates that Roquin-1 
directly targets c-Rel and thereby reduces its own expression via a negative feedback 
loop. On the other hand, Roquin levels are regulated by degradation of Roquin proteins 
upon T cell activation (Figure 10B). Recently, our group identified the Roquin 
fragments to be derived from site-specific cleavage by the paracaspase Malt1 (Jeltsch et 
al. 2014). T cell receptor stimulation in combination with costimulatory signals 
promotes Malt1-mediated cleavage of Roquin proteins, which results in the deregulation 
of Roquin targets. The most prominent Malt1 cleavage product of Roquin-1 comprises 
aa 1-510 and contains the RNA-binding ROQ domain (Jeltsch et al. 2014; Schlundt et 
al. 2014). However, it is not clear whether binding to target mRNAs takes place in T 
cells. Lacking the C-terminus, the protein fragment does not confer post-transcriptional 
regulation (Glasmacher et al. 2010; Jeltsch et al. 2014) and thus enables expression of 
Roquin targets. In this context, target mRNAs with less or lower-affinity cis-elements 
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would respond faster to reduced Roquin levels, whereas mRNAs with more or higher-
affinity cis-elements could still be repressed by low Roquin amounts (see Figure 48).  
 
 
 
Figure 48: Model of Roquin-mediated post-transcriptional regulation targeting different 3’UTRs. 
Upper half: High Roquin levels lead to comparable repression of targets with high- and low-affinity cis-
elements. Lower half: Reduced Roquin levels release targets with low-affinity cis-elements or little 
responsiveness from repression, whereas expression of targets with high-affinity binding sites and strong 
responsiveness remains suppressed. 
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Further validating the stability and function of Roquin cleavage products is necessary to 
fully understand the impact of Malt1 cleavage. Also, investigating transcriptional 
regulation of Roquin should be continued to get a more comprehensive picture of tissue- 
and differentiation-stage-specific processes. Furthermore, it remains elusive how 
Roquin is regulated on the post-transcriptional level. There is evidence that Roquin 
binds to its own 3’UTR via a CDE stem-loop (Leppek et al. 2013), but experimental 
confirmation is lacking. Currently, tightly regulated transcription, translation and 
cleavage in combination with negative feedback loops seem to coordinate a balanced 
expression of Roquin proteins in T cells (see Figure 49). This would be beneficial to 
prevent inappropriate T cell activation and autoimmunity and at the same time to allow 
fast and effective T cell responses upon pathogen encounter. 
On the molecular level, my data suggest mRNA binding by Roquin to be less stringent 
than expected. Thus, the question arises how specificity is achieved in Roquin-mediated 
post-transcriptional regulation. An obvious assumption is that Roquin-1 interacts with 
other proteins to confer regulation of translation or mRNA decay. The availability of 
different co-factors would add to the selectivity of Roquin-mediated regulation 
concerning target mRNAs as well as cell types or differentiation stages. The regulatory 
RNase Regnase-1, encoded by Zc3h12a, post-transcriptionally regulates a similar set of 
mRNAs like Roquin (Uehata et al. 2013; Jeltsch et al. 2014). Moreover, the phenotype 
of Zc3h12a-/- mice closely resembles that observed in Rc3h1-2fl/fl; CD4 Cre mice 
(Matsushita et al. 2009; Uehata et al. 2013). Together with our recently published data 
on cooperation of Roquin-1 and Regnase-1 in post-transcriptional regulation (Jeltsch et 
al. 2014), these observations suggest that Regnase-1 is a co-factor of Roquin proteins. 
In addition, the Zc3h12a mRNA is also a target candidate in the microarray analyses 
(Table 20), suggesting another negative feedback loop of Roquin.  
Integrating the different mechanisms regulating Roquin levels, the interplay with co-
factors and other trans-acting factors and the abundance of Roquin-targeted mRNAs 
with complex 3’UTRs will be the big challenge in continuative studies. Single aspects 
need to be addressed separately to collect the basic pieces of information, as shown in 
this study for the identification of mRNAs targeted by Roquin. However, only linking 
the various regulatory levels and pathways influencing each other will deepen the 
understanding of post-transcriptional gene regulation in general. Thereby, the study of 
Roquin offers a great chance to refine the picture of post-transcriptional mechanisms in 
T cells necessary to maintain self-tolerance and fast responsiveness. 
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Figure 49: Model of Roquin function in T cells. Roquin binds to stem-loop structures within the 3’UTR 
of its target mRNAs and thereby reduces protein expression levels. This interaction and subsequent 
regulation depend on the accessibility of cis-elements and the availability of co-factors. Roquin itself is 
regulated on the transcriptional level as indicated in the nucleus of the T cell (green). Furthermore, upon 
T cell activation by antigen presenting cells (blue) the paracaspase Malt1 is activated and specifically 
cleaves Roquin, which releases target mRNAs like Icos and Ox40 from Roquin-mediated post-
transcriptional repression. 
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Appendices 
 
Appendix I: Position of Roquin-1 SELEX-enriched hexamers within the random 
RNA sequence. 
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Appendix II: Shift assays using different concentrations of mutant versions of the 
ROQ domain (aa 147-326) binding to the 32P-labeled Tnf CDE stem-loop RNA. 
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Appendix III: Overview table of all ROQ mutants tested in binding assays with the 
Tnf CDE. Information about the RNA contacts of the respective amino acid 
residue is derived from the crystal structure of the ROQ-Tnf CDE complex. 
Dissociation constants (Kd values) were calculated by curve fitting and are given ±  
standard error. 
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Appendix IV: Titration of amphotropic retrovirus supernatants to achieve 
comparable infection levels (proportion of Thy1.1+ cells) and thus comparable 
expression of Roquin-1 proteins. Different volumes of virus supernatants (right 
side) were complemented with medium to use identical infection volumes during 
spin infection. For final experiments a volume was used that resulted in about 50% 
infection in the titration experiment. 
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Appendix V: Ox40 3’UTR, truncations and mutations abrogating putative stem- 
loop structures (SELEX-like stem-loop: green, CDE-like stem-loop: red).  
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